
<html lang="en"     class="pb-page"  data-request-id="1bce3a5f-ee1d-412f-8ec8-2c53a01b5f0a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01641;issue:issue:10.1021/jmcmar.2018.61.issue-6;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)" /></meta><meta name="dc.Creator" content="David J.  Edmonds" /></meta><meta name="dc.Creator" content="Daniel W.  Kung" /></meta><meta name="dc.Creator" content="Amit S.  Kalgutkar" /></meta><meta name="dc.Creator" content="Kevin J.  Filipski" /></meta><meta name="dc.Creator" content="David C.  Ebner" /></meta><meta name="dc.Creator" content="Shawn  Cabral" /></meta><meta name="dc.Creator" content="Aaron C.  Smith" /></meta><meta name="dc.Creator" content="Gary E.  Aspnes" /></meta><meta name="dc.Creator" content="Samit K.  Bhattacharya" /></meta><meta name="dc.Creator" content="Kris A.  Borzilleri" /></meta><meta name="dc.Creator" content="Janice A.  Brown" /></meta><meta name="dc.Creator" content="Matthew F.  Calabrese" /></meta><meta name="dc.Creator" content="Nicole L.  Caspers" /></meta><meta name="dc.Creator" content="Emily C.  Cokorinos" /></meta><meta name="dc.Creator" content="Edward L.  Conn" /></meta><meta name="dc.Creator" content="Matthew S.  Dowling" /></meta><meta name="dc.Creator" content="Heather  Eng" /></meta><meta name="dc.Creator" content="Bo  Feng" /></meta><meta name="dc.Creator" content="Dilinie P.  Fernando" /></meta><meta name="dc.Creator" content="Nathan E.  Genung" /></meta><meta name="dc.Creator" content="Michael  Herr" /></meta><meta name="dc.Creator" content="Ravi G.  Kurumbail" /></meta><meta name="dc.Creator" content="Sophie Y.  Lavergne" /></meta><meta name="dc.Creator" content="Esther C.-Y.  Lee" /></meta><meta name="dc.Creator" content="Qifang  Li" /></meta><meta name="dc.Creator" content="Sumathy  Mathialagan" /></meta><meta name="dc.Creator" content="Russell A.  Miller" /></meta><meta name="dc.Creator" content="Jane  Panteleev" /></meta><meta name="dc.Creator" content="Jana  Polivkova" /></meta><meta name="dc.Creator" content="Francis  Rajamohan" /></meta><meta name="dc.Creator" content="Allan R.  Reyes" /></meta><meta name="dc.Creator" content="Christopher T.  Salatto" /></meta><meta name="dc.Creator" content="Andre  Shavnya" /></meta><meta name="dc.Creator" content="Benjamin A.  Thuma" /></meta><meta name="dc.Creator" content="Meihua  Tu" /></meta><meta name="dc.Creator" content="Jessica  Ward" /></meta><meta name="dc.Creator" content="Jane M.  Withka" /></meta><meta name="dc.Creator" content="Jun  Xiao" /></meta><meta name="dc.Creator" content="Kimberly O.  Cameron" /></meta><meta name="dc.Description" content="Optimization of the pharmacokinetic (PK) properties of a series of activators of adenosine monophosphate-activated protein kinase (AMPK) is described. Derivatives of the previously described 5-aryl..." /></meta><meta name="Description" content="Optimization of the pharmacokinetic (PK) properties of a series of activators of adenosine monophosphate-activated protein kinase (AMPK) is described. Derivatives of the previously described 5-aryl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01641" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01641" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01641" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01641" /></link>
        
    
    

<title>Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01641" /></meta><meta property="og:title" content="Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0009.jpeg" /></meta><meta property="og:description" content="Optimization of the pharmacokinetic (PK) properties of a series of activators of adenosine monophosphate-activated protein kinase (AMPK) is described. Derivatives of the previously described 5-aryl-indole-3-carboxylic acid clinical candidate (1) were examined with the goal of reducing glucuronidation rate and minimizing renal excretion. Compounds 10 (PF-06679142) and 14 (PF-06685249) exhibited robust activation of AMPK in rat kidneys as well as desirable oral absorption, low plasma clearance, and negligible renal clearance in preclinical species. A correlation of in vivo renal clearance in rats with in vitro uptake by human and rat renal organic anion transporters (human OAT/rat Oat) was identified. Variation of polar functional groups was critical to mitigate active renal clearance mediated by the Oat3 transporter. Modification of either the 6-chloroindole core to a 4,6-difluoroindole or the 5-phenyl substituent to a substituted 5-(3-pyridyl) group provided improved metabolic stability while minimizing propensity for active transport by OAT3." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01641"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01641">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01641&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01641&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01641&amp;href=/doi/10.1021/acs.jmedchem.7b01641" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2372-2383</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01612" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01647" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">David J. Edmonds</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Edmonds</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For D.J.E.: phone, (617) 441-3263; E-mail, <a href="/cdn-cgi/l/email-protection#793d180f101d573c1d1416171d0a39091f10031c0b571a1614"><span class="__cf_email__" data-cfemail="b1f5d0c7d8d59ff4d5dcdedfd5c2f1c1d7d8cbd4c39fd2dedc">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Edmonds">David J. Edmonds</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9234-8618" title="Orcid link">http://orcid.org/0000-0001-9234-8618</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel W. Kung</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel W. Kung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For D.W.K.: E-mail, <a href="/cdn-cgi/l/email-protection#e4a0858a8d8188cab3caaf918a83a494828d9e8196ca878b89"><span class="__cf_email__" data-cfemail="90d4f1fef9f5fcbec7bedbe5fef7d0e0f6f9eaf5e2bef3fffd">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+W.++Kung">Daniel W. Kung</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5019-1939" title="Orcid link">http://orcid.org/0000-0002-5019-1939</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amit S. Kalgutkar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit S. Kalgutkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+S.++Kalgutkar">Amit S. Kalgutkar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin J. Filipski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin J. Filipski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Filipski">Kevin J. Filipski</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0845-5723" title="Orcid link">http://orcid.org/0000-0003-0845-5723</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David C. Ebner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David C. Ebner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Ebner">David C. Ebner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shawn Cabral</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shawn Cabral</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shawn++Cabral">Shawn Cabral</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aaron C. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aaron C. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aaron+C.++Smith">Aaron C. Smith</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6796-5155" title="Orcid link">http://orcid.org/0000-0001-6796-5155</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary E. Aspnes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary E. Aspnes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary+E.++Aspnes">Gary E. Aspnes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samit K. Bhattacharya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samit K. Bhattacharya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samit+K.++Bhattacharya">Samit K. Bhattacharya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kris A. Borzilleri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kris A. Borzilleri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kris+A.++Borzilleri">Kris A. Borzilleri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janice A. Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janice A. Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janice+A.++Brown">Janice A. Brown</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew F. Calabrese</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew F. Calabrese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+F.++Calabrese">Matthew F. Calabrese</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicole L. Caspers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicole L. Caspers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicole+L.++Caspers">Nicole L. Caspers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emily C. Cokorinos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emily C. Cokorinos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emily+C.++Cokorinos">Emily C. Cokorinos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edward L. Conn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward L. Conn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward+L.++Conn">Edward L. Conn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew S. Dowling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew S. Dowling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+S.++Dowling">Matthew S. Dowling</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heather Eng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather Eng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Eng">Heather Eng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bo Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bo Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bo++Feng">Bo Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dilinie P. Fernando</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dilinie P. Fernando</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dilinie+P.++Fernando">Dilinie P. Fernando</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nathan E. Genung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathan E. Genung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathan+E.++Genung">Nathan E. Genung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Herr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Herr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Herr">Michael Herr</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ravi G. Kurumbail</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravi G. Kurumbail</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravi+G.++Kurumbail">Ravi G. Kurumbail</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sophie Y. Lavergne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sophie Y. Lavergne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sophie+Y.++Lavergne">Sophie Y. Lavergne</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Esther C.-Y. Lee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Esther C.-Y. Lee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Esther+C.-Y.++Lee">Esther C.-Y. Lee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qifang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qifang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qifang++Li">Qifang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sumathy Mathialagan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sumathy Mathialagan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sumathy++Mathialagan">Sumathy Mathialagan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Russell A. Miller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Russell A. Miller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Russell+A.++Miller">Russell A. Miller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jane Panteleev</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane Panteleev</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Panteleev">Jane Panteleev</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jana Polivkova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jana Polivkova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Polivkova">Jana Polivkova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francis Rajamohan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francis Rajamohan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francis++Rajamohan">Francis Rajamohan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Allan R. Reyes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allan R. Reyes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allan+R.++Reyes">Allan R. Reyes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher T. Salatto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher T. Salatto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+T.++Salatto">Christopher T. Salatto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andre Shavnya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andre Shavnya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andre++Shavnya">Andre Shavnya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin A. Thuma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin A. Thuma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin+A.++Thuma">Benjamin A. Thuma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Meihua Tu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Meihua Tu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Meihua++Tu">Meihua Tu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jessica Ward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jessica Ward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Ward">Jessica Ward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jane M. Withka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane M. Withka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane+M.++Withka">Jane M. Withka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Xiao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Xiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Xiao">Jun Xiao</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kimberly O. Cameron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly O. Cameron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+O.++Cameron">Kimberly O. Cameron</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01641&amp;href=/doi/10.1021%2Facs.jmedchem.7b01641" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2372–2383</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 November 2017</li><li><span class="item_label"><b>Published</b> online</span>21 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 March 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01641" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01641</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2372%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%2BJ.%2BEdmonds%252C%2BDaniel%2BW.%2BKung%252C%2BAmit%2BS.%2BKalgutkar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D6%26contentID%3Dacs.jmedchem.7b01641%26title%3DOptimization%2Bof%2BMetabolic%2Band%2BRenal%2BClearance%2Bin%2Ba%2BSeries%2Bof%2BIndole%2BAcid%2BDirect%2BActivators%2Bof%2B5%25E2%2580%25B2-Adenosine%2BMonophosphate-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2383%26publicationDate%3DMarch%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01641"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2952</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01641" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Edmonds&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;W. Kung&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;S. Kalgutkar&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Filipski&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Ebner&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;Cabral&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;C. Smith&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;E. Aspnes&quot;},{&quot;first_name&quot;:&quot;Samit&quot;,&quot;last_name&quot;:&quot;K. Bhattacharya&quot;},{&quot;first_name&quot;:&quot;Kris&quot;,&quot;last_name&quot;:&quot;A. Borzilleri&quot;},{&quot;first_name&quot;:&quot;Janice&quot;,&quot;last_name&quot;:&quot;A. Brown&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;F. Calabrese&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;L. Caspers&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;C. Cokorinos&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;L. Conn&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;S. Dowling&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Eng&quot;},{&quot;first_name&quot;:&quot;Bo&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Dilinie&quot;,&quot;last_name&quot;:&quot;P. Fernando&quot;},{&quot;first_name&quot;:&quot;Nathan&quot;,&quot;last_name&quot;:&quot;E. Genung&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Herr&quot;},{&quot;first_name&quot;:&quot;Ravi&quot;,&quot;last_name&quot;:&quot;G. Kurumbail&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Y. Lavergne&quot;},{&quot;first_name&quot;:&quot;Esther&quot;,&quot;last_name&quot;:&quot;C.-Y. Lee&quot;},{&quot;first_name&quot;:&quot;Qifang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Sumathy&quot;,&quot;last_name&quot;:&quot;Mathialagan&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;A. Miller&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Panteleev&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Polivkova&quot;},{&quot;first_name&quot;:&quot;Francis&quot;,&quot;last_name&quot;:&quot;Rajamohan&quot;},{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;R. Reyes&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;T. Salatto&quot;},{&quot;first_name&quot;:&quot;Andre&quot;,&quot;last_name&quot;:&quot;Shavnya&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;A. Thuma&quot;},{&quot;first_name&quot;:&quot;Meihua&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Ward&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;M. Withka&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;O. Cameron&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2372-2383&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01641&quot;},&quot;abstract&quot;:&quot;Optimization of the pharmacokinetic (PK) properties of a series of activators of adenosine monophosphate-activated protein kinase (AMPK) is described. Derivatives of the previously described 5-aryl-indole-3-carboxylic acid clinical candidate (1) were examined with the goal of reducing glucuronidation rate and minimizing renal excretion. Compounds 10 (PF-06679142) and 14 (PF-06685249) exhibited robust activation of AMPK in rat kidneys as well as desirable oral absorption, low plasma clearance, and negligible renal clearance in preclinical species. A correlation of in vivo renal clearance in rats with in vitro uptake by human and rat renal organic anion transporters (human OAT/rat Oat) was identified. Variation of polar functional groups was critical to mitigate active renal clearance mediated by the Oat3 transporter. Modification of either the 6-chloroindole core to a 4,6-difluoroindole or the 5-phenyl substituent to a substituted 5-(3-pyridyl) group provided improved metabolic stability while minimizing prope&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01641&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01641" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01641&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01641" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01641&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01641" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01641&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01641&amp;href=/doi/10.1021/acs.jmedchem.7b01641" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01641" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01641" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01641%26sid%3Dliteratum%253Aachs%26pmid%3D29466005%26genre%3Darticle%26aulast%3DEdmonds%26date%3D2018%26atitle%3DOptimization%2Bof%2BMetabolic%2Band%2BRenal%2BClearance%2Bin%2Ba%2BSeries%2Bof%2BIndole%2BAcid%2BDirect%2BActivators%2Bof%2B5%25E2%2580%25B2-Adenosine%2BMonophosphate-Activated%2BProtein%2BKinase%2B%2528AMPK%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D6%26spage%3D2372%26epage%3D2383%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/jmcmar.2018.61.issue-6/20180322/jmcmar.2018.61.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Optimization of the pharmacokinetic (PK) properties of a series of activators of adenosine monophosphate-activated protein kinase (AMPK) is described. Derivatives of the previously described 5-aryl-indole-3-carboxylic acid clinical candidate (<b>1</b>) were examined with the goal of reducing glucuronidation rate and minimizing renal excretion. Compounds <b>10</b> (PF-06679142) and <b>14</b> (PF-06685249) exhibited robust activation of AMPK in rat kidneys as well as desirable oral absorption, low plasma clearance, and negligible renal clearance in preclinical species. A correlation of in vivo renal clearance in rats with in vitro uptake by human and rat renal organic anion transporters (human OAT/rat Oat) was identified. Variation of polar functional groups was critical to mitigate active renal clearance mediated by the Oat3 transporter. Modification of either the 6-chloroindole core to a 4,6-difluoroindole or the 5-phenyl substituent to a substituted 5-(3-pyridyl) group provided improved metabolic stability while minimizing propensity for active transport by OAT3.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Diabetic nephropathy (DN), the chronic impairment of renal function resulting from metabolic dysregulation, is a leading cause of end-stage renal disease, and patients with type II diabetes mellitus (T2DM) have a 6-fold increased risk of developing chronic kidney disease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The progression of DN is not well understood but involves impairment of glomerular filtration and dysfunction of renal tubule capillaries. The key hallmarks of T2DM, such as hyperglycemia, hyperinsulinemia, and hyperlipidemia, impair both aspects of kidney function. As the disease progresses, glomerular hyperfiltration leads to loss of filtration integrity and excess secretion of urinary protein (albuminuria). Ultimately, inflammation and fibrosis lead to reduced glomerular filtration rate (GFR) and end-stage renal disease requiring dialysis.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Despite the increasing prevalence of diabetes and its complications, there is no treatment approved specifically for DN. Rather, treatment relies on managing hypertension with angiotensin converting enzyme inhibitors or angiotensin receptor antagonists in addition to standard antidiabetic therapy to manage hyperglycemia.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As such, a novel therapeutic approach to DN would address a considerable unmet medical need.</div><div class="NLM_p">Adenosine monophosphate-activated protein kinase (AMPK) is a serine/threonine kinase that senses and regulates cellular energy levels. AMPK is a heterotrimeric complex consisting of a kinase domain-containing α-subunit and two regulatory subunits (β- and γ-). The seven known AMPK subunits (α1, α2, β1, β2, γ1, γ2, γ3) have differential expression profiles in tissues and can theoretically generate 12 possible trimeric isoforms.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> AMPK is regulated by upstream kinases by phosphorylation of Thr174 (Thr172 on α2) on the activation loop of its α-subunit, leading to a 500–1000-fold increase in activity. Rising cellular AMP and ADP levels during periods of energetic stress activate AMPK by binding to nucleotide binding sites on the γ-subunit and promoting phosphorylation of Thr174. In addition, the binding of AMP to the phospho-Thr174 form of AMPK (pAMPK) serves to increase cellular levels of activated AMPK by protecting the protein from dephosphorylation by phosphatases. Finally, a further 2–3-fold allosteric activation of the protein kinase activity of AMPK results from binding of AMP.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Other reported<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> small molecule activators of AMPK activity include AICAR (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which is phosphorylated in vivo to form the AMP-mimetic ZMP, and metformin, which does not bind to the protein but works indirectly by increasing intracellular AMP.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The first non-nucleotide direct activators were disclosed by Abbott Laboratories and come from a series of thienopyridines, exemplified by A-769662.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> More recently, Metabasis and Merck have disclosed both phosphate<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and nonphosphate-containing activators,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> including pan-AMPK activator MK-8722.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> AMPK activity is reduced in diseases of caloric excess, and pAMPK levels have been found to be reduced in the glomeruli of diabetic patients as compared to healthy subjects.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Rodent models of DN also exhibit reduced pAMPK levels. Chronic AMPK activation with AICAR or metformin has been shown to restore pAMPK levels and to improve kidney function in rodent kidney disease models.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16−18)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected AMPK activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We recently reported the identification of an indole-3-carboxylic acid containing clinical candidate PF-06409577 (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) for the treatment of diabetic nephropathy.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compound <b>1</b> is a selective activator of β1-containing AMPK isoforms that allosterically activates the enzyme by binding at the previously described “allosteric drug and metabolite” (ADaM) site at the interface of the α- and β-subunits.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> The carboxylic acid, the indole N–H, and the cyclobutanol form hydrogen bonds to protein atoms from the α1 and β1 subunits.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of <b>1</b> (A) and a view of the co-crystal structure of <b>1</b> with α1β1γ1-AMPK (B). Compound <b>1</b> (pink ball-and-stick) is bound in the ADaM site at the interface of the α1 and β1 subunits (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a>.pdb). Some of the key hydrogen bond interactions formed by the ligand are highlighted.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From an absorption, distribution, metabolism, and excretion (ADME) perspective, compound <b>1</b> is expected to be cleared in humans via a combination of phase II metabolism and renal excretion as an unchanged parent. Metabolism studies in cryopreserved hepatocytes from animals and human indicated that the principal metabolic fate of <b>1</b> was its conversion to an acyl glucuronide conjugate by uridine glucuronosyl transferase (UGT) isoforms.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">In addition to glucuronidation, renal excretion of unchanged <b>1</b> was observed in intravenous (iv) PK studies in rat, dog, and monkey.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The unbound renal clearance (CL<sub>renal,u</sub>) estimates in animals significantly exceeded the glomerular filtration rate (GFR) in these species (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), indicating an active renal elimination process possibly mediated by organic anion transporter (OAT) proteins expressed at the basolateral membrane of proximal tubules.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> Consistent with this hypothesis, subsequent in vitro transporter studies indicated that compound <b>1</b> was a substrate for both human OAT3 (SLC22A8) and rat Oat3 with net fold uptake values of 4.7 ± 0.1 and 8.3 ± 0.2, respectively (vide infra). However, <b>1</b> was not a substrate for the related human OAT1 (SLC22A6) transporter, which has been reported to exhibit some overlapping substrate specificity with human OAT3.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Given the potential for impaired renal function in the target DN patient population,<a onclick="showRef(event, 'ref2 ref26'); return false;" href="javascript:void(0);" class="ref ref2 ref26">(2,26)</a> including the possibility of impaired transporter function,<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a> we sought to minimize CL<sub>renal</sub> in a potential therapeutic agent targeted to treat DN. Described herein is the characterization and optimization of analogues of <b>1</b>, which achieve an overall decrease in plasma clearance resulting from reduction of both metabolic and renal clearance.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CL<sub>renal</sub> of Unchanged <b>1</b> after iv Administration to Preclinical Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">renal excretion (% of total dose)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">total CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">total CL<sub>renal</sub> (mL/min/kg)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>renal,u</sub> (mL/min/kg)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>renal,u</sub>/GFR ratio<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">15.9</td><td class="colsep0 rowsep0" align="char" char=".">22.6</td><td class="colsep0 rowsep0" align="char" char=".">7.64</td><td class="colsep0 rowsep0" align="char" char=".">849</td><td class="colsep0 rowsep0" align="char" char=".">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td><td class="colsep0 rowsep0" align="char" char=".">12.9</td><td class="colsep0 rowsep0" align="char" char=".">2.82</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">20.6</td><td class="colsep0 rowsep0" align="char" char=".">8.57</td><td class="colsep0 rowsep0" align="char" char=".">2.48</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Percentage of <b>1</b> recovered unchanged in urine over 24 h following a 1 mg/kg iv dose in male Wistar–Han rats and cynomolgus monkeys or 0.5 mg/kg in male beagle dogs. Compound <b>1</b> was formulated in 12% sulfobutylether-β-cyclodextrin solution (rats and monkeys) or 10% <i>N</i>-methyl-2-pyrrolidone: 90% of 30% sulfobutylether-β-cyclodextrin solution in water (dogs).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Total CL<sub>renal</sub> in blood was estimated by multiplying the total blood clearance (CL<sub>b</sub>) by the fraction of total iv dose of unchanged <b>1</b> excreted in urine. CL<sub>b</sub> was obtained by dividing the observed CL<sub>p</sub> by the blood to plasma ratio (B:P) of <b>1</b> in the individual animal species (rat B:P = 0.470, dog B:P = 0.538, monkey B:P = 0.710).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">CL<sub>renal,u</sub> in blood was estimated by dividing total CL<sub>renal</sub> by the unbound free fraction in blood (rat = 0.009, dog = 0.052, monkey = 0.045), which in turn was obtained by dividing the unbound plasma free fraction by B:P. The unbound fractions of <b>1</b> in rat, dog, and monkey plasma were 0.0044, 0.028, and 0.032, respectively.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">GFR values in rats, dogs, and monkeys are 8.7, 4.0, and 2.0 mL/min/kg, respectively.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></div></div></div><div id="sec1-1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">In Vitro Pharmacology and ADME Assays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Functional potency of AMPK activators was evaluated using a time-resolved fluorescence resonance energy transfer (TR-FRET) activation/protection assay, which incorporates a protein phosphatase 2a treatment prior to initiation of the kinase reaction.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Because phosphorylation of Thr174 is required for AMPK kinase activity, this assay is capable of detecting compounds that activate through allosteric activation or through protection of pAMPK from dephosphorylation. All data were normalized relative to the endogenous ligand AMP, which is known to increase AMPK activity via both mechanisms mentioned above. The human α1β1γ1-AMPK isoform, which is the predominant isoform expressed in the kidney,<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31−33)</a> was evaluated initially, and the same assay format was used to assess the isoform selectivity of key compounds (human α1β2γ1, human α2β1γ1, human α2β2γ1, and human α2β2γ3). The binding affinity of test compounds for α1β1γ1-AMPK was assessed using surface plasmon resonance (SPR) experiments (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Passive permeability (<i>P</i><sub>app</sub>) was measured in the Ralph Russ canine kidney (RRCK) assay,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> log <i>D</i> was determined at pH 7.4 using the shake-flask method,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and p<i>K</i><sub>a</sub> values were determined by electrophoresis,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> all as described previously.</div><div class="NLM_p">Human OAT/rat Oat transporter substrate properties of the test compounds were assessed using a differential uptake format in HEK293 cells transfected with the relevant transporter,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> details of which are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Supporting Information</a>. The net OAT-mediated uptake ratio was calculated as the total uptake in OAT-expressing cells divided by the uptake observed in vector-treated control cells. In this experimental setup, a normalized fold uptake of >2.0 was interpreted to indicate that the test compound is likely to be an OAT substrate in vitro.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">Since glucuronidation was identified as the major metabolic pathway of compound <b>1</b>, cryopreserved human hepatocytes were employed as the primary screening assay for measurement of in vitro hepatic intrinsic clearance (CL<sub>int</sub>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Hepatic CL<sub>int</sub> refers to metabolic clearance of the test compounds by the liver and is obtained via scaling of in vitro half-lives of the test compounds following incubation with cryopreserved human hepatocytes. Plasma clearance (CL<sub>p</sub>) in rats and monkeys was calculated as the iv dose divided by the area under the plasma concentration versus time curve from zero to infinity (AUC<sub>0–∞</sub>). Blood clearance (CL<sub>b</sub>) was estimated by dividing the CL<sub>p</sub> by the measured blood to plasma ratio (B:P) of the test compounds. Total renal clearance (CL<sub>renal</sub>), the rate at which the compound is cleared through the kidneys, was determined by multiplying the CL<sub>b</sub> by the percentage of the iv dose recovered unchanged in the urine. Unbound renal clearance (CL<sub>renal,u</sub>) in blood was estimated by dividing CL<sub>renal</sub> by the unbound free fraction in blood, which in turn was obtained by dividing the measured unbound plasma free fraction by the blood to plasma ratio.</div></div><div id="sec1-2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Synthesis of Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The reported compounds were synthesized by the routes depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. All compounds share a common substituted 5-aryl- or 5-heteroarylindole-3-carboxylic acid structure. The indole–(hetero)aryl bond was formed by Suzuki reaction, with the boronate and halide functional groups possible on either reacting partner, depending on availability, synthetic accessibility, and reactivity of the necessary starting materials. The 3-carboxy group was introduced to the indole either by formylation followed by oxidation or by esterification and subsequent hydrolysis. The Suzuki coupling and the carboxylation steps could be performed in either order, again depending on reactivity and compatibility of other functional groups.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes to Indole Acid AMPK Activators<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Conditions: (a) ClCHNMe<sub>2</sub>Cl (POCl<sub>3</sub>-DMF), CH<sub>3</sub>CN or DMF; then NaOH, H<sub>2</sub>O; (b) ArB(OH)<sub>2</sub> or ArB(OR)<sub>2</sub> (pinacol or neopentyl glycol boronate), Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, EtOH–toluene–THF–2-MeTHF; (c) NaClO<sub>2</sub>, 2-methyl-2-butene, NaH<sub>2</sub>PO<sub>4</sub>, H<sub>2</sub>O–CH<sub>3</sub>CN–THF–<i>t</i>-BuOH; (d) Cl<sub>3</sub>CCOCl, pyridine, DMAP; then NaOMe, MeOH; (e) B<sub>2</sub>(neop)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane; (f) ArBr, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, EtOH–toluene–dioxane; (g) NaOH, H<sub>2</sub>O–MeOH.</p></p></figure><div class="NLM_p last">Compounds <b>1</b>, <b>3</b>, <b>8</b>, <b>11</b>, <b>12</b>, and <b>13</b> were synthesized from starting indole <b>A</b> by acylation with trichloroacetyl chloride followed by methanolysis to afford ester <b>C</b>. Suzuki coupling with the appropriate aryl or heteroaryl boronate afforded intermediate <b>D</b>, with ester hydrolysis yielding the final compounds. Compounds <b>2</b>, <b>4</b>, <b>9</b>, and <b>10</b> were synthesized from indole <b>A</b> by a sequence of Vilsmeier–Haack formylation, Suzuki coupling with a substituted phenyl boronate to provide intermediate <b>B</b>, and final step Pinnick oxidation; chiral chromatographic separation afforded the separate enantiomers <b>9</b> and <b>10</b>. Compounds <b>5</b>, <b>6</b>, <b>7</b>, and <b>14</b> were synthesized by converting bromo-indole <b>C</b> to the corresponding neopentylglycol-boronate, followed by Suzuki coupling with the appropriate aryl or heteroarylhalide to afford intermediate <b>D</b>, and finally, ester hydrolysis to provide the final compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Considering our overall goal of reduced CL<sub>p</sub> relative to compound <b>1</b>, we sought to minimize both hepatic glucuronidation and renal excretion of the parent compound. To reduce CL<sub>renal</sub>, both decreased active excretion and increased <i>P</i><sub>app</sub>, to maximize passive reabsorption in the kidney, were desired. At the outset, there was insufficient data for compounds in this class to show a strong correlation between active CL<sub>renal</sub> in rat and rat Oat3 (or human OAT3) transporter activity measured in vitro. Creating a data set to demonstrate the in vitro–in vivo correlation was an integral part of this work.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">On the basis of strategies previously reported in the literature,<a onclick="showRef(event, 'ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49">(41−49)</a> several approaches were considered to reduce acyl glucuronidation: (a) increasing three-dimensional shape around the carboxylic acid to create a steric mismatch with the shape of the UGT active site, (b) replacing the carboxylic acid with an isostere, such as a heterocyclic ring, (c) stereoelectronic modulation of the acid motif by optimization of the indole ring, and (d) indirect or longer range effects, such as changing the hydroxycyclobutylphenyl ring, that might have some less-readily predicted effect on binding to the UGT binding pocket.</div><div class="NLM_p">Approaches a and b were limited by the balance of α1β1γ1-AMPK potency and ADME properties that could be achieved. Preliminary efforts to introduce partial saturation to the indole ring led to loss of AMPK activation potency. Several acid isosteres were explored but not pursued due to lack of sufficient potency or undesirable ADME properties. For example, <i>N</i>-sulfonyl amides of <b>1</b> retained potent activation of α1β1γ1-AMPK but had drastically reduced <i>P</i><sub>app</sub>, presumably due to increased polar surface area. These strategies were thus deprioritized in favor of more productive options involving indole core and 5-aryl substituent modifications.</div><div class="NLM_p">Previously reported structure–activity relationships (SAR) and AMPK co-crystal structures with indole-3-carboxylic acid derivatives indicated the importance of the C6 substituent for AMPK potency through enhanced hydrophobic interactions and its impact on biaryl torsion angle but also limited space in the pocket that accommodates this substituent.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Thus, in pursuit of strategy c, we focused on small electron-withdrawing substituents to improve the balance of potency and metabolic clearance (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The 6-cyano substituted derivative <b>2</b> showed both a reduction in α1β1γ1-AMPK activation potency and binding affinity. The cyano group decreased the log <i>D</i> as compared to compound <b>1</b>; however, human hepatocyte CL<sub>int</sub> was not significantly improved. The 6-fluoroindole <b>3</b> exhibited somewhat reduced potency as compared to <b>1</b>, albeit with a modest improvement in CL<sub>int</sub>. The substantially lower CL<sub>int</sub> for the 4,6-difluoro derivative <b>4</b>, coupled with a modest decrease in potency, was a notable point of differentiation. The substituent changes on the indole had limited impact on the measured p<i>K</i><sub>a</sub>, which was similar (4.6–4.9) for compounds <b>1</b>–<b>4</b>; however, the log <i>D</i> of <b>4</b> was lower than anticipated. The reduced log <i>D</i> of <b>4</b> may be due to the influence of the 4-fluoro substituent on the dipole of the core or an (experimentally unverified) interaction between the carboxylate and the proximal (C4) fluorine atom. The proximity of the C4-fluoro group to the carboxylic acid may also reduce the rate of glucuronidation, leading to the observed decrease in CL<sub>int</sub> of <b>4</b> as compared to the isolipophilic cyano analogue <b>2</b>. As with compound <b>1</b>, both fluoro analogues <b>3</b> and <b>4</b> were identified as substrates for hOAT3 in the HEK293 uptake assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Indole Core Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0006.gif" alt="" id="GRAPHIC-d385e1277-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">α1β1γ1-AMPK</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>4</sup>,R<sup>6</sup></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">%AMP<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>D</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>a</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="."><i>P</i><sub>app</sub><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a> (10<sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub><a class="ref internalNav" href="#t2fn6" aria-label="f">f</a> (μL/min/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char=".">hOAT3 uptake<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H,Cl</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">210</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">H,CN</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="center" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H,F</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">F,F</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">TR-FRET α1β1γ1-AMPK geometric mean EC<sub>50</sub> and mean maximal activation as a percentage of maximal AMP activation, determined from at least four replicates; 90% confidence intervals are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>D</sub> α1β1γ1-AMPK as determined by SPR reported as the global fit of the data using at least three replicates.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">log <i>D</i> was measured at pH 7.4 using the previously described shake-flask method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">p<i>K</i><sub>a</sub> was determined by electrophoresis as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Passive permeability (<i>P</i><sub>app</sub>) from the apical to basolateral (AB) direction was measured in Ralph Russ canine kidney (RRCK) cells as previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">CL<sub>int</sub> refers to total intrinsic clearance obtained from scaling in vitro half-lives in cryopreserved human hepatocytes as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t2fn7"><sup><sup>g</sup></sup><p class="last">Ratio of uptake in hOAT3 transfected HEK293 cells to uptake in vector-treated cells; a ratio >2.0 indicates that the test compound is an OAT3 substrate in vitro. ND: not determined.</p></div></div></div><div class="NLM_p">The core modifications shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> led to reductions in both log <i>D</i> and <i>P</i><sub>app</sub>. We reasoned that the substituted aryl ring at C5 on the indole ring would provide a simple opportunity for modulation of the overall physicochemical properties of the series. Previous X-ray crystallography studies indicated that the 4-position of this aryl ring pointed toward a solvent-exposed part of the α1β1γ1-AMPK binding pocket<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and thus was expected to be relatively tolerant of functional group variation. On the basis of the SAR developed during identification of compound <b>1</b>, a lipophilicity range of log <i>D</i> ∼ 1.5–2.5 was targeted for balancing AMPK activation potency, <i>P</i><sub>app</sub>, and human hepatocyte CL<sub>int</sub>. To increase <i>P</i><sub>app</sub>, substituents lacking an additional hydrogen bond donor (beyond the indole acid core) were favored. The alcohol and ether compound pair <b>5</b> and <b>6</b> highlights the differences in RRCK <i>P</i><sub>app</sub> observed with the presence/absence of an alcohol as H-bond donor (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and the challenge in balancing <i>P</i><sub>app</sub> with low metabolic clearance. Similarly, the <i>P</i><sub>app</sub> of <b>6</b> was markedly higher than that of either <b>1</b> or <b>3</b> despite similar lipophilicity. A weakly basic amine at the terminus of an alkyl ether linker was also tolerated, with morpholine derivative <b>7</b> affording a desirable balance of α1β1γ1-AMPK activation potency, <i>P</i><sub>app</sub>, and low CL<sub>int</sub>. The observed reduction of CL<sub>int</sub> was notable given the similar log <i>D</i> of compounds <b>6</b> and <b>7</b>, and is consistent with an earlier report<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> of distal basic groups reducing glucuronidation rates.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Modification of the R<sup>5</sup>-Aryl Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0007.gif" alt="" id="GRAPHIC-d385e1699-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0008.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">TR-FRET α1β1γ1-AMPK geometric mean EC<sub>50</sub> and mean maximal activation as a percentage of maximal AMP activation, determined from at least four replicates; 90% confidence intervals are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>D</sub> α1β1γ1-AMPK as determined by SPR reported as the global fit of the data using at least three replicates.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">log <i>D</i> was measured at pH 7.4 using the previously described shake-flask method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">p<i>K</i><sub>a</sub> was determined by electrophoresis as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">Passive permeability (<i>P</i><sub>app</sub>) from the apical to basolateral (AB) direction was measured in Ralph Russ canine kidney (RRCK) cells as previously described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">CL<sub>int</sub> refers to total intrinsic clearance obtained from scaling in vitro half-lives in cryopreserved human hepatocytes as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div><div class="footnote" id="t3fn7"><sup><sup>g</sup></sup><p class="last">Ratio of uptake in hOAT3 transfected HEK293 cells to uptake in vector-treated cells; a ratio >2.0 indicates that the test compound is an OAT3 substrate. ND: not determined.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>5</b> and <b>7</b> were selected for rat PK studies to evaluate the impact of the primary alcohol (<b>5</b>) and weakly basic center (<b>7</b>) on disposition attributes. While both compounds demonstrated low total CL<sub>p</sub> (relative to <b>1</b>) and moderate oral <i>F</i> (23 and 68%, respectively), significant renal excretion of unchanged parent was also noted for each compound. In fact, these compounds were identified as substrates for hOAT3, which is consistent with the observation of CL<sub>renal,u</sub> in excess of GFR (see <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>6</b> was not advanced to in vivo PK studies due to its high metabolic turnover in human hepatocytes.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Assessment of CL<sub>renal</sub> in Rat and OAT Substrate Properties of Selected AMPK Activators</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">%dose in urine<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">total CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">total CL<sub>renal</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">unbound CL<sub>renal</sub><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">unbound CL<sub>renal</sub>/GFR ratio<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="±">normalized OAT fold uptake<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">15.9</td><td class="colsep0 rowsep0" align="char" char=".">22.6</td><td class="colsep0 rowsep0" align="char" char=".">7.64</td><td class="colsep0 rowsep0" align="char" char=".">849</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 4.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">rOat3 8.3 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">20.0</td><td class="colsep0 rowsep0" align="char" char=".">8.07</td><td class="colsep0 rowsep0" align="char" char=".">2.69</td><td class="colsep0 rowsep0" align="char" char=".">280</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.0 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 3.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">10.7</td><td class="colsep0 rowsep0" align="char" char=".">3.16</td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">161</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 17 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="char" char=".">8.04</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">778</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.95 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 7.06 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">12.0</td><td class="colsep0 rowsep0" align="char" char=".">6.30</td><td class="colsep0 rowsep0" align="char" char=".">1.35</td><td class="colsep0 rowsep0" align="char" char=".">398</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.2 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 6.3 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">1.60</td><td class="colsep0 rowsep0" align="char" char=".">1.15</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 2.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">rOat3 2.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center" char=".">BLQ</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="center" char=".">NA</td><td class="colsep0 rowsep0" align="center" char=".">NA</td><td class="colsep0 rowsep0" align="center" char=".">NA</td><td class="colsep0 rowsep0" align="char" char="±">hOAT1 1.5 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">hOAT3 1.4 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">rOat3 2.0 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Percentage of iv dose recovered in urine over 24 h as unchanged parent compound.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Total CL<sub>renal</sub> in blood was estimated by multiplying the total blood clearance (CL<sub>b</sub>) with fraction of total iv dose of unchanged compound excreted in urine. CL<sub>b</sub> was obtained by dividing CL<sub>p</sub> by the blood to plasma ratio (B:P) of the respective test compounds.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Unbound CL<sub>renal</sub> in blood was estimated by dividing total CL<sub>renal</sub> by the unbound free fraction in blood, which in turn was obtained by dividing the unbound plasma free fraction by the blood to plasma ratio.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">GFR in rats is 8.7 mL/min/kg.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">OAT uptake of test compounds (1 μM) was evaluated in triplicate in HEK293 cells transfected with human OAT1/OAT3 or rat Oat3. BLQ: below lower limit of quantification (1 ng/mL). NA: not applicable.</p></div></div></div><div class="NLM_p">Racemic tetrahydropyran <b>8</b>, which contains a conformationally restrained ether group, demonstrated an attractive profile. Notably, in vitro data suggested <b>8</b> was not a hOAT3 substrate and, while its log <i>D</i> was higher than our target range, its human hepatocyte CL<sub>int</sub> remained low. The data from the indole core variations described above (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) provided an opportunity to balance the lipophilicity of the tetrahydropyran substituent without adding additional hydrogen bond donors. Such proved to be the case, with difluoro analogues <b>9</b> and <b>10</b> having a similar reduction in log <i>D</i> (∼1 unit) as compared to chloride <b>8</b>. As with compounds <b>1</b> and <b>4</b>, the lipophilicity change between the chloro (<b>8</b>, p<i>K</i><sub>a</sub> 4.9) and difluoro (<b>10</b>, p<i>K</i><sub>a</sub> 5.0) indole acids could not be attributed to modulation of the indole acid p<i>K</i><sub>a</sub>. Initial chromatographic separation of enantiomers, and subsequent asymmetric synthesis, led to identification of the (<i>S</i>)-tetrahydropyran <b>10</b> as the more active enantiomer. Compound <b>10</b> offered favorable in vitro ADME properties including decreased CL<sub>int</sub> in human hepatocytes and increased <i>P</i><sub>app</sub> in the RRCK assay relative to <b>1</b>. Uptake in the in vitro hOAT3 assay was also somewhat attenuated.</div><div class="NLM_p">An alternative method of modulating physical properties was explored through replacement of the phenyl ring at R<sup>5</sup> with heteroaryl derivatives. The well-enabled cross-coupling chemistry allowed inspection of a range of heterocyclic R<sup>5</sup> substituents, and the 3-pyridyl analogues <b>11</b> and <b>12</b> were identified as moderately potent activators of α1β1γ1-AMPK (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compounds <b>11</b> and <b>12</b> demonstrated promising <i>P</i><sub>app</sub> and log <i>D</i> within our target range; however, methoxypyridine analogue <b>11</b> was some 15-fold less potent than the previously published methoxyphenyl analogue (1200 vs 80 nM)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and showed significant turnover in human hepatocytes. The more electron-rich dimethylaminopyridine analogue <b>12</b> provided moderate improvements in both parameters. Inspection of the co-crystal structure of compound <b>1</b> bound to the ADaM site of α1β1γ1-AMPK indicated that the binding pocket around the R<sup>5</sup> aryl substituent is mostly hydrophobic, providing a rationale for the preferred binding of phenyl rings. We sought to improve the potency of these pyridyl analogues through the addition of further substituents. Introduction of a 2′-methoxy substituent had minimal impact on activation potency in the case of compound <b>13</b>, although its affinity was moderately improved. In contrast, addition of the 2′-methoxy substituent to compound <b>12</b> yielded the highly potent analogue <b>14</b>. The differential effect may be partially explained by the impact of the methoxy group on the p<i>K</i><sub>a</sub> of the aminopyridine, which is also reflected in the significant increase in log <i>D</i> for <b>14</b> as compared to <b>12</b>. Compound <b>14</b> retained excellent RRCK <i>P</i><sub>app</sub> and had reduced CL<sub>int</sub> relative to compound <b>1</b> despite its relatively high log <i>D</i>. Furthermore, it did not show preferential uptake in the hOAT3 transfected cell line, suggesting that it is not a substrate for that transporter.</div><div class="NLM_p">The co-crystal structure of compound <b>14</b> in the allosteric activation site of α1β1γ1-AMPK has been reported previously.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The structure (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) shows a similar binding mode to compound <b>1</b> at the ADaM site between the α- and β-subunits. The chloroindole acid core makes identical interactions, including electrostatic contacts with lysine 29 of the α-subunit, a hydrogen bond to aspartic acid 88 (also from the α-subunit), and a cation−π interaction with arginine 83 from the β-subunit, and the ligands overlap well. The pyridyl ring is twisted ∼60° relative to the plane of the indole, with the more polar edge oriented “up” toward the β-subunit. The methoxy group is oriented as expected,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> shielding the polarity of the pyridyl ring. This substituent is accommodated by a slight adjustment in the position of the carbohydrate binding module motif of the β-subunit proximal to asparagine 111 and fills a small pocket at the top of the binding site tunnel.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. View of compound <b>14</b> co-crystallized with α1β1γ1-AMPK (A) and an overlay (B) of the bound structures of <b>1</b> (pink) and <b>14</b> (cyan). Compound <b>14</b> (cyan sticks) is bound in the ADaM site at the interface of the α1 and β1 subunits (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T">5T5T</a>.pdb). Some of the key hydrogen bond interactions are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the evaluation of structure–metabolism relationships, selected indole-3-carboxylic acid analogues were examined as substrates for OAT-mediated uptake in HEK293 cells, as described above. From the limited set of compounds studied in these assays, a general trend was observed. Compounds with more overtly polar expressions (such as hydrogen bond donor alcohol OH or the presumably protonated morpholine ring) in the 4-substituent of the R5-aryl ring showed increased normalized uptake in the hOAT3 assay, while those with less polar groups (such as an ether or a pyridine nitrogen) showed reduced uptake. The minimal hOAT3-mediated uptake observed for compounds <b>6</b> and <b>10</b> as compared to compounds <b>1</b> and <b>7</b> indicates that this effect is not simply determined by log <i>D</i>, nor can it be explained fully by differential passive permeability. These data suggest that an H-bond donor or a weakly basic group (the protonated form of which may function similarly) may be a structural determinant of OAT3 substrate activity in this series. As with compound <b>1</b>, none of the compounds tested showed normalized uptake ratio in the hOAT1 assay greater than the 2.0-fold substrate threshold. The hypothesis that active excretion by OATs is responsible for the observed renal clearance of compound <b>1</b> is supported by the observation that each of the compounds assigned as an OAT3 substrate in vitro demonstrated unbound renal clearance significantly higher than GFR in rats (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compounds <b>10</b> and <b>14</b>, which derive their polarity from the indole core modification and a heterocyclic motif at R5, respectively, demonstrated a significant attenuation in the in vitro uptake assays. The reduced in vitro transporter-mediated uptake was consistent with their minimal (<b>10</b>) or lack of (<b>14</b>) renal excretion following iv administration in rats.</div><div class="NLM_p">The pharmacokinetics of <b>10</b> and <b>14</b> were studied in rats and nonhuman primates after iv and oral administration (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). For the purposes of comparison, the PK properties of <b>1</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in rats and monkeys are also provided in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Relative to compound <b>1</b>, <b>10</b> and <b>14</b> demonstrated significantly lower CL<sub>p</sub> in rats (<b>10</b>, 1.15 mL/min/kg; <b>14</b>, CL<sub>p</sub> = 0.05 mL/min/kg) and monkeys (<b>10</b>, 0.38 mL/min/kg; <b>14</b>, 0.98 mL/min/kg) and improvements in oral <i>F</i> in both species. Gratifyingly, both compounds were well absorbed following administration at the 3 mg/kg dose despite low to moderate thermodynamic solubility (pH 7.4: <b>10</b>, 14 μM; <b>14</b>, 120 μM).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Preclinical PK Assessment of Compounds <b>10</b> and <b>14</b> and Comparison with Compound <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>p</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–24)</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char=".">oral <i>F</i> (%)</th><th class="colsep0 rowsep0" align="center" char=".">% dose in urine</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">22.6</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">744</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">15.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">329</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NHP</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">8.57</td><td class="colsep0 rowsep0" align="char" char=".">2.33</td><td class="colsep0 rowsep0" align="char" char=".">8.54</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1970</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">20.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">733</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2690</td><td class="colsep0 rowsep0" align="char" char=".">59.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">1.15</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">4.95</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">16400</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1890</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">12800</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NHP</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">35900</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">8180</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">91600</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="11" align="left">     </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">27.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">254000</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center" char=".">BLQ</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">10200</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">160000</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NHP</td><td class="colsep0 rowsep0" align="center">iv</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">9.14</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">15500</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">po</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2540</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">31200</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">PK parameters for compound <b>1</b> were reported previously<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and are provided here for comparison.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Male Wistar–Han rats and male cynomolgus monkeys (NHP) were used for iv and po PK studies. Solution formulations were administered as an iv bolus dose (1 mg/kg) and crystalline material was used for po PK studies, dosed as a suspension via oral gavage (3 mg/kg). Pharmacokinetic parameters were calculated from plasma concentration–time data and are reported as average values for <i>n</i> = 2. Maximum plasma concentrations (<i>C</i><sub>max</sub>) after po dosing were determined directly from the experimental data, with <i>T</i><sub>max</sub> defined as the time of first occurrence of <i>C</i><sub>max</sub>. The area under the plasma concentration–time curve from <i>t</i> = 0–24 h (AUC<sub>0–24</sub>) was estimated using the linear trapezoidal rule. Oral F was calculated from dose-normalized AUC<sup>po</sup>/AUC<sup>iv</sup>. Urine was collected from 0–24 h in the iv studies in rats and monkeys to determine the percentage of dose excreted as unchanged parent in urine. BLQ: below lower limit of quantification (1 ng/mL).</p></div></div></div><div class="NLM_p">Examination of the metabolic fate of <b>10</b> and <b>14</b> in human and rat hepatocytes revealed that the principal route of biotransformation also involved glucuronidation of their respective carboxylic acid groups (similar to metabolism of <b>1</b>). Considering the similarity in log <i>D</i> values for <b>1</b>, <b>10</b>, and <b>14</b>, we speculate that the increased metabolic stability (↓ CL<sub>int</sub>) of <b>10</b> and <b>14</b> in human hepatocytes (relative to <b>1</b>) results from a slower rate of metabolism caused by a diminished affinity for the UGT binding site due to unfavorable active site interactions of the 4-fluoro or 5-aryl substituents rather than a decrease in lipophilicity.</div><div class="NLM_p">The isoform selectivity of compounds <b>10</b> and <b>14</b> was examined using the TR-FRET activation/protection assay format. Both compounds were potent activators of the human α1β1γ1- and α2β1γ1-isoforms but had minimal activity at each of the β2-containing isoforms tested (α1β2γ1, α2β2γ1, α2β2γ3, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Table S2</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">Figure S1</a>). These compounds were also advanced to an in vivo target engagement experiment in ZSF-1 rats, an obese/diabetic rodent model of diabetic nephropathy.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> In this study (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), ZSF-1 rats (<i>n</i> = 5) were dosed once daily with vehicle or test compound at 30 or 100 mg/kg for 3 days. One hour after the last dose, the animals were euthanized and kidney pole tissue was collected and analyzed for total AMPK (tAMPK) and pAMPK. In each treatment group, the ratio of pAMPK/tAMPK was significantly increased relative to vehicle control, indicating robust engagement of AMPK in the target tissue of interest. On the basis of its favorable potency and in vivo PK attributes, in particular its long half-life and lack of renal clearance in rats, compound <b>14</b> was selected for further in vivo characterization. Compound <b>14</b> demonstrated improvements in renal function after chronic dosing (30 mg/kg/day for 68 days) in the ZSF-1 rat model, details of which were reported previously.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo assessment of AMPK target engagement as measured by increases in pAMPK/tAMPK in kidney pole for compounds <b>1</b>, <b>10</b>, and <b>14</b> in ZSF-1 rats after 3 days of dosing (*** indicates <i>p</i> < 0.001 relative to vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec99" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have identified compounds <b>10</b> (PF-06679142) and <b>14</b> (PF-06685249), which, relative to compound <b>1</b>, demonstrated comparable β1-AMPK activation potency and in vivo target engagement, along with significantly increased half-lives and oral bioavailability in preclinical species, decreased intrinsic clearance in human hepatocytes, and markedly reduced propensity for active renal excretion by human organic anion transporters.</div><div class="NLM_p last">Structural changes both proximal to and remote from the carboxylic acid site of glucuronidation were found to significantly impact the rate of clearance in hepatocytes through SAR that was not readily predicted. Notably, clearance appeared to be driven by recognition of structural motifs by UGTs and was thus relatively insensitive to log <i>D</i>. The extent of renal clearance in key analogues was examined in preclinical species and was found to correlate with active uptake in vitro by rat Oat3 and human OAT3. The SAR of OAT3 was examined, and we hypothesize that more polar functional groups, such as alcohols and basic amines, are more readily recognized by these transporters. Electronic modulation of the indole core or the incorporation of a heteroaromatic ring, allowed for an optimal balance of metabolic stability, permeability, and minimal active uptake by OAT3. The extended half-life and negligible renal clearance of compounds <b>10</b> and <b>14</b> will facilitate further exploration of the potential of AMPK activation for the treatment of diabetic nephropathy.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Experiments Involving Laboratory Animals</h3><div class="NLM_p last">All procedures performed on animals were in accordance with regulations and established guidelines and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee (IACUC) or the IACUC of BioDuro or SBMRI, where applicable.</div></div><div id="sec3-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Experimental Methods</h3><div class="NLM_p">All chemicals, reagents, and solvents were purchased from commercial sources and were used without further purification unless otherwise noted. <sup>1</sup>H NMR data are reported relative to residual solvent signals and are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz), and integration. The multiplicities are denoted as follows: s, singlet; d, doublet; t, triplet; m, multiplet; br, broad. Silica gel chromatography was performed using a medium pressure Biotage or ISCO system and columns prepackaged by various commercial vendors including Biotage and ISCO. Whatman precoated silica gel plates (250 μm) were used for analytical thin-layer chromatography (TLC). The terms “concentrated” and “evaporated” refer to the removal of solvent at reduced pressure on a rotary evaporator with a water bath temperature not exceeding 60 °C. Purity of final compounds was assessed by reversed-phase HPLC with UV detection at 215 nM; all tested compounds were >95% purity.</div><div id="sec3-2-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>S</i>)-4,6-Difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carboxylic Acid (<b>10</b>)</h4><div class="NLM_p">Step 1: 1-(4-Bromophenyl)-5-chloropentan-1-ol. NaBH<sub>4</sub> (1.72 g, 45.4 mmol, 5.0 equiv) was added to a solution of 1-(4-bromophenyl)-5-chloropentan-1-one (2.50 g, 9.1 mmol, 1 equiv) in MeOH (200 mL) at 0 °C. The mixture was then warmed to ambient temperature, and after 3 h, a saturated aqueous solution of citric acid was added to bring the pH to 3. The mixture was concentrated to remove MeOH, and the remaining aqueous layer was extracted with EtOAc (3 × 200 mL). The combined organics were washed with brine (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a colorless oil (2.30 g, 91%) which was used without further purification. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.49 (d, <i>J</i> = 7.6 Hz, 2H), 7.29 (d, <i>J</i> = 7.6 Hz, 2H), 4.61 (dd, <i>J</i> = 7.0, 5.7 Hz, 1H), 3.55 (t, <i>J</i> = 6.6 Hz, 2H), 1.74 (m, 4H), 1.56 (m, 1H), 1.43 (m, 1H).</div><div class="NLM_p">Step 2: 2-(4-Bromophenyl)tetrahydro-2<i>H</i>-pyran. A solution of 1-(4-bromophenyl)-5-chloropentan-1-ol (2.0 g, 7.2 mmol, 1 equiv) in THF (100 mL) was added dropwise to NaH (60% dispersion in mineral oil, 432 mg, 10.8 mmol, 1.5 equiv) in THF (100 mL) at 0 °C. The mixture was warmed to ambient temperature and then was stirred for 18 h before being cooled to 0 °C. Excess hydride was quenched by the sequential addition of water (100 mL) and a saturated aqueous solution of NH<sub>4</sub>Cl (100 mL). The mixture was extracted with EtOAc (3 × 100 mL), and the combined organics were washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford a residue that was purified by silica gel chromatography (petroleum ether) to afford a yellow oil (1.8 g, >100%; with residual mineral oil). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.28 (d, <i>J</i> = 8.0 Hz, 2H), 4.34 (dd, <i>J</i> = 11.0, 2.0 Hz, 1H), 4.09 (m, 1H), 3.65 (m, 1H), 1.95 (m, 1H), 1.84 (m, 1H), 1.63 (m, 4H).</div><div class="NLM_p">Step 3: 5,5-Dimethyl-2-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1,3,2-dioxaborinane. Solid KOAc (2.20 g, 22.4 mmol, 3.0 equiv) was added to a solution of 2-(4-bromophenyl)tetrahydro-2<i>H</i>-pyran (1.8 g, 7.7 mmol, 1 equiv) and 5,5,5′,5′-tetramethyl-2,2′-bi(1,3,2-dioxaborinane) (1.85 g, 8.21 mmol, 1.1 equiv) in dioxane (100 mL). The mixture was sparged with nitrogen for 1 min then Pd(dppf)Cl<sub>2</sub> (273 mg, 0.37 mmol, 0.05 equiv) was added and the resulting mixture was stirred at 100 °C for 16 h. The mixture was cooled to ambient temperature and was filtered through Celite, rinsing with EtOAc (2 × 100 mL). The resulting residue was purified by silica gel chromatography (0–10% EtOAc:petroleum ether) to afford the product as a white solid (1.23 g, 60%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 7.73 (d, <i>J</i> = 7.6 Hz, 2H), 7.31 (d, <i>J</i> = 7.6 Hz, 2H), 4.36 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 4.10 (m, 1H), 3.78 (s, 4H), 3.64 (m, 1H), 1.94 (m, 1H), 1.83 (m, 1H), 1.65 (m, 4H), 1.02 (s, 6H).</div><div class="NLM_p">Step 4: 5-Bromo-4,6-difluoro-1<i>H</i>-indole-3-carbaldehyde. <i>N,N</i>-Dimethylformiminium chloride (1.07 g, 8.34 mmol, 1.5 equiv) was added to a solution of 5-bromo-4,6-difluoro-1<i>H</i>-indole (1.29 g, 5.56 mmol, 1 equiv) in CH<sub>3</sub>CN (7.0 mL). The mixture was stirred at room temperature for 45 min, and then an aqueous NaOH solution (1N , 15 mL, 15 mmol, 2.7 equiv) was added. The resulting mixture was heated to 100 °C for 1 h and then was cooled to 0 °C. The resulting solids were collected via filtration, washed with water, and dried with vacuum to provide the product (0.90 g). An additional portion of solids formed in the filtrate, which was collected and dried to provide an additional sample of material (1.27 g combined, 88%). MS (M + H)<sup>+</sup> 260.3. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.58 (br s, 1H), 9.93 (d, <i>J</i> = 3.9 Hz, 1H), 8.34 (s, 1H), 7.39 (dd, <i>J</i> = 8.5, 1.1 Hz, 1H).</div><div class="NLM_p">Step 5: 4,6-Difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carbaldehyde. A mixture of 5,5-dimethyl-2-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1,3,2-dioxaborinane (444 mg, 1.62 mmol, 1.1 equiv), 5-bromo-4,6-difluoro-1<i>H</i>-indole-3-carbaldehyde (400 mg, 1.54 mmol, 1 equiv), K<sub>2</sub>CO<sub>3</sub> (638 mg, 4.62 mmol, 3.0 equiv), and Pd(dppf)Cl<sub>2</sub> (44 mg, 0.06 mmol, 0.04 equiv) in dioxane (4.6 mL) and water (2.3 mL) was stirred at 100 °C for 3 h. After cooling to ambient temperature, the mixture was partitioned between water (20 mL) and EtOAc (3 × 20 mL). The combined organic layers were washed with brine (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a solid residue, which was triturated with 50% petroleum ether–MTBE. Filtration afforded the solid product which was used without further purification (400 mg, 76%). MS (M + H)<sup>+</sup> 342.0. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.53 (br s, 1H), 9.97 (s, 1H), 8.32 (s, 1H), 7.41 (m, 4H), 7.31 (d, <i>J</i> = 10.0 Hz, 1H), 4.37 (d, <i>J</i> = 11.2 Hz, 1H), 4.03 (br d, <i>J</i> = 11.2 Hz, 1H), 3.54 (m, 1H), 1.86 (m, 2H), 1.65 (m, 1H), 1.56 (m, 2H), 1.47 (m, 1H).</div><div class="NLM_p">Step 6: 4,6-Difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carboxylic acid. A solution of NaClO<sub>2</sub> (1.58 g, 14.0 mmol, 12 equiv) and sodium dihydrogen phosphate (3.20 g, 23.4 mmol, 20 equiv) in water (24 mL) was added to a solution of 4,6-difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carbaldehyde (400 mg, 1.17 mmol, 1 equiv) in CH<sub>3</sub>CN (24 mL), <i>t</i>-BuOH (24 mL), and 2-methyl-2-butene (15.6 mL) at 0 °C. The mixture was then stirred at room temperature for 2 days. To quench excess oxidant, a solution of Na<sub>2</sub>SO<sub>3</sub> (4.40 g, 35.1 mmol, 200 equiv) in water (10 mL) was added. The resulting mixture was stirred for 30 min, then was extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a crude residue, which was purified by preparative HPLC to afford the product as an off-white solid (80 mg, 19%). MS (M + H)<sup>+</sup> 357.9. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 1H), 12.01 (br s, 1H), 8.07 (d, <i>J</i> = 2.5 Hz, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 7.41 (d, <i>J</i> = 8.4 Hz, 2H), 7.26 (d, <i>J</i> = 9.6 Hz, 1H), 4.38 (d, <i>J</i> = 10.4 Hz,1H), 4.05 (m, 1H), 3.55 (m, 1H), 1.86 (m, 2H), 1.56 (m, 4H).</div><div class="NLM_p">Step 7: Chiral SFC purification afforded the separate enantiomers: Chiralcel OJ-H 250 mm × 4.6 mm, 5 μm, 5–40% methanol (0.05% Et<sub>2</sub>NH) in CO<sub>2</sub>, 2.35 mL/min, 220 nm.</div><div class="NLM_p">(<i>R</i>)-4,6-Difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carboxylic acid (<b>9</b>). Retention time 8.1 min (22 mg); 94% ee. MS (M + H)<sup>+</sup> 358. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 2H), 8.07 (s, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 2H), 7.40 (d, <i>J</i> = 8.2 Hz, 2H), 7.25 (d, <i>J</i> = 9.5 Hz, 1H), 4.39 (dd, <i>J</i> = 11.5, 1.0 Hz, 1H), 4.06 (m, 1H), 3.58 (m, 1H), 1.87 (m, 2H), 1.58 (m, 4H).</div><div class="NLM_p last">(<i>S</i>)-4,6-Difluoro-5-(4-(tetrahydro-2<i>H</i>-pyran-2-yl)phenyl)-1<i>H</i>-indole-3-carboxylic acid (<b>10</b>). Retention time = 7.5 min (30 mg), 97% ee. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (br s, 2H), 8.07 (s, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 2H), 7.40 (d, <i>J</i> = 8.4 Hz, 2H) 7.25 (d, <i>J</i> = 9.5 Hz, 1H), 4.39 (d, <i>J</i> = 10.5 Hz,1H), 4.06 (m, 1H), 3.56 (m, 1H), 1.87 (m, 2H), 1.59 (m, 4H). Characterization from a subsequent batch. HRMS (ESI): calcd for C<sub>20</sub>H<sub>18</sub>F<sub>2</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 358.1249, found 358.1244. Analytical (%) calcd: C, 67.22; H, 4.80; N, 3.92. Found: C, 66.86; H, 4.51; N, 3.84. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.2, 155.8, 151.7, 143.0, 137.2, 134.4, 130.3, 128.7, 125.5, 110.9, 110.5, 107.3, 95.1, 78.7, 68.0, 33.8, 25.5, 23.5.</div></div><div id="sec3-2-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 6-Chloro-5-(6-(dimethylamino)-2-methoxypyridin-3-yl)-1<i>H</i>-indole-3-carboxylic Acid (<b>14</b>)</h4><div class="NLM_p">Step 1: Methyl 6-chloro-5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1<i>H</i>-indole-3-carboxylate. A mixture of methyl 5-bromo-6-chloro-1<i>H</i>-indole-3-carboxylate<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (10.5 g, 36.4 mmol, 1 equiv), 5,5,5′,5′-tetramethyl-2,2′-bi-1,3,2-dioxaborinane (9.04 g, 40.0 mmol, 1.1 equiv), and oven-dried KOAc (17.9 g, 182 mmol, 5.0 equiv), in 1,4-dioxane (170 mL) was sparged with nitrogen for 10 min, then was treated with Pd(dppf)Cl<sub>2</sub> (1.60 g, 2.18 mmol, 0.06 equiv). The mixture was heated at 110 °C for 3 h. The mixture was then cooled to ambient temperature and was filtered through Celite, rinsing with EtOAc. The filtrate was concentrated and then was eluted from a pad of silica gel (EtOAc). After concentration, the residue was loaded onto a silica gel column with a minimal amount of CH<sub>2</sub>Cl<sub>2</sub> and was eluted with EtOAc:heptane (1:4 to 1:1) to provide a tan solid (5.6 g, 48%). MS (M + H)<sup>+</sup> 254.1 (M = RB(OH)<sub>2</sub> on LCMS). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.98 (br s, 1H), 8.29 (s, 1H), 8.10 (d, <i>J</i> = 2.93 Hz, 1H), 7.46 (s, 1H), 3.80 (s, 3H), 3.79 (s, 4H), 1.01 (s, 6H).</div><div class="NLM_p">Step 2: 5-Bromo-6-fluoro-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine. <i>N</i>-Bromosuccinimide (4.60 g, 25.9 mmol, 0.50 equiv) was added to a solution of 6-fluoro-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (7.25 g, 51.7 mmol, 1 equiv) in CH<sub>3</sub>CN (345 mL) at 0 °C. After 1 h, a second portion of <i>N</i>-bromosuccinimide (4.60 g, 25.9 mmol, 0.50 equiv) was added and the resulting mixture was warmed to ambient temperature. After 16 h, the mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (500 mL) and water (300 mL). The aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 200 mL), and the combined organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford a yellow solid (10.8 g, 95%). MS (M)<sup>+</sup> 218, 220. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.50 (t, <i>J</i> = 8.8 Hz, 1H), 6.14 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 2.98 (s, 6H).</div><div class="NLM_p">Step 3: 5-Bromo-6-methoxy-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine. 5-Bromo-6-fluoro-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (10.8 g, 50.8 mmol, 1 equiv) was added to a 25% solution of MeOK in MeOH (45 mL, 152 mmol, 3.0 equiv), and the resulting mixture was heated at reflux for 2.5 h. After cooling to ambient temperature, saturated aqueous NH<sub>4</sub>Cl solution (400 mL) was added, and the mixture was extracted with EtOAc (2 × 300 mL). The combined organics were washed with brine (300 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to afford a solid that was used without further purification (11.2 g, 95%). MS (M)<sup>+</sup> 230, 232. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.51 (d, <i>J</i> = 8.6 Hz, 1H), 5.96 (d, <i>J</i> = 8.6 Hz, 1H), 3.97 (s, 3H), 3.06 (s, 6H).</div><div class="NLM_p">Step 4: Methyl 6-chloro-5-(6-(dimethylamino)-2-methoxypyridin-3-yl)-1<i>H</i>-indole-3-carboxylate. A mixture of methyl 6-chloro-5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1<i>H</i>-indole-3-carboxylate (9.25 g, 28.8 mmol, 1.5 equiv), 5-bromo-6-methoxy-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (4.44 g, 19.2 mmol, 1 equiv), PdCl<sub>2</sub>(dppf) (1.12 g, 1.53 mmol, 0.08 equiv), an aqueous solution of K<sub>2</sub>CO<sub>3</sub> (7.95 g, 57.5 mmol, 3.0 equiv, in 29 mL water), EtOH (630 mL), and toluene (60 mL) was sparged with nitrogen for 20 min and then was heated at 120 °C for 16 h. The mixture was cooled to ambient temperature and was diluted with EtOAc (800 mL) and was filtered through a pad of Celite. The filtrate was washed with saturated aqueous NH<sub>4</sub>Cl solution (2 × 400 mL). The combined organics were dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting solids were suspended in MeOH (200 mL) and were heated to reflux then were cooled to ambient temperature and were filtered to afford a tan solid which contained residual 2,2-dimethylpropane-1,3-diol. The mother liquor was concentrated and crystallized from MeOH (100 mL) at reflux to afford another batch of solid. The combined solids were slurried in MeOH (40 mL) at ambient temperature for 30 min then were filtered to afford the desired product (5.15 g, 75%). MS (M + H)<sup>+</sup> 360.1. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.00 (br s, 1H), 8.14 (s, 1H), 7.84 (s, 1H), 7.58 (s, 1H), 7.33 (d, <i>J</i> = 8.0 Hz, 1H), 6.23 (d, <i>J</i> = 8.0 Hz, 1H), 3.79 (s, 3H), 3.77 (s, 3H), 3.08 (s, 6H).</div><div class="NLM_p last">Step 5: 6-Chloro-5-(6-(dimethylamino)-2-methoxypyridin-3-yl)-1<i>H</i>-indole-3-carboxylic acid (<b>14</b>). Aqueous NaOH solution (2 N, 10 mL, 20 mmol, 10 equiv) was added to a solution of methyl 6-chloro-5-(6-(dimethylamino)-2-methoxypyridin-3-yl)-1<i>H</i>-indole-3-carboxylate (700 mg, 1.94 mmol, 1 equiv) in MeOH–THF (6 mL each) at 70 °C. After 24 h, the mixture was cooled to 0 °C, and aqueous HCl solution (1 N, ∼20 mL) was added dropwise to bring the pH to ∼5–6. After extraction with EtOAc (3 × 75 mL), the combined organics were washed with brine (50 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated to afford an off-white solid (670 mg), which was suspended in MeOH (5 mL) and stirred at 40 °C for 16 h. After cooling to ambient temperature and filtration, the product was isolated as a white solid (500 mg, 74%). HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 346.0953, found 346.0953. Analytical (%) calcd: C, 59.05; H, 4.66; N, 12.15. Found: C, 59.01; H, 4.64; N, 12.00. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.03 (br s, 1H), 11.86 (br s, 1H), 8.04 (d, <i>J</i> = 2.7 Hz, 1H), 7.83 (s, 1H), 7.55 (s, 1H), 7.32 (d, <i>J</i> = 8.2 Hz, 1H), 6.21 (d, <i>J</i> = 8.2 Hz, 1H), 3.76 (s, 3H), 3.07 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.7, 159.0, 157.4, 141.2, 135.9, 133.3, 129.4, 127.9, 125.0, 123.3, 112.2, 108.9, 107.5, 96.7, 52.4, 37.5.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01641" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01641" class="ext-link">10.1021/acs.jmedchem.7b01641</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional experimental and characterization data for compound synthesis; experimental details for the SPR assay, the in vitro OAT uptake assays, the in vivo PK studies, and the in vivo ZSF-1 rat study; additional AMPK isoform pharmacology data including dose response curves and confidence intervals for the FRET and SPR assays; plasma protein binding data for compounds tested in vivo (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf">jm7b01641_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_002.csv">jm7b01641_si_002.csv (0.77 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates for compounds <b>1</b> and <b>14</b> have been deposited to the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>, accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T">5T5T</a>, respectively). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01641" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Edmonds</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9234-8618" title="Orcid link">http://orcid.org/0000-0001-9234-8618</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d692b7a0bfb2f893b2bbb9b8b2a596a6b0bfacb3a4f8b5b9bb"><span class="__cf_email__" data-cfemail="98dcf9eef1fcb6ddfcf5f7f6fcebd8e8fef1e2fdeab6fbf7f5">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel W. Kung</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5019-1939" title="Orcid link">http://orcid.org/0000-0002-5019-1939</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0347626d6a666f2d542d48766d644373656a7966712d606c6e"><span class="__cf_email__" data-cfemail="b0f4d1ded9d5dc9ee79efbc5ded7f0c0d6d9cad5c29ed3dfdd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit S. Kalgutkar</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Filipski</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0845-5723" title="Orcid link">http://orcid.org/0000-0003-0845-5723</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Ebner</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn Cabral</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron C. Smith</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6796-5155" title="Orcid link">http://orcid.org/0000-0001-6796-5155</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary E. Aspnes</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samit K. Bhattacharya</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kris A. Borzilleri</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janice A. Brown</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew F. Calabrese</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole L. Caspers</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily C. Cokorinos</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward L. Conn</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew S. Dowling</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Eng</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bo Feng</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilinie P. Fernando</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathan E. Genung</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Herr</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravi G. Kurumbail</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Y. Lavergne</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esther C.-Y. Lee</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qifang Li</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sumathy Mathialagan</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell A. Miller</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Panteleev</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Polivkova</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francis Rajamohan</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan R. Reyes</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher T. Salatto</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andre Shavnya</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin A. Thuma</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meihua Tu</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Ward</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane M. Withka</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Xiao</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly O. Cameron</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors were employed by Pfizer, Inc. at the time this work was done.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Yuxia Mao for compound formulation support, Marina Shalaeva for p<i>K</i><sub>a</sub> determinations, Derek Vrieze and Yingxin Zhang for synthesis contributions, Chris Limberakis for chemistry outsourcing support, and Jared Milbank and Laura McAllister for helpful discussions. Crystallographic data were collected at IMCA-CAT (17-ID) and GMCA-CAT at the Advanced Photon Source. IMCA was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman–Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ADaM</td><td class="NLM_def"><p class="first last">allosteric drug and metabolite</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism and excretion</p></td></tr><tr><td class="NLM_term">ADP</td><td class="NLM_def"><p class="first last">5′-adenosine diphosphate</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">5′-adenosine monophosphate</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">5′-adenosine monophosphate-activated protein kinase</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>p</sub></td><td class="NLM_def"><p class="first last">plasma clearance</p></td></tr><tr><td class="NLM_term">CL<sub>renal</sub></td><td class="NLM_def"><p class="first last">renal clearance</p></td></tr><tr><td class="NLM_term">CL<sub>b</sub></td><td class="NLM_def"><p class="first last">blood clearance</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DN</td><td class="NLM_def"><p class="first last">diabetic nephropathy</p></td></tr><tr><td class="NLM_term">ee</td><td class="NLM_def"><p class="first last">enantiomeric excess</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalents</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">GFR</td><td class="NLM_def"><p class="first last">glomerular filtration rate</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">neop</td><td class="NLM_def"><p class="first last">neopentyl</p></td></tr><tr><td class="NLM_term">OAT</td><td class="NLM_def"><p class="first last">organic anion transporter</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent passive permeability</p></td></tr><tr><td class="NLM_term">pAMPK</td><td class="NLM_def"><p class="first last">phospho-AMPK</p></td></tr><tr><td class="NLM_term">Pd(dppf)Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">[1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II)</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">RRCK</td><td class="NLM_def"><p class="first last">Ralph Russ canine kidney</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">tAMPK</td><td class="NLM_def"><p class="first last">total AMPK</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type II diabetes mellitus</p></td></tr><tr><td class="NLM_term">MTBE</td><td class="NLM_def"><p class="first last"><i>t</i>-butylmethyl ether</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">UGT</td><td class="NLM_def"><p class="first last">uridine 5′-diphospho-glucuronosyltransferase</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, R. J.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1111/dom.12630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fdom.12630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26743887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC28rotlahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=641-647&author=H.+Gallagherauthor=R.+J.+Suckling&title=Diabetic+nephropathy%3A+where+are+we+on+the+journey+from+pathophysiology+to+treatment%3F&doi=10.1111%2Fdom.12630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?</span></div><div class="casAuthors">Gallagher H; Suckling R J</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, obesity & metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">641-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetic nephropathy affects 30-40% of people with diabetes, and is the leading cause of end-stage kidney disease.  The current treatment paradigm relies on early detection, glycaemic control and tight blood pressure management with preferential use of renin-angiotensin system blockade.  This strategy has transformed outcomes in diabetic kidney disease over the last 20 years.  Over the last two decades we have also witnessed significant advances in the understanding of the pathophysiology of diabetic nephropathy; however, despite this new knowledge, we have yet to develop new treatments of proven efficacy.  Whilst a continued emphasis on preclinical and clinical research is clearly needed, clinicians treating people with diabetes should not forget that, in the short term, the greatest gains are likely to be realised by more consistent deployment of existing therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtBJZchC7NpotVjB3IRIyfW6udTcc2eaBkaIG1o8Aj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rotlahtQ%253D%253D&md5=ed3a06804b4995832b00d9f955123a20</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fdom.12630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.12630%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DH.%26aulast%3DSuckling%26aufirst%3DR.%2BJ.%26atitle%3DDiabetic%2520nephropathy%253A%2520where%2520are%2520we%2520on%2520the%2520journey%2520from%2520pathophysiology%2520to%2520treatment%253F%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2016%26volume%3D18%26spage%3D641%26epage%3D647%26doi%3D10.1111%2Fdom.12630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjornstad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maahs, D. M.</span></span> <span> </span><span class="NLM_article-title">Update on estimation of kidney function in diabetic kidney disease</span>. <i>Curr. Diabetes Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">57</span>, <span class="refDoi"> DOI: 10.1007/s11892-015-0633-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1007%2Fs11892-015-0633-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26188736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkslWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=57&author=P.+Bjornstadauthor=D.+Z.+Cherneyauthor=D.+M.+Maahs&title=Update+on+estimation+of+kidney+function+in+diabetic+kidney+disease&doi=10.1007%2Fs11892-015-0633-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Estimation of Kidney Function in Diabetic Kidney Disease</span></div><div class="casAuthors">Bjornstad Petter; Cherney David Z; Maahs David M</div><div class="citationInfo"><span class="NLM_cas:title">Current diabetes reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The American Diabetes Association recommends annual assessment of glomerular filtration rate (GFR) to screen for diabetic nephropathy.  GFR is measured indirectly using markers that, ideally, are eliminated only by glomerular filtration.  Measured GFR, although the gold standard, remains cumbersome and expensive.  GFR is therefore routinely estimated using creatinine and/or cystatin C and clinical variables.  In pediatrics, the Schwartz creatinine-based equation is most frequently used even though combined creatinine and cystatin C-based equations demonstrate stronger agreement with measured GFR.  In adults, the CKD Epidemiology Collaboration (CKD-EPI) equations with creatinine and/or cystatin C are the most accurate and precise estimating equations.  Despite recent advances, current estimates of GFR lack precision and accuracy before chronic kidney disease stage 3 (GFR < 60 mL/min/1.73 m(2)).  There is therefore an urgent need to improve the methods for estimating and measuring GFR.  In this review, we examine the current literature and data addressing measurement and estimation of GFR in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH_GNAkXtkK1vAgqb2vdc5fW6udTcc2eaBkaIG1o8Aj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkslWgtg%253D%253D&md5=b818c2a03101d8ed8091b87dc472026f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11892-015-0633-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11892-015-0633-2%26sid%3Dliteratum%253Aachs%26aulast%3DBjornstad%26aufirst%3DP.%26aulast%3DCherney%26aufirst%3DD.%2BZ.%26aulast%3DMaahs%26aufirst%3DD.%2BM.%26atitle%3DUpdate%2520on%2520estimation%2520of%2520kidney%2520function%2520in%2520diabetic%2520kidney%2520disease%26jtitle%3DCurr.%2520Diabetes%2520Rep.%26date%3D2015%26volume%3D15%26spage%3D57%26doi%3D10.1007%2Fs11892-015-0633-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komers, R.</span></span> <span> </span><span class="NLM_article-title">Pathophysiology of the diabetic kidney</span>. <i>Compr. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1002/cphy.c100049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fcphy.c100049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23733640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC3snpsVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1175-1232&author=V.+Vallonauthor=R.+Komers&title=Pathophysiology+of+the+diabetic+kidney&doi=10.1002%2Fcphy.c100049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of the diabetic kidney</span></div><div class="casAuthors">Vallon Volker; Komers Radko</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1175-232</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes mellitus contributes greatly to morbidity, mortality, and overall health care costs.  In major part, these outcomes derive from the high incidence of progressive kidney dysfunction in patients with diabetes making diabetic nephropathy a leading cause of end-stage renal disease.  A better understanding of the molecular mechanism involved and of the early dysfunctions observed in the diabetic kidney may permit the development of new strategies to prevent diabetic nephropathy.  Here we review the pathophysiological changes that occur in the kidney in response to hyperglycemia, including the cellular responses to high glucose and the responses in vascular, glomerular, podocyte, and tubular function.  The molecular basis, characteristics, and consequences of the unique growth phenotypes observed in the diabetic kidney, including glomerular structures and tubular segments, are outlined.  We delineate mechanisms of early diabetic glomerular hyperfiltration including primary vascular events as well as the primary role of tubular growth, hyperreabsorption, and tubuloglomerular communication as part of a "tubulocentric" concept of early diabetic kidney function.  The latter also explains the "salt paradox" of the early diabetic kidney, that is, a unique and inverse relationship between glomerular filtration rate and dietary salt intake.  The mechanisms and consequences of the intrarenal activation of the renin-angiotensin system and of diabetes-induced tubular glycogen accumulation are discussed.  Moreover, we aim to link the changes that occur early in the diabetic kidney including the growth phenotype, oxidative stress, hypoxia, and formation of advanced glycation end products to mechanisms involved in progressive kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUksfu_AqPfIJKJbLTgsvCfW6udTcc2eYy0xJ19EgigLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpsVenuw%253D%253D&md5=f8a87e98229981f236b5f0e4352a1628</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcphy.c100049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcphy.c100049%26sid%3Dliteratum%253Aachs%26aulast%3DVallon%26aufirst%3DV.%26aulast%3DKomers%26aufirst%3DR.%26atitle%3DPathophysiology%2520of%2520the%2520diabetic%2520kidney%26jtitle%3DCompr.%2520Physiol.%26date%3D2011%26volume%3D1%26spage%3D1175%26epage%3D1232%26doi%3D10.1002%2Fcphy.c100049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pofi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Mario, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigante, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidori, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbano, B.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy: focus on current and future therapeutic strategies</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.2174/138920021705160324165553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2174%2F138920021705160324165553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27025881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=497-502&author=R.+Pofiauthor=F.+Di+Marioauthor=A.+Giganteauthor=E.+Rosatoauthor=A.+M.+Isidoriauthor=A.+Amorosoauthor=R.+Cianciauthor=B.+Barbano&title=Diabetic+nephropathy%3A+focus+on+current+and+future+therapeutic+strategies&doi=10.2174%2F138920021705160324165553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies</span></div><div class="casAuthors">Pofi, Riccardo; Di Mario, Francesca; Gigante, Antonietta; Rosato, Edoardo; Isidori, Andrea M.; Amoroso, Antonio; Cianci, Rosario; Barbano, Biagio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-502</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Diabetic nephropathy (DN) is currently the most common cause of end-stage renal disease (ESRD).  Although nowadays much is known about its classification, pathogenesis, clin. manifestations and evolution, to date we are not yet able to stop the natural progression of nephropathy in diabetic patients.  Methods: Treatment options are: lifestyle change with close blood pressure monitoring and tight glycemic control.  The most common therapies adopted for this condition are Angiotensing Converting Enzyme-inhibitors (ACEi).  However these drugs are able to block the progression of renal damage only in a small proportion of patients.  In the remaining, DN progresses and may evolve into ESRD.  Conclusion: The purpose of this review is to summarize the "state of art" of current novel therapeutic strategies to stem this debilitating kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplcNGcI2UHBLVg90H21EOLACvtfcHk0lgd9MbArsiw-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kgur0%253D&md5=faffcf485059720f4deaa5b19c7f08b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F138920021705160324165553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920021705160324165553%26sid%3Dliteratum%253Aachs%26aulast%3DPofi%26aufirst%3DR.%26aulast%3DDi%2BMario%26aufirst%3DF.%26aulast%3DGigante%26aufirst%3DA.%26aulast%3DRosato%26aufirst%3DE.%26aulast%3DIsidori%26aufirst%3DA.%2BM.%26aulast%3DAmoroso%26aufirst%3DA.%26aulast%3DCianci%26aufirst%3DR.%26aulast%3DBarbano%26aufirst%3DB.%26atitle%3DDiabetic%2520nephropathy%253A%2520focus%2520on%2520current%2520and%2520future%2520therapeutic%2520strategies%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2016%26volume%3D17%26spage%3D497%26epage%3D502%26doi%3D10.2174%2F138920021705160324165553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1111/febs.13698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Ffebs.13698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26934201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=2987-3001&author=F.+A.+Rossauthor=C.+MacKintoshauthor=D.+G.+Hardie&title=AMP-activated+protein+kinase%3A+a+cellular+energy+sensor+that+comes+in+12+flavours&doi=10.1111%2Ffebs.13698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours</span></div><div class="casAuthors">Ross, Fiona A.; MacKintosh, Carol; Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2987-3001</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The AMP-activated protein kinase (AMPK) is a sensor of cellular energy status that is expressed in essentially all eukaryotic cells, suggesting that it arose during early eukaryotic evolution.  It occurs universally as heterotrimeric complexes contg. catalytic α subunits and regulatory β and γ subunits.  Although Drosophila melanogaster contains single genes encoding each subunit, in mammals, each subunit exists as multiple isoforms encoded by distinct genes, giving rise to up to 12 heterotrimeric combinations.  The multiple isoforms of each subunit are 2R-ohnologues generated by the two rounds of whole genome duplication that occurred at the evolutionary origin of the vertebrates.  Although the differential roles of these isoform combinations remain only partly understood, there are indications that they may have different subcellular locations, different inputs and outputs, and different functions.  The multiple isoforms are of particular interest with respect to the roles of AMPK in cancer because the genes encoding some isoforms, such as PRKAA1 and PRKAB2 (encoding α1 and β2), are quite frequently amplified in tumor cells, whereas the genes encoding others, such as PRKAA2 (encoding α2), tend to be mutated, which, in some but not all cases, may result in a loss of function.  Thus, although AMPK acts downstream of the tumor suppressor liver kinase B1, and some of its isoform combinations may act as tumor suppressors that restrain the growth and proliferation of tumor cells, other isoform combinations may paradoxically act as oncogenes, perhaps by aiding the survival of tumor cells undergoing environmental stresses such as hypoxia or nutrient deprivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfm7YmLb0fCLVg90H21EOLACvtfcHk0lgd9MbArsiw-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVSjtro%253D&md5=0b65385fe0f4973621e06b0a204c15aa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13698%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-activated%2520protein%2520kinase%253A%2520a%2520cellular%2520energy%2520sensor%2520that%2520comes%2520in%252012%2520flavours%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D2987%26epage%3D3001%26doi%3D10.1111%2Ffebs.13698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihaylova, M.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span> <span> </span><span class="NLM_article-title">The AMPK signalling pathway coordinates cell growth, autophagy and metabolism</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1038/ncb2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fncb2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21892142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWlsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1016-1023&author=M.%0AM.+Mihaylovaauthor=R.+J.+Shaw&title=The+AMPK+signalling+pathway+coordinates+cell+growth%2C+autophagy+and+metabolism&doi=10.1038%2Fncb2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The AMPK signaling pathway coordinates cell growth, autophagy and metabolism</span></div><div class="casAuthors">Mihaylova, Maria M.; Shaw, Reuben J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1016-1023</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One of the central regulators of cellular and organismal metab. in eukaryotes is AMP-activated protein kinase (AMPK), which is activated when intracellular ATP prodn. decreases.  AMPK plays crit. roles in regulating growth and reprogramming metab., and has recently been connected to cellular processes such as autophagy and cell polarity.  Here, the authors review a no. of recent breakthroughs in the mechanistic understanding of AMPK function, focusing on a no. of newly identified downstream effectors of AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFKHyhC51s5bVg90H21EOLACvtfcHk0lgTNxBhM1MksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWlsrfO&md5=ad907d9e0f7754f359114327c98aed19</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncb2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2329%26sid%3Dliteratum%253Aachs%26aulast%3DMihaylova%26aufirst%3DM.%2BM.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520AMPK%2520signalling%2520pathway%2520coordinates%2520cell%2520growth%252C%2520autophagy%2520and%2520metabolism%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1016%26epage%3D1023%26doi%3D10.1038%2Fncb2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5139</span>– <span class="NLM_lpage">5148</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.09.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.bmcl.2016.09.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27727125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5139-5148&author=K.+O.+Cameronauthor=R.+G.+Kurumbail&title=Recent+progress+in+the+identification+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29+activators&doi=10.1016%2Fj.bmcl.2016.09.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators</span></div><div class="casAuthors">Cameron, Kimberly O.; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5139-5148</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine monophosphate-activated protein kinase (AMPK), a serine/threonine heterotrimeric protein kinase, is a crit. regulator of cellular and whole body energy homeostasis.  There are twelve known AMPK isoforms that are differentially expressed in tissues and species.  Dysregulation of AMPK signaling is assocd. with a multitude of human pathologies.  Hence isoform-selective activators of AMPK are actively being sought for the treatment of cardiovascular and metabolic diseases.  The present review summarizes the status of direct AMPK activators from the patent and published literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGznmXmj3uArVg90H21EOLACvtfcHk0lgTNxBhM1MksQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CltLrM&md5=4581cdf6c050bd165e9e058ea5551ffb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.09.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.09.065%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DRecent%2520progress%2520in%2520the%2520identification%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5139%26epage%3D5148%26doi%3D10.1016%2Fj.bmcl.2016.09.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasenour, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughey, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, D. H.</span></span> <span> </span><span class="NLM_article-title">5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">5950</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.528232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1074%2Fjbc.M113.528232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5950-5959&author=C.+M.+Hasenourauthor=D.+E.+Ridleyauthor=C.+C.+Hugheyauthor=F.+D.+Jamesauthor=E.+P.+Donahueauthor=J.+Shearerauthor=B.+Violletauthor=M.+Foretzauthor=D.+H.+Wasserman&title=5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside+%28AICAR%29+effect+on+glucose+production%2C+but+not+energy+metabolism%2C+is+independent+of+hepatic+AMPK+in+vivo&doi=10.1074%2Fjbc.M113.528232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.528232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.528232%26sid%3Dliteratum%253Aachs%26aulast%3DHasenour%26aufirst%3DC.%2BM.%26aulast%3DRidley%26aufirst%3DD.%2BE.%26aulast%3DHughey%26aufirst%3DC.%2BC.%26aulast%3DJames%26aufirst%3DF.%2BD.%26aulast%3DDonahue%26aufirst%3DE.%2BP.%26aulast%3DShearer%26aufirst%3DJ.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DWasserman%26aufirst%3DD.%2BH.%26atitle%3D5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside%2520%2528AICAR%2529%2520effect%2520on%2520glucose%2520production%252C%2520but%2520not%2520energy%2520metabolism%252C%2520is%2520independent%2520of%2520hepatic%2520AMPK%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5950%26epage%3D5959%26doi%3D10.1074%2Fjbc.M113.528232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinpashneh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mithieux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span> <span> </span><span class="NLM_article-title">Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">2355</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.1172/JCI40671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1172%2FJCI40671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=2355-2369&author=M.+Foretzauthor=S.+Hebrardauthor=J.+Leclercauthor=E.+Zarrinpashnehauthor=M.+Sotyauthor=G.+Mithieuxauthor=K.+Sakamotoauthor=F.+Andreelliauthor=B.+Viollet&title=Metformin+inhibits+hepatic+gluconeogenesis+in+mice+independently+of+the+LKB1%2FAMPK+pathway+via+a+decrease+in+hepatic+energy+state&doi=10.1172%2FJCI40671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1172%2FJCI40671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI40671%26sid%3Dliteratum%253Aachs%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DHebrard%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DJ.%26aulast%3DZarrinpashneh%26aufirst%3DE.%26aulast%3DSoty%26aufirst%3DM.%26aulast%3DMithieux%26aufirst%3DG.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DAndreelli%26aufirst%3DF.%26aulast%3DViollet%26aufirst%3DB.%26atitle%3DMetformin%2520inhibits%2520hepatic%2520gluconeogenesis%2520in%2520mice%2520independently%2520of%2520the%2520LKB1%252FAMPK%2520pathway%2520via%2520a%2520decrease%2520in%2520hepatic%2520energy%2520state%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D2355%26epage%3D2369%26doi%3D10.1172%2FJCI40671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cool, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kifle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyengar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kym, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frevert, E.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2006.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.cmet.2006.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=16753576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1eku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=403-416&author=B.+Coolauthor=B.+Zinkerauthor=W.+Chiouauthor=L.+Kifleauthor=N.+Caoauthor=M.+Perhamauthor=R.+Dickinsonauthor=A.+Adlerauthor=G.+Gagneauthor=R.+Iyengarauthor=G.+Zhaoauthor=K.+Marshauthor=P.+Kymauthor=P.+Jungauthor=H.+S.+Campauthor=E.+Frevert&title=Identification+and+characterization+of+a+small+molecule+AMPK+activator+that+treats+key+components+of+type+2+diabetes+and+the+metabolic+syndrome&doi=10.1016%2Fj.cmet.2006.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome</span></div><div class="casAuthors">Cool, Barbara; Zinker, Bradley; Chiou, William; Kifle, Lemma; Cao, Ning; Perham, Matthew; Dickinson, Robert; Adler, Andrew; Gagne, Gerard; Iyengar, Rajesh; Zhao, Gang; Marsh, Kennan; Kym, Philip; Jung, Paul; Camp, Heidi S.; Frevert, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">403-416</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a key sensor and regulator of intracellular and whole-body energy metab.  The authors have identified a thienopyridone family of AMPK activators.  A-769662 directly stimulated partially purified rat liver AMPK (EC50 = 0.8 μM) and inhibited fatty acid synthesis in primary rat hepatocytes (IC50 = 3.2 μM).  Short-term treatment of normal Sprague Dawley rats with A-769662 decreased liver malonyl Co-A levels and the respiratory exchange ratio, VCO2/VO2, indicating an increased rate of whole-body fatty acid oxidn.  Treatment of ob/ob mice with 30 mg/kg b.i.d. A-769662 decreased hepatic expression of PEPCK, G6Pase, and FAS, lowered plasma glucose by 40%, reduced body wt. gain and significantly decreased both plasma and liver triglyceride levels.  These results demonstrate that small mol. mediated activation of AMPK in vivo is feasible and represents a promising approach for the treatment of type 2 diabetes and the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcoMCQ6mqiLVg90H21EOLACvtfcHk0ljQHUV76fPbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1eku70%253D&md5=710c43b18664c5f29b9cdd5dee5e9e90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DCool%26aufirst%3DB.%26aulast%3DZinker%26aufirst%3DB.%26aulast%3DChiou%26aufirst%3DW.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DPerham%26aufirst%3DM.%26aulast%3DDickinson%26aufirst%3DR.%26aulast%3DAdler%26aufirst%3DA.%26aulast%3DGagne%26aufirst%3DG.%26aulast%3DIyengar%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKym%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DP.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DFrevert%26aufirst%3DE.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520small%2520molecule%2520AMPK%2520activator%2520that%2520treats%2520key%2520components%2520of%2520type%25202%2520diabetes%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D403%26epage%3D416%26doi%3D10.1016%2Fj.cmet.2006.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Galeno, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grote, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craigo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Poelje, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cable, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolzin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linemeyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span> <span> </span><span class="NLM_article-title">A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1021/ml100143q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100143q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=478-482&author=J.+E.+Gomez-Galenoauthor=Q.+Dangauthor=T.+H.+Nguyenauthor=S.+H.+Boyerauthor=M.+P.+Groteauthor=Z.+Sunauthor=M.+Chenauthor=W.+A.+Craigoauthor=P.+D.+van+Poeljeauthor=D.+A.+MacKennaauthor=E.+E.+Cableauthor=P.+A.+Rolzinauthor=P.+D.+Finnauthor=B.+Chiauthor=D.+L.+Linemeyerauthor=S.+J.+Heckerauthor=M.+D.+Erion&title=A+Potent+and+Selective+AMPK+Activator+That+Inhibits+de+Novo+Lipogenesis&doi=10.1021%2Fml100143q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fml100143q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100143q%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Galeno%26aufirst%3DJ.%2BE.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DGrote%26aufirst%3DM.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCraigo%26aufirst%3DW.%2BA.%26aulast%3Dvan%2BPoelje%26aufirst%3DP.%2BD.%26aulast%3DMacKenna%26aufirst%3DD.%2BA.%26aulast%3DCable%26aufirst%3DE.%2BE.%26aulast%3DRolzin%26aufirst%3DP.%2BA.%26aulast%3DFinn%26aufirst%3DP.%2BD.%26aulast%3DChi%26aufirst%3DB.%26aulast%3DLinemeyer%26aufirst%3DD.%2BL.%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DA%2520Potent%2520and%2520Selective%2520AMPK%2520Activator%2520That%2520Inhibits%2520de%2520Novo%2520Lipogenesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D478%26epage%3D482%26doi%3D10.1021%2Fml100143q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization and discovery of 5-((5-([1,1’-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid (MK-3903): a novel class of benzimidazole-based activators of amp-activated protein kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9040</span>– <span class="NLM_lpage">9052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9040-9052&author=P.+Lanauthor=F.+A.+Romeroauthor=D.+Wodkaauthor=A.+J.+Kassickauthor=Q.+Dangauthor=T.+Gibsonauthor=D.+Cashionauthor=G.+Zhouauthor=Y.+Chenauthor=X.+Zhangauthor=A.+Zhangauthor=Y.+Liauthor=M.+E.+Trujilloauthor=Q.+Shaoauthor=M.+Wuauthor=S.+Xuauthor=H.+Heauthor=D.+MacKennaauthor=J.+Stauntonauthor=K.+T.+Chapmanauthor=A.+Weberauthor=I.+K.+Sebhatauthor=G.+M.+Makara&title=Hit-to-lead+optimization+and+discovery+of+5-%28%285-%28%5B1%2C1%E2%80%99-Biphenyl%5D-4-yl%29-6-chloro-1H-benzo%5Bd%5Dimidazol-2-yl%29oxy%29-2-methylbenzoic+acid+%28MK-3903%29%3A+a+novel+class+of+benzimidazole-based+activators+of+amp-activated+protein+kinase&doi=10.1021%2Facs.jmedchem.7b01344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase</span></div><div class="casAuthors">Lan, Ping; Romero, F. Anthony; Wodka, Dariusz; Kassick, Andrew J.; Dang, Qun; Gibson, Tony; Cashion, Daniel; Zhou, Gaochao; Chen, Yuli; Zhang, Xiaoping; Zhang, Aihua; Li, Ying; Trujillo, Maria E.; Shao, Qing; Wu, Margaret; Xu, Shiyao; He, Huaibing; MacKenna, Deidre; Staunton, Jocelyn; Chapman, Kevin T.; Weber, Ann; Sebhat, Iyassu K.; Makara, Gergely M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9040-9052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays an essential role as a cellular energy sensor and master regulator of metab. in eukaryotes.  Dysregulated lipid and carbohydrate metab. resulting from insulin resistance leads to hyperglycemia, the hallmark of type 2 diabetes mellitus (T2DM).  While pharmacol. activation of AMPK is anticipated to improve these parameters, the discovery of selective, direct activators has proven challenging.  The authors now describe a hit-to-lead effort resulting in the discovery of a potent and selective class of benzimidazole-based direct AMPK activators, exemplified by 5-((5-([1,1'-biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid, (I) (MK-3903).  Compd. I exhibited robust target engagement in mouse liver following oral dosing, leading to improved lipid metab. and insulin sensitization in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq1hsQVY4LybVg90H21EOLACvtfcHk0ljQHUV76fPbZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns77K&md5=83e7343b1bfa589036c3bcb5ab8e62c1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01344%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DP.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DMacKenna%26aufirst%3DD.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DHit-to-lead%2520optimization%2520and%2520discovery%2520of%25205-%2528%25285-%2528%255B1%252C1%25E2%2580%2599-Biphenyl%255D-4-yl%2529-6-chloro-1H-benzo%255Bd%255Dimidazol-2-yl%2529oxy%2529-2-methylbenzoic%2520acid%2520%2528MK-3903%2529%253A%2520a%2520novel%2520class%2520of%2520benzimidazole-based%2520activators%2520of%2520amp-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9040%26epage%3D9052%26doi%3D10.1021%2Facs.jmedchem.7b01344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahalada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Trotter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conarello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Painter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohm, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFranco Scheuch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1126/science.aah5582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1126%2Fscience.aah5582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=28705990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GgsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=507-511&author=R.+W.+Myersauthor=H.+P.+Guanauthor=J.+Ehrhartauthor=A.+Petrovauthor=S.+Prahaladaauthor=E.+Tozzoauthor=X.+Yangauthor=M.+M.+Kurtzauthor=M.+Trujilloauthor=D.+Gonzalez+Trotterauthor=D.+Fengauthor=S.+Xuauthor=G.+Eiermannauthor=M.+A.+Holahanauthor=D.+Rubinsauthor=S.+Conarelloauthor=X.+Niuauthor=S.+C.+Souzaauthor=C.+Millerauthor=J.+Liuauthor=K.+Luauthor=W.+Fengauthor=Y.+Liauthor=R.+E.+Painterauthor=J.+A.+Milliganauthor=H.+Heauthor=F.+Liuauthor=A.+Ogawaauthor=D.+Wisniewskiauthor=R.+J.+Rohmauthor=L.+Wangauthor=M.+Bunzelauthor=Y.+Qianauthor=W.+Zhuauthor=H.+Wangauthor=B.+Bennetauthor=L.+LaFranco+Scheuchauthor=G.+E.+Fernandezauthor=C.+Liauthor=M.+Klimasauthor=G.+Zhouauthor=M.+van+Heekauthor=T.+Biftuauthor=A.+Weberauthor=D.+E.+Kelleyauthor=N.+Thornberryauthor=M.+D.+Erionauthor=D.+M.+Kempauthor=I.+K.+Sebhat&title=Systemic+pan-AMPK+activator+MK-8722+improves+glucose+homeostasis+but+induces+cardiac+hypertrophy&doi=10.1126%2Fscience.aah5582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span></div><div class="casAuthors">Myers, Robert W.; Guan, Hong-Ping; Ehrhart, Juliann; Petrov, Aleksandr; Prahalada, Srinivasa; Tozzo, Effie; Yang, Xiaodong; Kurtz, Marc M.; Trujillo, Maria; Gonzalez Trotter, Dinko; Feng, Danqing; Xu, Shiyao; Eiermann, George; Holahan, Marie A.; Rubins, Daniel; Conarello, Stacey; Niu, Xiaoda; Souza, Sandra C.; Miller, Corin; Liu, Jinqi; Lu, Ku; Feng, Wen; Li, Ying; Painter, Ronald E.; Milligan, James A.; He, Huaibing; Liu, Franklin; Ogawa, Aimie; Wisniewski, Douglas; Rohm, Rory J.; Wang, Liyang; Bunzel, Michelle; Qian, Ying; Zhu, Wei; Wang, Hongwu; Bennet, Bindu; La Franco Scheuch, Lisa; Fernandez, Guillermo E.; Li, Cai; Klimas, Michael; Zhou, Gaochao; van Heek, Margaret; Biftu, Tesfaye; Weber, Ann; Kelley, David E.; Thornberry, Nancy; Erion, Mark D.; Kemp, Daniel M.; Sebhat, Iyassu K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6350</span>),
    <span class="NLM_cas:pages">507-511</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">5'-Adenosine monophosphate-activated protein kinase (AMPK) is a master regulator of energy homeostasis in eukaryotes.  Despite three decades of investigation, the biol. roles of AMPK and its potential as a drug target remain incompletely understood, largely because of a lack of optimized pharmacol. tools.  We developed MK-8722, a potent, direct, allosteric activator of all 12 mammalian AMPK complexes.  In rodents and rhesus monkeys, MK-8722-mediated AMPK activation in skeletal muscle induced robust, durable, insulin-independent glucose uptake and glycogen synthesis, with resultant improvements in glycemia and no evidence of hypoglycemia.  These effects translated across species, including diabetic rhesus monkeys, but manifested with concomitant cardiac hypertrophy and increased cardiac glycogen without apparent functional sequelae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0ek6_5L1ybVg90H21EOLACvtfcHk0lj7ditzPrpxMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GgsrfO&md5=9dcb25412cf382cb3e1c8908a467f4b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5582%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DPrahalada%26aufirst%3DS.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DGonzalez%2BTrotter%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DRubins%26aufirst%3DD.%26aulast%3DConarello%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DSouza%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPainter%26aufirst%3DR.%2BE.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DRohm%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBunzel%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBennet%26aufirst%3DB.%26aulast%3DLaFranco%2BScheuch%26aufirst%3DL.%26aulast%3DFernandez%26aufirst%3DG.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DKlimas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DKemp%26aufirst%3DD.%2BM.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DSystemic%2520pan-AMPK%2520activator%2520MK-8722%2520improves%2520glucose%2520homeostasis%2520but%2520induces%2520cardiac%2520hypertrophy%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D507%26epage%3D511%26doi%3D10.1126%2Fscience.aah5582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kekec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dropinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8722: a systemic, direct pan-activator of AMP-activated protein kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2mt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=39-44&author=D.+Fengauthor=T.+Biftuauthor=F.+A.+Romeroauthor=A.+Kekecauthor=J.+Dropinskiauthor=A.+Kassickauthor=S.+Xuauthor=M.+M.+Kurtzauthor=A.+Gollapudiauthor=Q.+Shaoauthor=X.+Yangauthor=K.+Luauthor=G.+Zhouauthor=D.+Kempauthor=R.+W.+Myersauthor=H.+P.+Guanauthor=M.+E.+Trujilloauthor=C.+Liauthor=A.+Weberauthor=I.+K.+Sebhat&title=Discovery+of+MK-8722%3A+a+systemic%2C+direct+pan-activator+of+AMP-activated+protein+kinase&doi=10.1021%2Facsmedchemlett.7b00417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase</span></div><div class="casAuthors">Feng, Danqing; Biftu, Tesfaye; Romero, F. Anthony; Kekec, Ahmet; Dropinski, James; Kassick, Andrew; Xu, Shiyao; Kurtz, Marc M.; Gollapudi, Anantha; Shao, Qing; Yang, Xiaodong; Lu, Ku; Zhou, Gaochao; Kemp, Daniel; Myers, Robert W.; Guan, Hong-Ping; Trujillo, Maria E.; Li, Cai; Weber, Ann; Sebhat, Iyassu K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-44</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5'-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and wt. loss including lipid and glucose trafficking.  As such, the enzyme has long been of interest as a target for the treatment of Type 2 Diabetes Mellitus.  The authors describe the optimization of β1-selective, liver-targeted AMPK activators and their evolution into systemic pan-activators capable of acutely lowering glucose in mouse models.  Identifying surrogates for the key acid moiety in early generation compds. proved essential in improving β2-activation and in balancing improvements in plasma unbound fraction while avoiding liver sequestration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ68Ya7WPDaLVg90H21EOLACvtfcHk0lj7ditzPrpxMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2mt77J&md5=c3cc173033071b400200fbed73d91087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00417%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DKekec%26aufirst%3DA.%26aulast%3DDropinski%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DKemp%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DDiscovery%2520of%2520MK-8722%253A%2520a%2520systemic%252C%2520direct%2520pan-activator%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D39%26epage%3D44%26doi%3D10.1021%2Facsmedchemlett.7b00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Stanic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhtman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepetan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosius, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4899</span>, <span class="refDoi"> DOI: 10.1172/JCI66218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1172%2FJCI66218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24135141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4888-4899&author=L.+L.+Duganauthor=Y.+H.+Youauthor=S.+S.+Aliauthor=M.+Diamond-Stanicauthor=S.+Miyamotoauthor=A.+E.+DeClevesauthor=A.+Andreyevauthor=T.+Quachauthor=S.+Lyauthor=G.+Shekhtmanauthor=W.+Nguyenauthor=A.+Chepetanauthor=T.+P.+Leauthor=L.+Wangauthor=M.+Xuauthor=K.+P.+Paikauthor=A.+Fogoauthor=B.+Violletauthor=A.+Murphyauthor=F.+Brosiusauthor=R.+K.+Naviauxauthor=K.+Sharma&title=AMPK+dysregulation+promotes+diabetes-related+reduction+of+superoxide+and+mitochondrial+function&doi=10.1172%2FJCI66218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span></div><div class="casAuthors">Dugan, Laura L.; You, Young-Hyun; Ali, Sameh S.; Diamond-Stanic, Maggie; Miyamoto, Satoshi; De Cleves, Anne-Emilie; Andreyev, Aleksander; Quach, Tammy; Ly, San; Shekhtman, Grigory; Nguyen, William; Chepetan, Andre; Le, Thuy P.; Wang, Lin; Xu, Ming; Paik, Kacie P.; Fogo, Agnes; Viollet, Benoit; Murphy, Anne; Brosius, Frank; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4888-4899</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion prodn.  Here, we report that superoxide prodn. was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and ESR anal.  Redn. of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were obsd. in kidneys from diabetic mice.  These observations were consistent with an overall redn. of mitochondrial glucose oxidn.  Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans.  Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR).  AICAR treatment induced superoxide prodn. and was linked with glomerular matrix and albuminuria redn. in the diabetic kidney.  Furthermore, diabetic heterozygous superoxide dismutase 2 (Sod2+/-) mice had no evidence of increased renal disease, and Ampka2-/- mice had increased albuminuria that was not reduced with AICAR treatment.  Redn. of mitochondrial superoxide prodn. with rotenone was sufficient to reduce AMPK phosphorylation in mouse kidneys.  Taken together, these results demonstrate that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide prodn. and mitochondrial function while reducing disease activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQbY5f3Z-crVg90H21EOLACvtfcHk0lh_mNjPODEXzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O&md5=e907941fec351c3da469acc473e24ae6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI66218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66218%26sid%3Dliteratum%253Aachs%26aulast%3DDugan%26aufirst%3DL.%2BL.%26aulast%3DYou%26aufirst%3DY.%2BH.%26aulast%3DAli%26aufirst%3DS.%2BS.%26aulast%3DDiamond-Stanic%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DDeCleves%26aufirst%3DA.%2BE.%26aulast%3DAndreyev%26aufirst%3DA.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DShekhtman%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DW.%26aulast%3DChepetan%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DK.%2BP.%26aulast%3DFogo%26aufirst%3DA.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DBrosius%26aufirst%3DF.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520dysregulation%2520promotes%2520diabetes-related%2520reduction%2520of%2520superoxide%2520and%2520mitochondrial%2520function%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4888%26epage%3D4899%26doi%3D10.1172%2FJCI66218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariappan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sataranatarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahimainathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasinath, B. S.</span></span> <span> </span><span class="NLM_article-title">A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">F617</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00278.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1152%2Fajprenal.00278.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=17018841" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=F617-627&author=M.+J.+Leeauthor=D.+Feliersauthor=M.+M.+Mariappanauthor=K.+Sataranatarajanauthor=L.+Mahimainathanauthor=N.+Musiauthor=M.+Foretzauthor=B.+Violletauthor=J.+M.+Weinbergauthor=G.+G.+Choudhuryauthor=B.+S.+Kasinath&title=A+role+for+AMP-activated+protein+kinase+in+diabetes-induced+renal+hypertrophy&doi=10.1152%2Fajprenal.00278.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00278.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00278.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFeliers%26aufirst%3DD.%26aulast%3DMariappan%26aufirst%3DM.%2BM.%26aulast%3DSataranatarajan%26aufirst%3DK.%26aulast%3DMahimainathan%26aufirst%3DL.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DWeinberg%26aufirst%3DJ.%2BM.%26aulast%3DChoudhury%26aufirst%3DG.%2BG.%26aulast%3DKasinath%26aufirst%3DB.%2BS.%26atitle%3DA%2520role%2520for%2520AMP-activated%2520protein%2520kinase%2520in%2520diabetes-induced%2520renal%2520hypertrophy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DF617%26epage%3D627%26doi%3D10.1152%2Fajprenal.00278.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011010026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1681%2FASN.2011010026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21921143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1846-1855&author=A.+E.+Declevesauthor=A.+V.+Mathewauthor=R.+Cunardauthor=K.+Sharma&title=AMPK+mediates+the+initiation+of+kidney+disease+induced+by+a+high-fat+diet&doi=10.1681%2FASN.2011010026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span></div><div class="casAuthors">Decleves, Anne-Emilie; Mathew, Anna V.; Cunard, Robyn; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1855</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The mechanisms underlying the assocn. between obesity and progressive renal disease are not well understood.  Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiol. of kidney disease induced by a high-fat diet is unknown.  In this study, we randomly assigned C57BL/6J mice to a std. or high-fat diet.  After 1 wk, mice fed a high-fat diet exhibited an increase in body wt., renal hypertrophy, an increase in urine H2O2 and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity.  Urine ACR progressively increased after 4 wk of a high-fat diet.  After 12 wk, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed.  To det. whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 wk.  Although AMPK activation did not abrogate the wt. gain, it reduced the renal hypertrophy, urine H2O2, and urine and renal MCP-1.  In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells.  In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyy7LBMHJALVg90H21EOLACvtfcHk0lh_mNjPODEXzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM&md5=7e1ca714e5b6c691934a75df032eda20</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1681%2FASN.2011010026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011010026%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DMathew%26aufirst%3DA.%2BV.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520mediates%2520the%2520initiation%2520of%2520kidney%2520disease%2520induced%2520by%2520a%2520high-fat%2520diet%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D1846%26epage%3D1855%26doi%3D10.1681%2FASN.2011010026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K. P.</span></span> <span> </span><span class="NLM_article-title">Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2013.1508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.3892%2Fijmm.2013.1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24068196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFymtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1293-1302&author=D.+Kimauthor=J.+E.+Leeauthor=Y.+J.+Jungauthor=A.+S.+Leeauthor=S.+Leeauthor=S.+K.+Parkauthor=S.+H.+Kimauthor=B.+H.+Parkauthor=W.+Kimauthor=K.+P.+Kang&title=Metformin+decreases+high-fat+diet-induced+renal+injury+by+regulating+the+expression+of+adipokines+and+the+renal+AMP-activated+protein+kinase%2Facetyl-CoA+carboxylase+pathway+in+mice&doi=10.3892%2Fijmm.2013.1508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice</span></div><div class="casAuthors">Kim, Dal; Lee, Jung Eun; Jung, Yu Jin; Lee, Ae Sin; Lee, Sik; Park, Sung Kwang; Kim, Suhn Hee; Park, Byung-Hyun; Kim, Won; Kang, Kyung Pyo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-1302</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Metabolic syndrome is characterized by insulin resistance, dyslipidemia and hypertension.  These metabolic changes contribute to the development of obesity-induced kidney injury.  AMP-activated protein kinase (AMPK) is a ubiquitous enzyme that is involved in the cellular metabolic response to metabolic stress.  Metformin, an AMPK activator, has been reported to exert a protective effect against nonalcoholic steatohepatitis.  However, little is known about its role in the pathogenesis of obesity-induced renal injury.  The aim of this study was to investigate the effects of metformin on high-fat diet (HFD)-induced kidney injury.  Obesity was induced by HFD (60% of total calories from fat, 20% protein and 20% carbohydrates) in 6-wk-old C57BL/6 mice.  Mice were fed HFD plus 0.5% metformin.  The effects of metformin on HFD-induced renal injury were evaluated by detg. metabolic parameters, serum adipokine levels and renal AMPK/acetyl-CoA carboxylase (ACC) activities, as well as a histol. examn.  HFD induced metabolic derangement, systemic insulin resistance and glomerular mesangial matrix expansion.  The administration of metformin reduced HFD-induced metabolic derangement and renal injury.  The administration of metformin reduced the HFD-induced increase in adipokine expression and macrophage infiltration.  Moreover, renal AMPK activity, which was decreased by HFD, was recovered following the administration of metformin; in addn., fatty acid oxidn. was increased by the inhibition of ACC.  These results indicate that metformin exerts beneficial effects on obesity-induced renal injury by regulating systemic inflammation, insulin resistance and the renal AMPK/ACC pathway.  The clin. application of metformin to obese or early diabetic patients may be helpful in preventing obesity- or diabetes-related kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGat_Fam-w-7Vg90H21EOLACvtfcHk0ljt5R5xxxIZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFymtrvI&md5=8c8662b3eb7903dbddfe68c4baa4b587</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2013.1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2013.1508%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DKang%26aufirst%3DK.%2BP.%26atitle%3DMetformin%2520decreases%2520high-fat%2520diet-induced%2520renal%2520injury%2520by%2520regulating%2520the%2520expression%2520of%2520adipokines%2520and%2520the%2520renal%2520AMP-activated%2520protein%2520kinase%252Facetyl-CoA%2520carboxylase%2520pathway%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2013%26volume%3D32%26spage%3D1293%26epage%3D1302%26doi%3D10.3892%2Fijmm.2013.1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0ljt5R5xxxIZ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eYqNfgHA5f5nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabudhe, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.str.2014.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=25066137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1161-1172&author=M.+F.+Calabreseauthor=F.+Rajamohanauthor=M.+S.+Harrisauthor=N.+L.+Caspersauthor=R.+Magyarauthor=J.+M.+Withkaauthor=H.+Wangauthor=K.+A.+Borzilleriauthor=P.+V.+Sahasrabudheauthor=L.+R.+Hothauthor=K.+F.+Geogheganauthor=S.+Hanauthor=J.+Brownauthor=T.+A.+Subashiauthor=A.+R.+Reyesauthor=R.+K.+Frisbieauthor=J.+Wardauthor=R.+A.+Millerauthor=J.+A.+Landroauthor=A.+T.+Londreganauthor=P.+A.+Carpinoauthor=S.+Cabralauthor=A.+C.+Smithauthor=E.+L.+Connauthor=K.+O.+Cameronauthor=X.+Qiuauthor=R.+G.+Kurumbail&title=Structural+basis+for+AMPK+activation%3A+natural+and+synthetic+ligands+regulate+kinase+activity+from+opposite+poles+by+different+molecular+mechanisms&doi=10.1016%2Fj.str.2014.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms</span></div><div class="casAuthors">Calabrese, Matthew F.; Rajamohan, Francis; Harris, Melissa S.; Caspers, Nicole L.; Magyar, Rachelle; Withka, Jane M.; Wang, Hong; Borzilleri, Kris A.; Sahasrabudhe, Parag V.; Hoth, Lise R.; Geoghegan, Kieran F.; Han, Seungil; Brown, Janice; Subashi, Timothy A.; Reyes, Allan R.; Frisbie, Richard K.; Ward, Jessica; Miller, Russell A.; Landro, James A.; Londregan, Allyn T.; Carpino, Philip A.; Cabral, Shawn; Smith, Aaron C.; Conn, Edward L.; Cameron, Kimberly O.; Qiu, Xiayang; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1172</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a principal metabolic regulator affecting growth and response to cellular stress.  Comprised of catalytic and regulatory subunits, each present in multiple forms, AMPK is best described as a family of related enzymes.  In recent years, AMPK has emerged as a desirable target for modulation of numerous diseases, yet clin. therapies remain elusive.  Challenges result, in part, from an incomplete understanding of the structure and function of full-length heterotrimeric complexes.  In this work, we provide the full-length structure of the widely expressed α1β1γ1 isoform of mammalian AMPK, along with detailed kinetic and biophys. characterization.  We characterize binding of the broadly studied synthetic activator A769662 and its analogs.  Our studies follow on the heels of the recent disclosure of the α2β1γ1 structure and provide insight into the distinct mol. mechanisms of AMPK regulation by AMP and A769662.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFqyeOwFToerVg90H21EOLACvtfcHk0liMa-2z8FH6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM&md5=8a4edd6c5ff990d9e4c7e0cb16b7b873</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DMagyar%26aufirst%3DR.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%2BV.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DStructural%2520basis%2520for%2520AMPK%2520activation%253A%2520natural%2520and%2520synthetic%2520ligands%2520regulate%2520kinase%2520activity%2520from%2520opposite%2520poles%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D1161%26epage%3D1172%26doi%3D10.1016%2Fj.str.2014.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, G.</span></span> <span> </span><span class="NLM_article-title">Drug transport by organic anion transporters (OATs)</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.pharmthera.2012.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=22841915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=106-130&author=G.+Burckhardt&title=Drug+transport+by+organic+anion+transporters+%28OATs%29&doi=10.1016%2Fj.pharmthera.2012.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transport by Organic Anion Transporters (OATs)</span></div><div class="casAuthors">Burckhardt, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-130</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Common to all so far functionally characterized Org. Anion Transporters (OATs) is their broad substrate specificity and their ability to exchange extracellular against intracellular org. anions.  Many OATs occur in renal proximal tubules, the site of active drug secretion.  Exceptions are murine Oat6 (nasal epithelium), human OAT7 (liver), and rat Oat8 (renal collecting ducts).  In human kidneys, OAT1, OAT2, and OAT3 are localized in the basolateral membrane, and OAT4, OAT10, and URAT1 in the apical cell membrane of proximal tubule cells, resp.  In rats and mice, Oat1 and Oat3 are located basolaterally, and Oat2, Oat5, Oat9, Oat10, and Urat1 apically.  Several classes of drugs interact with human OAT1-3, including ACE inhibitors, angiotensin II receptor antagonists, diuretics, HMG CoA reductase inhibitors, β-lactam antibiotics, antineoplastic and antiviral drugs, and uricosuric drugs.  For most drugs, interaction was demonstrated in vitro by inhibition of OAT-mediated transport of model substrates; for some drugs, transport by OATs was directly proven.  Based on IC50 values reported in the literature, OAT1 and OAT3 show comparable affinities for diuretics, cephalosporins, and nonsteroidal anti-inflammatory drugs whereas OAT2 has a lower affinity to most of these compds.  Drug-drug interactions at OAT1 and OAT3 may retard renal drug secretion and cause untoward effects.  OAT4, OAT10, and URAT1 in the apical membrane contribute to proximal tubular urate absorption, and OAT10 to nicotinate absorption.  OAT4 is in addn. able to release drugs, e.g. diuretics, into the tubule lumen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGgKkR2dJ8ZbVg90H21EOLACvtfcHk0liMa-2z8FH6qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7zE&md5=b037994259a278be88d5dae854857abf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DBurckhardt%26aufirst%3DG.%26atitle%3DDrug%2520transport%2520by%2520organic%2520anion%2520transporters%2520%2528OATs%2529%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D106%26epage%3D130%26doi%3D10.1016%2Fj.pharmthera.2012.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromm, M. F.</span></span> <span> </span><span class="NLM_article-title">Transporter-mediated drug-drug interactions</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.2217/pgs.11.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2217%2Fpgs.11.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1017-1037&author=F.+Mullerauthor=M.+F.+Fromm&title=Transporter-mediated+drug-drug+interactions&doi=10.2217%2Fpgs.11.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2217%2Fpgs.11.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fpgs.11.44%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DF.%26aulast%3DFromm%26aufirst%3DM.%2BF.%26atitle%3DTransporter-mediated%2520drug-drug%2520interactions%26jtitle%3DPharmacogenomics%26date%3D2011%26volume%3D12%26spage%3D1017%26epage%3D1037%26doi%3D10.2217%2Fpgs.11.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanWert, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gionfriddo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, D. H.</span></span> <span> </span><span class="NLM_article-title">Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1002/bdd.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fbdd.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19953504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2jtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1-71&author=A.+L.+VanWertauthor=M.+R.+Gionfriddoauthor=D.+H.+Sweet&title=Organic+anion+transporters%3A+discovery%2C+pharmacology%2C+regulation+and+roles+in+pathophysiology&doi=10.1002%2Fbdd.693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology</span></div><div class="casAuthors">VanWert, Adam L.; Gionfriddo, Michael R.; Sweet, Douglas H.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-71</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the mechanisms behind inter- and intra-patient variability in drug response is inadequate.  Advances in the cytochrome P 450 drug metabolizing enzyme field have been remarkable, but those in the drug transporter field have trailed behind.  Currently, however, interest in carrier-mediated disposition of pharmacotherapeutics is on a substantial uprise.  This is exemplified by the 2006 FDA guidance statement directed to the pharmaceutical industry.  The guidance recommended that industry ascertain whether novel drug entities interact with transporters.  This suggestion likely stems from the observation that several novel cloned transporters contribute significantly to the disposition of various approved drugs.  Many drugs bear anionic functional groups, and thus interact with org. anion transporters (OATs).  Collectively, these transporters are nearly ubiquitously expressed in barrier epithelia.  Moreover, several reports indicate that OATs are subject to diverse forms of regulation, much like drug metabolizing enzymes and receptors.  Thus, crit. to furthering our understanding of patient- and condition-specific responses to pharmacotherapy is the complete characterization of OAT interactions with drugs and regulatory factors.  This review provides the reader with a comprehensive account of the function and substrate profile of cloned OATs.  In addn., a major focus of this review is on the regulation of OATs including the impact of transcriptional and epigenetic factors, phosphorylation, hormones and gender.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xJ8gprENA7Vg90H21EOLACvtfcHk0liJjOzCO8_RYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2jtrzM&md5=edffeb6b5fedca641828c2c077abda13</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fbdd.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.693%26sid%3Dliteratum%253Aachs%26aulast%3DVanWert%26aufirst%3DA.%2BL.%26aulast%3DGionfriddo%26aufirst%3DM.%2BR.%26aulast%3DSweet%26aufirst%3DD.%2BH.%26atitle%3DOrganic%2520anion%2520transporters%253A%2520discovery%252C%2520pharmacology%252C%2520regulation%2520and%2520roles%2520in%2520pathophysiology%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D1%26epage%3D71%26doi%3D10.1002%2Fbdd.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balac, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigam, S. K.</span></span> <span> </span><span class="NLM_article-title">Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approach</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.116.232660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27488918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWju77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2016&pages=215-229&author=H.+C.+Liuauthor=A.+Goldenbergauthor=Y.+Chenauthor=C.+Lunauthor=W.+Wuauthor=K.+T.+Bushauthor=N.+Balacauthor=P.+Rodriguezauthor=R.+Abagyanauthor=S.+K.+Nigam&title=Molecular+properties+of+drugs+interacting+with+SLC22+transporters+OAT1%2C+OAT3%2C+OCT1%2C+and+OCT2%3A+a+machine-learning+approach&doi=10.1124%2Fjpet.116.232660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approachs</span></div><div class="casAuthors">Liu, Henry C.; Goldenberg, Anne; Chen, Yuchen; Lun, Christina; Wu, Wei; Bush, Kevin T.; Balac, Natasha; Rodriguez, Paul; Abagyan, Ruben; Nigam, Sanjay K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-229</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Statistical anal. was performed on physicochem. descriptors of ∼250 drugs known to interact with one or more SLC22 "drug" transporters (i.e., SLC22A6 or OAT1, SLC22A8 or OAT3, SLC22A1 or OCT1, and SLC22A2 or OCT2), followed by application of machine-learning methods and wet lab. testing of novel predictions.  In addn. to mol. charge, org. anion transporters (OATs) were found to prefer interacting with planar structures, whereas org. cation transporters (OCTs) interact with more three-dimensional structures (i.e., greater SP3 character).  Moreover, compared with OAT1 ligands, OAT3 ligands possess more acyclic tetravalent bonds and have a more zwitterionic/cationic character.  In contrast, OCT1 and OCT2 ligands were not clearly distinquishable form one another by the methods employed.  Multiple pharmacophore models were generated on the basis of the drugs and, consistent with themachinelearning analyses, one unique pharmacophore created from ligands of OAT3 possessed cationic properties similar to OCT ligands; this was confirmed by quant. at. property field anal.  Virtual screening with this pharmacophore, followed by transport assays, identified several cationic drugs that selectively interact with OAT3 but not OAT1.  Although the present anal. may be somewhat limited by the need to rely largely on inhibition data formodeling, wet lab./in vitro transport studies, as well as anal. of drug/metabolite handling in Oat and Oct knockout animals, support the general validity of the approach-which can also be applied to other SLC and ATP binding cassette drug transporters.  This may make it possible to predict the mol. properties of a drug or metabolite necessary for interaction with the transporter(s), thereby enabling better prediction of drug-drug interactions and drug-metabolite interactions.  Furthermore, understanding the overlapping specificities of OATs and OCTs in the context of dynamic transporter tissue expression patterns should help predict net flux in a particular tissue of anionic, cationic, and zwitterionic mols. in normal and pathophysiol. states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBDvxy5NzvY7Vg90H21EOLACvtfcHk0liJjOzCO8_RYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWju77L&md5=89d3dbedb4b038fa5c4da6d8aa93d01d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232660%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DGoldenberg%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLun%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBush%26aufirst%3DK.%2BT.%26aulast%3DBalac%26aufirst%3DN.%26aulast%3DRodriguez%26aufirst%3DP.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DNigam%26aufirst%3DS.%2BK.%26atitle%3DMolecular%2520properties%2520of%2520drugs%2520interacting%2520with%2520SLC22%2520transporters%2520OAT1%252C%2520OAT3%252C%2520OCT1%252C%2520and%2520OCT2%253A%2520a%2520machine-learning%2520approach%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D359%26spage%3D215%26epage%3D229%26doi%3D10.1124%2Fjpet.116.232660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radcliffe, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seah, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerums, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekinci, E. I.</span></span> <span> </span><span class="NLM_article-title">Clinical predictive factors in diabetic kidney disease progression</span>. <i>J. Diabetes Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1111/jdi.12533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fjdi.12533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27181363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=6-18&author=N.+J.+Radcliffeauthor=J.+M.+Seahauthor=M.+Clarkeauthor=R.+J.+MacIsaacauthor=G.+Jerumsauthor=E.+I.+Ekinci&title=Clinical+predictive+factors+in+diabetic+kidney+disease+progression&doi=10.1111%2Fjdi.12533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical predictive factors in diabetic kidney disease progression</span></div><div class="casAuthors">Radcliffe, Nicholas J.; Seah, Jas-mine; Clarke, Michele; MacIsaac, Richard J.; Jerums, George; Ekinci, Elif I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Diabetes Investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-18</span>CODEN:
                <span class="NLM_cas:coden">JDIOAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-1124</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diabetic kidney disease (DKD) represents a major component of the health burden assocd. with type 1 and type 2 diabetes.  Recent advances have produced an explosion of 'novel' assay-based risk markers for DKD, though clin. use remains restricted.  Although many patients with progressive DKD follow a classical albuminuria-based pathway, non-albuminuric DKD progression is now well recognized.  In general, the following clin. and biochem. characteristics have been assocd. with progressive DKD in both type 1 and type 2 diabetes: increased Hb A1c, systolic blood pressure, albuminuria grade, early glomerular filtration rate decline, duration of diabetes, age (including pubertal onset) and serum uric acid; the presence of concomitant microvascular complications; and pos. family history.  The same is true in type 2 diabetes for male sex category, in patients following an albuminuric pathway to DKD, and also true for the presence of increased pulse wave velocity.  The following baseline clin. characteristics have been proposed as risk factors for DKD progression, but with further research required to assess the nature of any relationship: dyslipidemia (including low-d. lipoprotein, total and high-d. lipoprotein cholesterol); elevated body mass index; smoking status; hyperfiltration; decreases in vitamin D, Hb and uric acid excretion (all known consequences of advanced DKD); and patient test result visit-to-visit variability (Hb A1c, blood pressure and high-d. lipoprotein cholesterol).  The development of multifactorial 'renal risk equations' for type 2 diabetes has the potential to simplify the task of DKD prognostication; however, there are currently none for type 1 diabetes-specific populations.  Significant progress has been made in the prediction of DKD progression using readily available clin. data, though further work is required to elicit the role of several variables, and to consolidate data to facilitate clin. implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolhKY_NSRrX7Vg90H21EOLACvtfcHk0liJjOzCO8_RYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1Kksg%253D%253D&md5=2fe1e8dbe268dadbff81bb3d17373a7b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fjdi.12533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdi.12533%26sid%3Dliteratum%253Aachs%26aulast%3DRadcliffe%26aufirst%3DN.%2BJ.%26aulast%3DSeah%26aufirst%3DJ.%2BM.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DMacIsaac%26aufirst%3DR.%2BJ.%26aulast%3DJerums%26aufirst%3DG.%26aulast%3DEkinci%26aufirst%3DE.%2BI.%26atitle%3DClinical%2520predictive%2520factors%2520in%2520diabetic%2520kidney%2520disease%2520progression%26jtitle%3DJ.%2520Diabetes%2520Invest.%26date%3D2017%26volume%3D8%26spage%3D6%26epage%3D18%26doi%3D10.1111%2Fjdi.12533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thallas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osicka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerums, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghabrial, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharidis, P.</span></span> <span> </span><span class="NLM_article-title">Reduced tubular cation transport in diabetes: prevented by ACE inhibition</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2152</span>– <span class="NLM_lpage">2161</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2003.00006.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1046%2Fj.1523-1755.2003.00006.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=12753302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVyiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2152-2161&author=M.+C.+Thomasauthor=C.+Tikellisauthor=W.+C.+Burnsauthor=V.+Thallasauthor=J.+M.+Forbesauthor=Z.+Caoauthor=T.+M.+Osickaauthor=L.+M.+Russoauthor=G.+Jerumsauthor=H.+Ghabrialauthor=M.+E.+Cooperauthor=P.+Kantharidis&title=Reduced+tubular+cation+transport+in+diabetes%3A+prevented+by+ACE+inhibition&doi=10.1046%2Fj.1523-1755.2003.00006.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced tubular cation transport in diabetes: prevented by ACE inhibition</span></div><div class="casAuthors">Thomas, Merlin C.; Tikellis, Chris; Burns, Wendy C.; Thallas, Vicki; Forbes, Josephine M.; Cao, Zemin; Osicka, Tanya M.; Russo, Leileata M.; Jerums, George; Ghabrial, Hany; Cooper, Mark E.; Kantharidis, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2152-2161</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">The renal clearance of org. cations is important for the homeostasis of a no. of exogenous and endogenous compds.  The org. cation transporters (OCTs) situated on the basolateral surface of proximal tubular cells mediate active cation excretion.  Alterations of cation transport may occur in diabetes, although the role of the OCTs has not been previously assessed.  Exptl. diabetes was induced in rats with streptozotocin (55 mg/kg) and animals were randomly assigned to receive ramipril (3 mg/mL) in drinking water for 24 wk.  In a second protocol, rats were infused with angiotensin II (Ang II) at a dose of 58.3 ng/kg/min for 2 wk via an implanted osmotic pump.  Expression of the OCTs and renal clearance of the endogenous cation N-methyl-nicotinamide (NMN) was assessed.  Diabetes was assocd. with a redn. in gene and protein expression of both OCT-1 and OCT-2 and a redn. in NMN clearance.  These effects were prevented by ramipril, assocd. with the prevention of albuminuria and tubular injury as demonstrated by the expression of osteopontin and glutathione peroxidase 3 (GPX-3).  An infusion of Ang II also reduced NMN clearance but without altering the renal expression of OCTs.  We hypothesize that reduced expression of OCTs in diabetes may be a marker of tubular injury.  However, Ang II may also directly augment renal cation clearance independent of changes in transporter expression.  Together these effects may provide addnl. mechanism to explain treatment-related improvements in creatinine clearance and renoprotection in diabetes following blockade of the renin-angiotensin system (RAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohYJGbHac5hbVg90H21EOLACvtfcHk0lj4qbglZ7Bxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVyiu7k%253D&md5=bb0888b2e017ad07ff5d12433ef335d2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00006.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00006.x%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BC.%26aulast%3DTikellis%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DW.%2BC.%26aulast%3DThallas%26aufirst%3DV.%26aulast%3DForbes%26aufirst%3DJ.%2BM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DOsicka%26aufirst%3DT.%2BM.%26aulast%3DRusso%26aufirst%3DL.%2BM.%26aulast%3DJerums%26aufirst%3DG.%26aulast%3DGhabrial%26aufirst%3DH.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DKantharidis%26aufirst%3DP.%26atitle%3DReduced%2520tubular%2520cation%2520transport%2520in%2520diabetes%253A%2520prevented%2520by%2520ACE%2520inhibition%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D63%26spage%3D2152%26epage%3D2161%26doi%3D10.1046%2Fj.1523-1755.2003.00006.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, T.</span></span> <span> </span><span class="NLM_article-title">Roles of organic anion transporters in the progression of chronic renal failure</span>. <i>Ther. Apheresis Dial.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">S27</span>– <span class="NLM_lpage">S31</span>, <span class="refDoi"> DOI: 10.1111/j.1744-9987.2007.00515.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fj.1744-9987.2007.00515.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=17976081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=S27-S31&author=A.+Enomotoauthor=T.+Niwa&title=Roles+of+organic+anion+transporters+in+the+progression+of+chronic+renal+failure&doi=10.1111%2Fj.1744-9987.2007.00515.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of organic anion transporters in the progression of chronic renal failure</span></div><div class="casAuthors">Enomoto, Atsushi; Niwa, Toshimitsu</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Apheresis and Dialysis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S27-S31</span>CODEN:
                <span class="NLM_cas:coden">TADHA9</span>;
        ISSN:<span class="NLM_cas:issn">1744-9979</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Renal proximal and distal tubules carry out specialized directional transport of various solutes.  The family of org. anion transporters (OATs), which belongs to the major facilitator superfamily (SLC22A), are expressed in the renal epithelial cells to regulate the excretion and the reabsorption of endogenous and exogenous org. anions that include various kinds of drugs and their metabolites.  In recent years, it is revealed that indoxyl sulfate, one of uremic toxins, is a novel physiol. substrate for OAT family, and its accumulation within the renal tubules via OATs induces renal dysfunction.  The OATs are also expressed in the blood-brain barrier, muscle cells, and bone osteoblasts, which hint at various pathogenic roles of OAT-mediated transport of uremic toxins.  In this review, we introduce and discuss the function of OATs in the context of their roles in the progression of chronic renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2WE3TyycBLVg90H21EOLACvtfcHk0lj4qbglZ7Bxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFOitg%253D%253D&md5=de74d877264aa6d4460120994d1711db</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1744-9987.2007.00515.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1744-9987.2007.00515.x%26sid%3Dliteratum%253Aachs%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DNiwa%26aufirst%3DT.%26atitle%3DRoles%2520of%2520organic%2520anion%2520transporters%2520in%2520the%2520progression%2520of%2520chronic%2520renal%2520failure%26jtitle%3DTher.%2520Apheresis%2520Dial.%26date%3D2007%26volume%3D11%26spage%3DS27%26epage%3DS31%26doi%3D10.1111%2Fj.1744-9987.2007.00515.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnikov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinour, D.</span></span> <span> </span><span class="NLM_article-title">Urinary organic anion transporter protein profiles in AKI</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfr541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1093%2Fndt%2Fgfr541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21945944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=1387-1395&author=M.+Kuninauthor=E.+J.+Holtzmanauthor=S.+Melnikovauthor=D.+Dinour&title=Urinary+organic+anion+transporter+protein+profiles+in+AKI&doi=10.1093%2Fndt%2Fgfr541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary organic anion transporter protein profiles in AKI</span></div><div class="casAuthors">Kunin, Margarita; Holtzman, Eli J.; Melnikov, Semyon; Dinour, Dganit</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1387-1395</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Org. anion transporters (OATs) are located on either the basolateral or the apical membrane of the proximal tubule cell and mediate the absorption and secretion of various drugs and endogenous metabolites.  It has been shown that cellular damage in acute kidney injury (AKI) involves three forms of injury: sublethal damage resulting in loss of cell polarity, cell death through apoptosis and necrosis.  We hypothesize that cellular mistargeting of OAT proteins in AKI will change the profile of OAT proteins in urine.  Methods: Thirty AKI patients were included in the study.  AKI was defined by clin. course, daily urine output, response to fluid repletion, urinary sediment, fractional excretion of sodium (FeNa) and urine osmolality.  Urinary OAT1, OAT3 and OAT4 protein abundance was measured from semiquant. immunoblots of urine membrane fraction samples (exosome) collected from patients with AKI and from control subjects.  Results: Although all patients studied reached a similar severity of renal failure measured by serum creatinine, some of them recovered from AKI with supportive care only, while others required renal replacement therapy (RRT).  OAT1 and OAT3, which are normally localized in the basolateral membrane of the proximal tubule cell, were detected at low levels in urine from control subjects and were increased significantly in all patients with AKI.  OAT4 protein, which is normally localized in the luminal membrane of proximal tubule cells, was present in abundance in urine of control subjects.  Interestingly, in patients with AKI who eventually recovered, urinary OAT4 was found to be significantly lower than in controls, while in patients who needed RRT, it was higher than in controls.  Conclusions: We have shown that OATs are mistargeted in AKI.  The urinary OAT protein profile can help us to learn about the pathophysiol. of the disease and might be a marker of AKI severity.  AKI patients with early reversible proximal tubular damage will have high urine OAT1 and OAT3 and low OAT4, while patients with severe AKI will have high urine OAT1, OAT3 and OAT4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGper23DU_wrMbVg90H21EOLACvtfcHk0lj4qbglZ7Bxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFGktLs%253D&md5=bd62fc18ff53df91a40988e7c344b6c2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfr541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfr541%26sid%3Dliteratum%253Aachs%26aulast%3DKunin%26aufirst%3DM.%26aulast%3DHoltzman%26aufirst%3DE.%2BJ.%26aulast%3DMelnikov%26aufirst%3DS.%26aulast%3DDinour%26aufirst%3DD.%26atitle%3DUrinary%2520organic%2520anion%2520transporter%2520protein%2520profiles%2520in%2520AKI%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2012%26volume%3D27%26spage%3D1387%26epage%3D1395%26doi%3D10.1093%2Fndt%2Fgfr541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span> <span> </span><span class="NLM_article-title">Species similarities and differences in pharmacokinetics</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1008</span>– <span class="NLM_lpage">1021</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=8654187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK2MXovFGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=1008-1021&author=J.+H.+Lin&title=Species+similarities+and+differences+in+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Species similarities and differences in pharmacokinetics</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1008-21</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 141 refs.  One of the fundamental challenges drug metab. scientists face in drug discovery and development is the extrapolation of metabolic data and risk assessment from animals to humans.  Although it is generally believed that data from animal studies can be reasonably extrapolated to humans with the application of appropriate pharmacokinetic principles, there are certainly some limitations.  The purpose of this review is to show some species similarities and differences in absorption, distribution, metab., and excretion, with an attempt to address the questions of whether animal data can be extrapolated and what the limitations are.  The underlying mechanisms responsible for these similarities and differences are discussed and examples given for illustration.  In addn., the concepts of allometric and physiol. models for extrapolation of kinetic data are briefly highlighted.  In conclusion, although pharmacokinetics has been advanced greatly in recent years, it is not yet possible to predict all of the pharmacokinetic parameters of a drug in humans from animal studies.  Nevertheless, under certain well-defined conditions, it may be possible to make reasonably good predictions.  For example, the intrinsic absorption of a given drug across the wall of the gastrointestinal tract is probably similar among species, because the nature of the biomembrane of epithelial cells is similar in mammals and because the absorption process is basically an interaction between the drug and the biomembrane.  However, other factors, such as pH-dependent soly. and first-pass metab. that affect the absorption, may differ from species to species resulting in species differences in absorption.  Predicting the renal excretion of drugs in humans has been relatively successful using the glomerular filtration rate ratio between humans and animals.  Similarly, if the elimination of a drug is mainly by the liver and the rate of elimination is limited by hepatic blood flow, one could predict the clearance of the drug in humans by the hepatic blood flow.  However, biochem. parameters, such as protein binding and drug metab., are less predictable.  These parameters vary considerably among species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqiSrG8wRhqrVg90H21EOLACvtfcHk0lj4qbglZ7Bxsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFGksbw%253D&md5=75eb38c7d6c9ed949c93c2363545b2d8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DSpecies%2520similarities%2520and%2520differences%2520in%2520pharmacokinetics%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1995%26volume%3D23%26spage%3D1008%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">GTEx
Consortium</span> <span> </span><span class="NLM_article-title">The Genotype-Tissue
Expression (GTEx) project</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/ng.2653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fng.2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23715323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=580-585&author=GTEx%0AConsortium&title=The+Genotype-Tissue%0AExpression+%28GTEx%29+project&doi=10.1038%2Fng.2653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fng.2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2653%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520Genotype-Tissue%250AExpression%2520%2528GTEx%2529%2520project%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D580%26epage%3D585%26doi%3D10.1038%2Fng.2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puppala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapworth, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">35904</span>– <span class="NLM_lpage">35912</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.508747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1074%2Fjbc.M113.508747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24187138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=35904-35912&author=J.+Wuauthor=D.+Puppalaauthor=X.+Fengauthor=M.+Monettiauthor=A.+L.+Lapworthauthor=K.+F.+Geoghegan&title=Chemoproteomic+analysis+of+intertissue+and+interspecies+isoform+diversity+of+AMP-activated+protein+kinase+%28AMPK%29&doi=10.1074%2Fjbc.M113.508747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic Analysis of Intertissue and Interspecies Isoform Diversity of AMP-activated Protein Kinase (AMPK)</span></div><div class="casAuthors">Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Monetti, Mara; Lapworth, Amanda Lee; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">35904-35912</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that senses and governs changes in the cellular energy balance represented by concns. of AMP, ADP, and ATP.  Each of its three chains (α, β, and γ) exists as either two or three subtypes, theor. allowing up to 12 different forms of the complete enzyme.  Tissue specificity in the distribution of AMPK subtypes is believed to underpin a range of biol. functions for AMPK, a central regulator of metabolic function and response.  It is of particular interest for drug discovery purposes to compare AMPK isoforms that are most prevalent in human liver and muscle with isoforms present in key preclin. species.  To complement immunocapture/immunodetection methods, which for AMPK are challenged by sequence similarities and difficulties of obtaining accurate relative quantitation, AMPK was captured from lysates of a range of cells and tissues using the ActivX ATP probe.  This chem. probe covalently attaches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinases, including AMPK, while also labeling a wide range of ATP-utilizing proteins.  Affinity-based recovery of labeled proteins followed by gel-based fractionation of the captured sample was followed by proteomic characterization of AMPK polypeptides.  In agreement with transcript-based anal. and previous indications from immunodetection, the results indicated that the predominant AMPK heterotrimer in human liver is α1β2γ1 but that dog and rat livers mainly contain the α1β1γ1 and α2β1γ1 forms, resp.  Differences were not detected between the AMPK profiles of normal and diabetic human liver tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqkqJBumTmLVg90H21EOLACvtfcHk0liUOGlg0IeQ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7jM&md5=3a4b7aa1268fe2bd6d460d319bf48b0b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.508747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.508747%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPuppala%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DChemoproteomic%2520analysis%2520of%2520intertissue%2520and%2520interspecies%2520isoform%2520diversity%2520of%2520AMP-activated%2520protein%2520kinase%2520%2528AMPK%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D35904%26epage%3D35912%26doi%3D10.1074%2Fjbc.M113.508747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cialdea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, T.</span></span> <span> </span><span class="NLM_article-title">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.116.237925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=28289077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=303-311&author=C.+T.+Salattoauthor=R.+A.+Millerauthor=K.+O.+Cameronauthor=E.+Cokorinosauthor=A.+Reyesauthor=J.+Wardauthor=M.+Calabreseauthor=R.+Kurumbailauthor=F.+Rajamohanauthor=A.+S.+Kalgutkarauthor=D.+A.+Tessauthor=A.+Shavnyaauthor=N.+E.+Genungauthor=D.+J.+Edmondsauthor=A.+Jatkarauthor=B.+S.+Maciejewskiauthor=M.+Amaroauthor=H.+Gandhokauthor=M.+Monettiauthor=K.+Cialdeaauthor=E.+Bollingerauthor=J.+M.+Kreegerauthor=T.+M.+Coskranauthor=A.+C.+Opsahlauthor=G.+G.+Boucherauthor=M.+J.+Birnbaumauthor=P.+DaSilva-Jardineauthor=T.+Rolph&title=Selective+activation+of+AMPK+%CE%B21-containing+isoforms+improves+kidney+function+in+a+rat+model+of+diabetic+nephropathy&doi=10.1124%2Fjpet.116.237925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span></div><div class="casAuthors">Salatto, Christopher T.; Miller, Russell A.; Cameron, Kimberly O.; Cokorinos, Emily; Reyes, Allan; Ward, Jessica; Calabrese, Matthew F.; Kurumbail, Ravi G.; Rajamohan, Francis; Kalgutkar, Amit S.; Tess, David A.; Shavnya, Andre; Genung, Nathan E.; Edmonds, David J.; Jatkar, Aditi; Maciejewski, Benjamin S.; Amaro, Marina; Gandhok, Harmeet; Monetti, Mara; Cialdea, Katherine; Bollinger, Eliza; Kreeger, John M.; Coskran, Timothy M.; Opsahl, Alan C.; Boucher, Germaine G.; Birnbaum, Morris J.; Da Silva-Jardine, Paul; Rolph, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311, S1-S33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diabetic nephropathy remains an area of high unmet medical need, with current therapies that slow down, but do not prevent, the progression of disease.  A reduced phosphorylation state of adenosine monophosphate-activated protein kinase (AMPK) has been correlated with diminished kidney function in both humans and animal models of renal disease.  Here, we describe the identification of novel, potent, small mol. activators of AMPK that selectively activate AMPK heterotrimers contg. the β1 subunit.  After confirming that human and rodent kidney predominately express AMPK β1, we explore the effects of pharmacol. activation of AMPK in the ZSF1 rat model of diabetic nephropathy.  Chronic administration of these direct activators elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria to a greater degree than the current std. of care, angiotensin-converting enzyme inhibitor ramipril.  Further analyses of urine biomarkers and kidney tissue gene expression reveal AMPK activation leads to the modulation of multiple pathways implicated in kidney injury, including cellular hypertrophy, fibrosis, and oxidative stress.  These results support the need for further investigation into the potential beneficial effects of AMPK activation in kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8STmG-nZsrVg90H21EOLACvtfcHk0liUOGlg0IeQ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E&md5=808a4036f5c55486c3d8f61beeb2faa4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237925%26sid%3Dliteratum%253Aachs%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DJatkar%26aufirst%3DA.%26aulast%3DMaciejewski%26aufirst%3DB.%2BS.%26aulast%3DAmaro%26aufirst%3DM.%26aulast%3DGandhok%26aufirst%3DH.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DCialdea%26aufirst%3DK.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%2BC.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DRolph%26aufirst%3DT.%26atitle%3DSelective%2520activation%2520of%2520AMPK%2520%25CE%25B21-containing%2520isoforms%2520improves%2520kidney%2520function%2520in%2520a%2520rat%2520model%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26spage%3D303%26epage%3D311%26doi%3D10.1124%2Fjpet.116.237925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lheXSN-qVJDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, S.</span></span> <span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0lheXSN-qVJDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenseth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastin, A.</span></span> <span> </span><span class="NLM_article-title">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2581</span>– <span class="NLM_lpage">2606</span>, <span class="refDoi"> DOI: 10.1002/jps.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fjps.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=18228610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2581-2606&author=M.+Shalaevaauthor=J.+Kensethauthor=F.+Lombardoauthor=A.+Bastin&title=Measurement+of+dissociation+constants+%28pKa+values%29+of+organic+compounds+by+multiplexed+capillary+electrophoresis+using+aqueous+and+cosolvent+buffers&doi=10.1002%2Fjps.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span></div><div class="casAuthors">Shalaeva, Marina; Kenseth, Jeremy; Lombardo, Franco; Bastin, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2581-2606</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Evaluation of a multiplexed capillary electrophoresis (CE) method for pKa measurements of org. compds., including low soly. compds., is presented.  The method is validated on a set of 105 diverse compds., mostly drugs, and results are compared to literature values obtained from multiple refs.  Two versions of the instrument in two different labs were used to collect data over a period of 3 years and inter-lab. and inter-instrument variations are discussed.  Twenty-four point aq. and mixed cosolvent buffer systems were employed to improve the accuracy of pKa measurements.  It has been demonstrated that the method allows direct pKa measurements in aq. buffers for many compds. of low soly., often unattainable by other methods.  The pKa measurements of compds. with extremely low soly. using multiplexed CE with methanol/water cosolvent buffers are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyedITaWF77Vg90H21EOLACvtfcHk0lheXSN-qVJDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D&md5=0945460c6ace92ced07cfc4209995c7d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21287%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DKenseth%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DBastin%26aufirst%3DA.%26atitle%3DMeasurement%2520of%2520dissociation%2520constants%2520%2528pKa%2520values%2529%2520of%2520organic%2520compounds%2520by%2520multiplexed%2520capillary%2520electrophoresis%2520using%2520aqueous%2520and%2520cosolvent%2520buffers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2581%26epage%3D2606%26doi%3D10.1002%2Fjps.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, B. R.</span></span> <span> </span><span class="NLM_article-title">Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.149476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.108.149476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19349522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=191-197&author=H.+Yuanauthor=B.+Fengauthor=Y.+Yuauthor=J.+Chupkaauthor=J.+Y.+Zhengauthor=T.+G.+Heathauthor=B.+R.+Bond&title=Renal+organic+anion+transporter-mediated+drug-drug+interaction+between+gemcabene+and+quinapril&doi=10.1124%2Fjpet.108.149476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril</span></div><div class="casAuthors">Yuan, Haodan; Feng, Bo; Yu, Ying; Chupka, Jonathan; Zheng, Jenny Y.; Heath, Timothy G.; Bond, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In humans and rats, a synergistic blood pressure redn. was obsd. when the fibrate gemcabene (CI-1027) was coadministered with the angiotensin-converting enzyme inhibitor quinapril.  In a quinapril (3 mg/kg) pharmacokinetic rat study, there was a 40% decrease in urinary excretion and a 53% increase in plasma area under the curve from 0 to 24 h of the active metabolite quinaprilat when coadministered with gemcabene (30 mg/kg).  This observation revealed a possible transporter-mediated drug-drug interaction (DDI) between gemcabene and quinapril.  This led to a series of studies investigating the underlying clearance mechanisms assocd. with these compds. intended to elucidate renal transporter interactions between quinapril and gemcabene.  In vitro transporter studies using human embryonic kidney 293 cells transfected with human or rat org. anion transporter 3 (hOAT3, rOat3) revealed that quinaprilat is a substrate in both species, with a Km value of 13.4 μM for hOAT3.  Subsequent studies discovered that gemcabene inhibited quinaprilat uptake by hOAT3 and rOat3 at IC50 values of 35 and 48 μM, resp.  Moreover, gemcabene acylglucuronide, the major metabolite of gemcabene glucuronidation, also inhibited hOAT3- and rOat3-mediated uptake of quinaprilat at IC50 values of 197 and 133 μM, resp.  High plasma concns. of gemcabene (>100 μM) achieved in humans and rats upon oral dosing corroborate with gemcabene inhibition of renal OAT3-mediated secretion of quinaprilat in vitro.  This investigation established that a DDI between gemcabene and quinapril involving inhibition of renal transporters and subsequent elevation in plasma concns. of quinaprilat is responsible for the apparent synergistic blood pressure redn. obsd. with these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofjsC2fkPbn7Vg90H21EOLACvtfcHk0lheXSN-qVJDCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeltbw%253D&md5=1bcf7a9378e604bca5321c30fb18ec85</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.149476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.149476%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChupka%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%2BY.%26aulast%3DHeath%26aufirst%3DT.%2BG.%26aulast%3DBond%26aufirst%3DB.%2BR.%26atitle%3DRenal%2520organic%2520anion%2520transporter-mediated%2520drug-drug%2520interaction%2520between%2520gemcabene%2520and%2520quinapril%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D191%26epage%3D197%26doi%3D10.1124%2Fjpet.108.149476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/clpt.2013.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fclpt.2013.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23588318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC3srltl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=113-125&author=D.+Tweedieauthor=J.+W.+Polliauthor=E.+G.+Berglundauthor=S.+M.+Huangauthor=L.+Zhangauthor=A.+Poirierauthor=X.+Chuauthor=B.+Feng&title=Transporter+studies+in+drug+development%3A+experience+to+date+and+follow-up+on+decision+trees+from+the+International+Transporter+Consortium&doi=10.1038%2Fclpt.2013.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium</span></div><div class="casAuthors">Tweedie D; Polli J W; Berglund E Gil; Huang S M; Zhang L; Poirier A; Chu X; Feng B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The International Transporter Consortium (ITC) organized a second workshop in March 2012 to expand on the themes developed during the inaugural ITC workshop held in 2008.  The final session of the workshop provided perspectives from regulatory and industry-based scientists, with input from academic scientists, and focused primarily on the decision trees published from the first workshop.  These decision trees have become a central part of subsequent regulatory drug-drug interaction (DDI) guidances issued over the past few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTujrz08uS8s1WTCLT8lX9SfW6udTcc2eYODSXv8nAc4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srltl2ruw%253D%253D&md5=bc460caa642b9132681aa4184f8c9f58</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2013.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2013.77%26sid%3Dliteratum%253Aachs%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBerglund%26aufirst%3DE.%2BG.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DTransporter%2520studies%2520in%2520drug%2520development%253A%2520experience%2520to%2520date%2520and%2520follow-up%2520on%2520decision%2520trees%2520from%2520the%2520International%2520Transporter%2520Consortium%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D94%26spage%3D113%26epage%3D125%26doi%3D10.1038%2Fclpt.2013.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.+A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0lh7KuTt-OYN4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.%2BA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sproston, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Application of an in vitro OAT assay in drug design and optimization of renal clearance</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.3109/00498254.2013.879625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.3109%2F00498254.2013.879625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=657-665&author=M.+G.+Soarsauthor=P.+Bartonauthor=L.+L.+Elkinauthor=K.+W.+Mosureauthor=J.+L.+Sprostonauthor=R.+J.+Riley&title=Application+of+an+in+vitro+OAT+assay+in+drug+design+and+optimization+of+renal+clearance&doi=10.3109%2F00498254.2013.879625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.879625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.879625%26sid%3Dliteratum%253Aachs%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DElkin%26aufirst%3DL.%2BL.%26aulast%3DMosure%26aufirst%3DK.%2BW.%26aulast%3DSproston%26aufirst%3DJ.%2BL.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DApplication%2520of%2520an%2520in%2520vitro%2520OAT%2520assay%2520in%2520drug%2520design%2520and%2520optimization%2520of%2520renal%2520clearance%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D657%26epage%3D665%26doi%3D10.3109%2F00498254.2013.879625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wautlet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.bmcl.2004.12.079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429-1433&author=R.+M.+Borzilleriauthor=Z.+W.+Caiauthor=C.+Ellisauthor=J.+Fargnoliauthor=A.+Furaauthor=T.+Gerhardtauthor=B.+Goyalauthor=J.+T.+Huntauthor=S.+Mortilloauthor=L.+Qianauthor=J.+Tokarskiauthor=V.+Vyasauthor=B.+Wautletauthor=X.+Zhengauthor=R.+S.+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2004.12.079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.079%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DGerhardt%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2004.12.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. W.</span></span> <span> </span><span class="NLM_article-title">Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=9311617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=1032-1038&author=J.+J.+Bouskaauthor=R.+L.+Bellauthor=C.+L.+Goodfellowauthor=A.+O.+Stewartauthor=C.+D.+Brooksauthor=G.+W.+Carter&title=Improving+the+in+vivo+duration+of+5-lipoxygenase+inhibitors%3A+application+of+an+in+vitro+glucuronosyltransferase+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay</span></div><div class="casAuthors">Bouska, Jennifer J.; Bell, Randy L.; Goodfellow, Carole L.; Stewart, Andrew O.; Brooks, Clint D. W.; Carter, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1038</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">An in vitro glucuronidation assay was used to optimize a series of N-hydroxyurea-contg. 5-lipoxygenase inhibitors for metabolic stability.  The glucuronidation of these compds. in cynomolgus monkey microsomes followed Michaelis-Menten kinetics allowing calcn. of Vmax and KM.  The Vmax values ranged from 0.02 to 7.9 nmol/min/mg microsomal protein, a 400-fold difference, whereas KM ranged from 204 to 2500 μM, only a 12-fold difference.  In vitro intrinsic clearance values (CLint) were calcd. for 18 compds. tested in the kinetic assay and compared with the in vivo plasma clearance (CLp) calcd. from i.v. studies done in cynomolgus monkeys.  These initial results suggested a relation between the in vitro CLint and in vivo duration as defined by CLp.  A more rapid in vitro assay was developed in a 96-well format using a single concn. of substrate (100 μM) from which a glucuronidation rate was calcd.  The results from this assay for 40 compds. correlated with in vivo plasma clearance (r = 0.57).  This more efficient assay was used to test more than 100 compds. and develop structure-metab. relationships based on metabolic stability and improved duration.  The culmination of this effort contributed to the discovery of ABT-761, a 5-lipoxygenase inhibitor with in vivo duration in monkey improved 40-fold over the first generation inhibitor.  Further studies performed in human liver microsomes demonstrated a similar trend that was corroborated by the 8-fold increase in duration after oral dosing in humans obsd. with ABT-761.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKusP0a0dCmbVg90H21EOLACvtfcHk0ljE_ZcO9CMuVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1Wqsbg%253D&md5=1779014c9842d5927a96e5ea3e4503fb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DGoodfellow%26aufirst%3DC.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3DImproving%2520the%2520in%2520vivo%2520duration%2520of%25205-lipoxygenase%2520inhibitors%253A%2520application%2520of%2520an%2520in%2520vitro%2520glucuronosyltransferase%2520assay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D1032%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsaker, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoigne, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conery, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spillane, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective in vivo probe (GNE-272) for the bromodomains of CBP/EP300</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10549</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGhsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10549-10563&author=T.+D.+Crawfordauthor=F.+A.+Romeroauthor=K.+W.+Laiauthor=V.+Tsuiauthor=A.+M.+Taylorauthor=G.+de+Leon+Boenigauthor=C.+L.+Nolandauthor=J.+Murrayauthor=J.+Lyauthor=E.+F.+Chooauthor=T.+L.+Hunsakerauthor=E.+W.+Chanauthor=M.+Merchantauthor=S.+Kharbandaauthor=K.+E.+Gascoigneauthor=S.+Kaufmanauthor=M.+H.+Beresiniauthor=J.+Liaoauthor=W.+Liuauthor=K.+X.+Chenauthor=Z.+Chenauthor=A.+R.+Coneryauthor=A.+Coteauthor=H.+Jayaramauthor=Y.+Jiangauthor=J.+R.+Kieferauthor=T.+Kleinheinzauthor=Y.+Liauthor=J.+Maherauthor=E.+Pardoauthor=F.+Poyauthor=K.+L.+Spillaneauthor=F.+Wangauthor=J.+Wangauthor=X.+Weiauthor=Z.+Xuauthor=Z.+Xuauthor=I.+Yenauthor=L.+Zawadzkeauthor=X.+Zhuauthor=S.+Bellonauthor=R.+Cummingsauthor=A.+G.+Cochranauthor=B.+K.+Albrechtauthor=S.+Magnuson&title=Discovery+of+a+potent+and+selective+in+vivo+probe+%28GNE-272%29+for+the+bromodomains+of+CBP%2FEP300&doi=10.1021%2Facs.jmedchem.6b01022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300</span></div><div class="casAuthors">Crawford, Terry D.; Romero, F. Anthony; Lai, Kwong Wah; Tsui, Vickie; Taylor, Alexander M.; de Leon Boenig, Gladys; Noland, Cameron L.; Murray, Jeremy; Ly, Justin; Choo, Edna F.; Hunsaker, Thomas L.; Chan, Emily W.; Merchant, Mark; Kharbanda, Samir; Gascoigne, Karen E.; Kaufman, Susan; Beresini, Maureen H.; Liao, Jiangpeng; Liu, Wenfeng; Chen, Kevin X.; Chen, Zhongguo; Conery, Andrew R.; Cote, Alexandre; Jayaram, Hariharan; Jiang, Ying; Kiefer, James R.; Kleinheinz, Tracy; Li, Yingjie; Maher, Jonathan; Pardo, Eneida; Poy, Florence; Spillane, Kerry L.; Wang, Fei; Wang, Jian; Wei, Xiaocang; Xu, Zhaowu; Xu, Zhongya; Yen, Ivana; Zawadzke, Laura; Zhu, Xiaoyu; Bellon, Steven; Cummings, Richard; Cochran, Andrea G.; Albrecht, Brian K.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10549-10563</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation.  A co-crystal structure of a ligand-efficient screening hit and the CBP bromodomain guided initial design targeting the LPF shelf, ZA loop, and acetylated lysine binding regions.  Structure-activity relationship studies allowed the authors to identify a more potent analog.  Optimization of permeability and microsomal stability and subsequent improvement of mouse hepatocyte stability afforded 59 (GNE-272, TR-FRET IC50 = 0.02 μM, BRET IC50 = 0.41 μM, BRD4(1) IC50 = 13 μM) that retained the best balance of cell potency, selectivity, and in vivo PK.  GNE-272 showed a marked antiproliferative effect in hematol. cancer cell lines and modulates MYC expression in vivo that corresponds with antitumor activity in an AML tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6T5ODn2Q-2LVg90H21EOLACvtfcHk0ljE_ZcO9CMuVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGhsb%252FO&md5=22ed46cb031022aa6aff23c20d07e7dd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01022%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DNoland%26aufirst%3DC.%2BL.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DHunsaker%26aufirst%3DT.%2BL.%26aulast%3DChan%26aufirst%3DE.%2BW.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSpillane%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520in%2520vivo%2520probe%2520%2528GNE-272%2529%2520for%2520the%2520bromodomains%2520of%2520CBP%252FEP300%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10549%26epage%3D10563%26doi%3D10.1021%2Facs.jmedchem.6b01022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dounay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rago, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1039/C2MD20166F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1039%2FC2MD20166F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=125-129&author=J.+L.+Hendersonauthor=A.+Sawant-Basakauthor=J.+B.+Tuttleauthor=A.+B.+Dounayauthor=L.+A.+McAllisterauthor=J.+Panditauthor=S.+Rongauthor=X.+Houauthor=B.+M.+Bechleauthor=J.-Y.+Kimauthor=V.+Parikhauthor=S.+Ghoshauthor=E.+Evrardauthor=L.+E.+Zawadzkeauthor=M.+A.+Salafiaauthor=B.+Ragoauthor=R.+S.+Obachauthor=A.+Clarkauthor=K.+R.+Fonsecaauthor=C.+Changauthor=P.+R.+Verhoest&title=Discovery+of+hydroxamate+bioisosteres+as+KAT+II+inhibitors+with+improved+oral+bioavailability+and+pharmacokinetics&doi=10.1039%2FC2MD20166F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC2MD20166F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20166F%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DSalafia%26aufirst%3DM.%2BA.%26aulast%3DRago%26aufirst%3DB.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DClark%26aufirst%3DA.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520hydroxamate%2520bioisosteres%2520as%2520KAT%2520II%2520inhibitors%2520with%2520improved%2520oral%2520bioavailability%2520and%2520pharmacokinetics%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D125%26epage%3D129%26doi%3D10.1039%2FC2MD20166F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boustany-Kari, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenotic, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leininger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masterson, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobol, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugnait, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2952</span>– <span class="NLM_lpage">2960</span>, <span class="refDoi"> DOI: 10.1021/jm200049r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200049r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVCntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2952-2960&author=V.+Mascittiauthor=T.+S.+Maurerauthor=R.+P.+Robinsonauthor=J.+Bianauthor=C.+M.+Boustany-Kariauthor=T.+Brandtauthor=B.+M.+Collmanauthor=A.+S.+Kalgutkarauthor=M.+K.+Klenoticauthor=M.+T.+Leiningerauthor=A.+Loweauthor=R.+J.+Maguireauthor=V.+M.+Mastersonauthor=Z.+Miaoauthor=E.+Mukaiyamaauthor=J.+D.+Patelauthor=J.+C.+Pettersenauthor=C.+Previlleauthor=B.+Samasauthor=L.+Sheauthor=Z.+Sobolauthor=C.+M.+Steppanauthor=B.+D.+Stevensauthor=B.+A.+Thumaauthor=M.+Tugnaitauthor=D.+Zengauthor=T.+Zhu&title=Discovery+of+a+clinical+candidate+from+the+structurally+unique+dioxa-bicyclo%5B3.2.1%5Doctane+class+of+sodium-dependent+glucose+cotransporter+2+inhibitors&doi=10.1021%2Fjm200049r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors</span></div><div class="casAuthors">Mascitti, Vincent; Maurer, Tristan S.; Robinson, Ralph P.; Bian, Jianwei; Boustany-Kari, Carine M.; Brandt, Thomas; Collman, Benjamin M.; Kalgutkar, Amit S.; Klenotic, Michelle K.; Leininger, Michael T.; Lowe, Andre; Maguire, Robert J.; Masterson, Victoria M.; Miao, Zhuang; Mukaiyama, Emi; Patel, Jigna D.; Pettersen, John C.; Preville, Cathy; Samas, Brian; She, Li; Sobol, Zhanna; Steppan, Claire M.; Stevens, Benjamin D.; Thuma, Benjamin A.; Tugnait, Meera; Zeng, Dongxiang; Zhu, Tong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2952-2960</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PF-04971729 (I) belongs to a new class of potent and selective sodium-dependent glucose cotransporter 2 inhibitors incorporating a unique dioxa-bicyclo[3.2.1]octane (bridged ketal) ring system.  In this paper we present the design, synthesis, preclin. evaluation, and human dose predictions related to I.  This compd. demonstrated robust urinary glucose excretion in rats and an excellent preclin. safety profile.  It is currently in phase 2 clin. trials and is being evaluated for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytwz0hHDVmrVg90H21EOLACvtfcHk0lhdYhxF7z0nLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVCntrY%253D&md5=80e156d19d3a6a87a61dca59cc1a0e99</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm200049r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200049r%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DBrandt%26aufirst%3DT.%26aulast%3DCollman%26aufirst%3DB.%2BM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKlenotic%26aufirst%3DM.%2BK.%26aulast%3DLeininger%26aufirst%3DM.%2BT.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DMasterson%26aufirst%3DV.%2BM.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DMukaiyama%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSobol%26aufirst%3DZ.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTugnait%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520clinical%2520candidate%2520from%2520the%2520structurally%2520unique%2520dioxa-bicyclo%255B3.2.1%255Doctane%2520class%2520of%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2952%26epage%3D2960%26doi%3D10.1021%2Fjm200049r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship (SAR): effort towards blocking N-glucuronidation of indazoles (PF-03376056) by human UGT1A enzymes</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.2174/187231209787176371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2174%2F187231209787176371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19356114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=28-34&author=K.+Roseauthor=Y.+S.+Yangauthor=R.+Sciottiauthor=H.+Cai&title=Structure-activity+relationship+%28SAR%29%3A+effort+towards+blocking+N-glucuronidation+of+indazoles+%28PF-03376056%29+by+human+UGT1A+enzymes&doi=10.2174%2F187231209787176371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship (SAR): effort towards blocking N-glucuronidation of indazoles (PF-03376056) by human UGT1A enzymes</span></div><div class="casAuthors">Rose, Kelly; Yang, Young-Sun; Sciotti, Richard; Cai, Hongliang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">GyrATPase is a cellular enzyme that has been used as an antibacterial target for treatment of nosocomial and community acquired bacterial infections.  The leading chem. series targeted at inhibiting this enzyme, indazoles, were rapidly cleared in rats (CL > 70 mL/min/kg).  The predominant metabolite identified in both urine and bile samples from a bile duct-cannulated study corresponded to direct glucuronidation of the parent compd. and was excreted rapidly.  Subsequently, a carefully designed analog was used to pinpoint the site of glucuronidation (N-glucuronidation) by incubation with rat hepatocytes and followed by mass spectrometry anal.  Reaction mapping with an array of recombinant UGT isoenzymes revealed that N-glucuronidation was predominantly catalyzed by the UGT1A family of enzymes.  Based on the results, the following approaches were considered to reduce or eliminate glucuronidation: 1) adding sterically hindered substitutions on the Ph ring of the indazole core; 2) changing the electron distribution by substituting with electron-dontaing or-withdrawing groups; 3) replacing the site of glucuronidation.  The resulted compds. were evaluated in vitro in rat hepatocytes to assess their metabolic stabilities followed by in vivo efficacy studies in the murine peritonitis sepsis model (at 50 mg/kg) for selected compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWg2vSxGL57Vg90H21EOLACvtfcHk0lhdYhxF7z0nLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsbk%253D&md5=314aed3e65d2a899ad591e076ef93bcb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F187231209787176371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209787176371%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DSciotti%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DStructure-activity%2520relationship%2520%2528SAR%2529%253A%2520effort%2520towards%2520blocking%2520N-glucuronidation%2520of%2520indazoles%2520%2528PF-03376056%2529%2520by%2520human%2520UGT1A%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D28%26epage%3D34%26doi%3D10.2174%2F187231209787176371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takenaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamei, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumori, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship in O-glucuronidation of indolocarbazole analogs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1124/dmd.30.5.494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fdmd.30.5.494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=494-497&author=N.+Takenagaauthor=M.+Ishiiauthor=T.+Kameiauthor=T.+Yasumori&title=Structure-activity+relationship+in+O-glucuronidation+of+indolocarbazole+analogs&doi=10.1124%2Fdmd.30.5.494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.5.494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.5.494%26sid%3Dliteratum%253Aachs%26aulast%3DTakenaga%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DKamei%26aufirst%3DT.%26aulast%3DYasumori%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationship%2520in%2520O-glucuronidation%2520of%2520indolocarbazole%2520analogs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D494%26epage%3D497%26doi%3D10.1124%2Fdmd.30.5.494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Structure–metabolism relationships in the glucuronidation of d-amino acid oxidase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1021/ml500335z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500335z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1251-1253&author=S.+C.+Zimmermannauthor=R.+Raisauthor=J.+Altauthor=C.+Burzynskiauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Structure%E2%80%93metabolism+relationships+in+the+glucuronidation+of+d-amino+acid+oxidase+inhibitors&doi=10.1021%2Fml500335z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fml500335z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500335z%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593metabolism%2520relationships%2520in%2520the%2520glucuronidation%2520of%2520d-amino%2520acid%2520oxidase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1251%26epage%3D1253%26doi%3D10.1021%2Fml500335z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriques, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holms, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczyk, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazdiyasni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdesky, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of <i>N</i>-hydroxyurea 5-lipoxygenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1955</span>– <span class="NLM_lpage">1968</span>, <span class="refDoi"> DOI: 10.1021/jm9700474</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9700474" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1955-1968&author=A.+O.+Stewartauthor=P.+A.+Bhatiaauthor=J.+G.+Martinauthor=J.+B.+Summersauthor=K.+E.+Rodriquesauthor=M.+B.+Martinauthor=J.+H.+Holmsauthor=J.+L.+Mooreauthor=R.+A.+Craigauthor=T.+Kolasaauthor=J.+D.+Ratajczykauthor=H.+Mazdiyasniauthor=F.+A.+Kerdeskyauthor=S.+L.+DeNinnoauthor=R.+G.+Makiauthor=J.+B.+Bouskaauthor=P.+R.+Youngauthor=C.+Lanniauthor=R.+L.+Bellauthor=G.+W.+Carterauthor=C.+D.+Brooks&title=Structure-activity+relationships+of+N-hydroxyurea+5-lipoxygenase+inhibitors&doi=10.1021%2Fjm9700474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm9700474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9700474%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBhatia%26aufirst%3DP.%2BA.%26aulast%3DMartin%26aufirst%3DJ.%2BG.%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DRodriques%26aufirst%3DK.%2BE.%26aulast%3DMartin%26aufirst%3DM.%2BB.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DMoore%26aufirst%3DJ.%2BL.%26aulast%3DCraig%26aufirst%3DR.%2BA.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DRatajczyk%26aufirst%3DJ.%2BD.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DKerdesky%26aufirst%3DF.%2BA.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DBouska%26aufirst%3DJ.%2BB.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%26atitle%3DStructure-activity%2520relationships%2520of%2520N-hydroxyurea%25205-lipoxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1955%26epage%3D1968%26doi%3D10.1021%2Fjm9700474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.%0AA.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0ljm7uwb8rClNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="note"><p class="first last">Solubility was measured at Analiza, Ohio, USA; compounds were added to 50 mM sodium phosphate buffer (pH 7.4), stirred for 24 h, filtered, and the dissolved concentration determined by nitrogen detection.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilan, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salah, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastacky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poucher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tofovic, S. P.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1530/JOE-11-0122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1530%2FJOE-11-0122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21680617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOhtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2011&pages=293-308&author=V.+P.+Bilanauthor=E.+M.+Salahauthor=S.+Bastackyauthor=H.+B.+Jonesauthor=R.+M.+Mayersauthor=B.+Zinkerauthor=S.+M.+Poucherauthor=S.+P.+Tofovic&title=Diabetic+nephropathy+and+long-term+treatment+effects+of+rosiglitazone+and+enalapril+in+obese+ZSF1+rats&doi=10.1530%2FJOE-11-0122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats</span></div><div class="casAuthors">Bilan, Victor P.; Salah, Eman M.; Bastacky, Sheldon; Jones, Huw B.; Mayers, Rachel M.; Zinker, Bradley; Poucher, Simon M.; Tofovic, Stevan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-308</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Diabetic nephropathy (DN) is a major cause of end-stage renal disease.  Yet the pathogenic mechanisms underlying the development of DN are not fully defined, partially due to lack of suitable models that mimic the complex pathogenesis of renal disease in diabetic patients.  In this study, we describe early and late renal manifestations of DN and renal responses to long-term treatments with rosiglitazone or high-dose enalapril in ZSF1 rats, a model of metabolic syndrome, diabetes, and chronic renal disease.  At 8 wk of age, obese ZSF1 rats developed metabolic syndrome and diabetes (hyperglycemia, glucosuria, hyperlipidemia, and hypertension) and early signs of renal disease (proteinuria, glomerular collagen IV deposition, tubulointerstitial inflammation, and renal hypertrophy).  By 32 wk of age, animals developed renal histopathol. consistent with DN, including mesangial expansion, glomerulosclerosis, tubulointerstitial inflammation and fibrosis, tubular dilation and atrophy, and arteriolar thickening.  Rosiglitazone markedly increased body wt. but reduced food intake, improved glucose control, and attenuated hyperlipidemia and liver and kidney injury.  In contrast, rosiglitazone markedly increased cardiac hypertrophy via a blood pressure-independent mechanism.  High-dose enalapril did not improve glucose homeostasis, but normalized blood pressure, and nearly prevented diabetic renal injury.  The ZSF1 model thus detects the clin. observations seen with rosiglitazone and enalapril in terms of primary and secondary endpoints of cardiac and renal effects.  This and previous reports indicate that the obese ZSF1 rat meets currently accepted criteria for progressive exptl. diabetic renal disease in rodents, suggesting that this may be the best available rat model for simulation of human DN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbsfPXctq-mbVg90H21EOLACvtfcHk0ljm7uwb8rClNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOhtL7N&md5=0dd45862d740985f1417234d4df8344d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1530%2FJOE-11-0122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJOE-11-0122%26sid%3Dliteratum%253Aachs%26aulast%3DBilan%26aufirst%3DV.%2BP.%26aulast%3DSalah%26aufirst%3DE.%2BM.%26aulast%3DBastacky%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DH.%2BB.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DZinker%26aufirst%3DB.%26aulast%3DPoucher%26aufirst%3DS.%2BM.%26aulast%3DTofovic%26aufirst%3DS.%2BP.%26atitle%3DDiabetic%2520nephropathy%2520and%2520long-term%2520treatment%2520effects%2520of%2520rosiglitazone%2520and%2520enalapril%2520in%2520obese%2520ZSF1%2520rats%26jtitle%3DJ.%2520Endocrinol.%26date%3D2011%26volume%3D210%26spage%3D293%26epage%3D308%26doi%3D10.1530%2FJOE-11-0122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boustany-Kari, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueneva-Boucheva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosanac, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. S.</span></span> <span> </span><span class="NLM_article-title">A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.115.230706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26729306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=712-719&author=C.+M.+Boustany-Kariauthor=P.+C.+Harrisonauthor=H.+Chenauthor=K.+A.+Lincolnauthor=H.+S.+Qianauthor=H.+Cliffordauthor=H.+Wangauthor=X.+Zhangauthor=K.+Gueneva-Bouchevaauthor=T.+Bosanacauthor=D.+Wongauthor=R.+M.+Fryerauthor=J.+G.+Richmanauthor=C.+Sarkoauthor=S.+S.+Pullen&title=A+soluble+guanylate+cyclase+activator+inhibits+the+progression+of+diabetic+nephropathy+in+the+ZSF1+rat&doi=10.1124%2Fjpet.115.230706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat</span></div><div class="casAuthors">Boustany-Kari, Carine M.; Harrison, Paul C.; Chen, Hongxing; Lincoln, Kathleen A.; Qian, Hu Sheng; Clifford, Holly; Wang, Hong; Zhang, Xiaomei; Gueneva-Boucheva, Kristina; Bosanac, Todd; Wong, Diane; Fryer, Ryan M.; Richman, Jeremy G.; Sarko, Chris; Pullen, Steven S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Therapies that restore renal cGMP levels are hypothesized to slow the progression of diabetic nephropathy.  We investigated the effect of BI 703704, a sol. guanylate cyclase (sGC) activator, on disease progression in obese ZSF1 rats.  BI 703704 was administered at doses of 0.3, 1, 3, and 10 mg/kg/d to male ZSF1 rats for 15 wk, during which mean arterial pressure (MAP), heart rate (HR), and urinary protein excretion (UPE) were detd.  Histol. assessment of glomerular and interstitial lesions was also performed.  Renal cGMP levels were quantified as an indicator of target modulation.  BI 703704 resulted in sGC activation, as evidenced by dose-dependent increases in renal cGMP levels.  After 15 wk of treatment, sGC activation resulted in dose-dependent decreases in UPE (from 463 ± 58 mg/d in vehicle controls to 328 ± 55, 348 ± 23, 283 ± 45, and 108 ± 23 mg/d in BI 703704-treated rats at 0.3, 1, 3, and 10 mg/kg, resp.).  These effects were accompanied by a significant redn. in the incidence of glomerulosclerosis and interstitial lesions.  Decreases in MAP and increases in HR were only obsd. at the high dose of BI 703704.  These results are the first demonstration of renal protection with sGC activation in a nephropathy model induced by type 2 diabetes.  Importantly, beneficial effects were obsd. at doses that did not significantly alter MAP and HR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriDtsMxLG1NLVg90H21EOLACvtfcHk0lj791OJ80H0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelu7Y%253D&md5=638e527952bd81b55d7d70ecaa3e1786</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230706%26sid%3Dliteratum%253Aachs%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLincoln%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DH.%2BS.%26aulast%3DClifford%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DBosanac%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DRichman%26aufirst%3DJ.%2BG.%26aulast%3DSarko%26aufirst%3DC.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26atitle%3DA%2520soluble%2520guanylate%2520cyclase%2520activator%2520inhibits%2520the%2520progression%2520of%2520diabetic%2520nephropathy%2520in%2520the%2520ZSF1%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D712%26epage%3D719%26doi%3D10.1124%2Fjpet.115.230706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':[],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tim F. Ryder, Matthew F. Calabrese, Gregory S. Walker, Kimberly O. Cameron, Allan R. Reyes, Kris A. Borzilleri, Jake Delmore, Russell Miller, Ravi G. Kurumbail, Jessica Ward, Daniel W. Kung, Janice A. Brown, David J. Edmonds, Heather Eng, Angela C. Wolford, <span class="NLM_string-name hlFld-ContribAuthor">Amit S. Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (16)
                                     , 7273-7288. <a href="https://doi.org/10.1021/acs.jmedchem.8b00807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcyl%252BGlucuronide%252BMetabolites%252Bof%252B6-Chloro-5-%25255B4-%2525281-hydroxycyclobutyl%252529phenyl%25255D-1H-indole-3-carboxylic%252BAcid%252B%252528PF-06409577%252529%252Band%252BRelated%252BIndole-3-carboxylic%252BAcid%252BDerivatives%252Bare%252BDirect%252BActivators%252Bof%252BAdenosine%252BMonophosphate-Activated%252BProtein%252BKinase%252B%252528AMPK%252529%26aulast%3DRyder%26aufirst%3DTim%2BF.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21052018%26date%3D02082018%26date%3D23072018%26volume%3D61%26issue%3D16%26spage%3D7273%26epage%3D7288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aaron C. Smith, Daniel W. Kung, Andre Shavnya, Thomas A. Brandt, Philip D. Dent, Nathan E. Genung, Shawn Cabral, Jane Panteleev, Michael Herr, Ka Ning Yip, Gary E. Aspnes, Edward L. Conn, Matthew S. Dowling, David J. Edmonds, Ian D. Edmonds, Dilinie P. Fernando, Paul M. Herrinton, Nandell F. Keene, Sophie Y. Lavergne, Qifang Li, Jana Polivkova, Colin R. Rose, Benjamin A. Thuma, Michael G. Vetelino, Guoqiang Wang, John D. Weaver, III, Daniel W. Widlicka, Kristin E. Price Wiglesworth, Jun Xiao, Todd Zahn, <span class="NLM_string-name hlFld-ContribAuthor">Yingxin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of the Synthesis of AMPK Activators for the Treatment of Diabetic Nephropathy: From Three Preclinical Candidates to the Investigational New Drug PF-06409577. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (6)
                                     , 681-696. <a href="https://doi.org/10.1021/acs.oprd.8b00059" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00059%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEvolution%252Bof%252Bthe%252BSynthesis%252Bof%252BAMPK%252BActivators%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetic%252BNephropathy%25253A%252BFrom%252BThree%252BPreclinical%252BCandidates%252Bto%252Bthe%252BInvestigational%252BNew%252BDrug%252BPF-06409577%26aulast%3DSmith%26aufirst%3DAaron%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23022018%26date%3D29052018%26date%3D10052018%26volume%3D22%26issue%3D6%26spage%3D681%26epage%3D696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Huan  Chen</span>, <span class="hlFld-ContribAuthor ">Yanqi  Lei</span>, <span class="hlFld-ContribAuthor ">Xiaonan  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Xu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenya  Fan</span>, <span class="hlFld-ContribAuthor ">Zequn  Ma</span>, <span class="hlFld-ContribAuthor ">Zhechang  Yin</span>, <span class="hlFld-ContribAuthor ">Lingyun  Li</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Bing  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113269. <a href="https://doi.org/10.1016/j.ejmech.2021.113269" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113269%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252Bagents%252Bbased%252Bon%252Bbenzoxazolone%252Bas%252Bpromising%252Btherapeutic%252Bdrugs%252Bfor%252Bdiabetic%252Bnephropathy%26aulast%3DZhang%26aufirst%3DXin%26date%3D2021%26volume%3D215%26spage%3D113269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihong  Xiao</span>, <span class="hlFld-ContribAuthor ">Yajun  Peng</span>, <span class="hlFld-ContribAuthor ">Bifeng  Zheng</span>, <span class="hlFld-ContribAuthor ">Qi  Chang</span>, <span class="hlFld-ContribAuthor ">Yating  Guo</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Qianbin  Li</span>, <span class="hlFld-ContribAuthor ">Gaoyun  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 1,2,4‐oxadiazole‐containing pyrazolo[3,4‐
              b
              ]pyridinones as a new series of AMPKɑ1β1γ1 activators. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1002/ardp.202000458" title="DOI URL">https://doi.org/10.1002/ardp.202000458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000458%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B1%25252C2%25252C4%2525E2%252580%252590oxadiazole%2525E2%252580%252590containing%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bb%252B%25255Dpyridinones%252Bas%252Ba%252Bnew%252Bseries%252Bof%252BAMPK%2525C9%2525911%2525CE%2525B21%2525CE%2525B31%252Bactivators%26aulast%3DXiao%26aufirst%3DZhihong%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biswajit  Kundu</span>, <span class="hlFld-ContribAuthor ">Dipayan  Sarkar</span>, <span class="hlFld-ContribAuthor ">Srijita Paul  Chowdhuri</span>, <span class="hlFld-ContribAuthor ">Sourav  Pal</span>, <span class="hlFld-ContribAuthor ">Subhendu K.  Das</span>, <span class="hlFld-ContribAuthor ">Benu Brata  Das</span>, <span class="hlFld-ContribAuthor ">Arindam  Talukdar</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a metabolically stable topoisomerase I poison as anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112551. <a href="https://doi.org/10.1016/j.ejmech.2020.112551" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112551%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bmetabolically%252Bstable%252Btopoisomerase%252BI%252Bpoison%252Bas%252Banticancer%252Bagent%26aulast%3DKundu%26aufirst%3DBiswajit%26date%3D2020%26volume%3D202%26spage%3D112551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-304. <a href="https://doi.org/10.1002/9781119607311.ch4" title="DOI URL">https://doi.org/10.1002/9781119607311.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DBioisosteres%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D304%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected AMPK activators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structure of <b>1</b> (A) and a view of the co-crystal structure of <b>1</b> with α1β1γ1-AMPK (B). Compound <b>1</b> (pink ball-and-stick) is bound in the ADaM site at the interface of the α1 and β1 subunits (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a>.pdb). Some of the key hydrogen bond interactions formed by the ligand are highlighted.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes to Indole Acid AMPK Activators<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Conditions: (a) ClCHNMe<sub>2</sub>Cl (POCl<sub>3</sub>-DMF), CH<sub>3</sub>CN or DMF; then NaOH, H<sub>2</sub>O; (b) ArB(OH)<sub>2</sub> or ArB(OR)<sub>2</sub> (pinacol or neopentyl glycol boronate), Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, EtOH–toluene–THF–2-MeTHF; (c) NaClO<sub>2</sub>, 2-methyl-2-butene, NaH<sub>2</sub>PO<sub>4</sub>, H<sub>2</sub>O–CH<sub>3</sub>CN–THF–<i>t</i>-BuOH; (d) Cl<sub>3</sub>CCOCl, pyridine, DMAP; then NaOMe, MeOH; (e) B<sub>2</sub>(neop)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, KOAc, dioxane; (f) ArBr, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, EtOH–toluene–dioxane; (g) NaOH, H<sub>2</sub>O–MeOH.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. View of compound <b>14</b> co-crystallized with α1β1γ1-AMPK (A) and an overlay (B) of the bound structures of <b>1</b> (pink) and <b>14</b> (cyan). Compound <b>14</b> (cyan sticks) is bound in the ADaM site at the interface of the α1 and β1 subunits (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T">5T5T</a>.pdb). Some of the key hydrogen bond interactions are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/medium/jm-2017-01641b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo assessment of AMPK target engagement as measured by increases in pAMPK/tAMPK in kidney pole for compounds <b>1</b>, <b>10</b>, and <b>14</b> in ZSF-1 rats after 3 days of dosing (*** indicates <i>p</i> < 0.001 relative to vehicle).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.7b01641/20180315/images/large/jm-2017-01641b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01641&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i22">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13821" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13821" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckling, R. J.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1111/dom.12630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fdom.12630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26743887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC28rotlahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=641-647&author=H.+Gallagherauthor=R.+J.+Suckling&title=Diabetic+nephropathy%3A+where+are+we+on+the+journey+from+pathophysiology+to+treatment%3F&doi=10.1111%2Fdom.12630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?</span></div><div class="casAuthors">Gallagher H; Suckling R J</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, obesity & metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">641-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetic nephropathy affects 30-40% of people with diabetes, and is the leading cause of end-stage kidney disease.  The current treatment paradigm relies on early detection, glycaemic control and tight blood pressure management with preferential use of renin-angiotensin system blockade.  This strategy has transformed outcomes in diabetic kidney disease over the last 20 years.  Over the last two decades we have also witnessed significant advances in the understanding of the pathophysiology of diabetic nephropathy; however, despite this new knowledge, we have yet to develop new treatments of proven efficacy.  Whilst a continued emphasis on preclinical and clinical research is clearly needed, clinicians treating people with diabetes should not forget that, in the short term, the greatest gains are likely to be realised by more consistent deployment of existing therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtBJZchC7NpotVjB3IRIyfW6udTcc2eYFKyzJqrnPsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rotlahtQ%253D%253D&md5=ed3a06804b4995832b00d9f955123a20</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fdom.12630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.12630%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DH.%26aulast%3DSuckling%26aufirst%3DR.%2BJ.%26atitle%3DDiabetic%2520nephropathy%253A%2520where%2520are%2520we%2520on%2520the%2520journey%2520from%2520pathophysiology%2520to%2520treatment%253F%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2016%26volume%3D18%26spage%3D641%26epage%3D647%26doi%3D10.1111%2Fdom.12630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bjornstad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherney, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maahs, D. M.</span></span> <span> </span><span class="NLM_article-title">Update on estimation of kidney function in diabetic kidney disease</span>. <i>Curr. Diabetes Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">57</span>, <span class="refDoi"> DOI: 10.1007/s11892-015-0633-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1007%2Fs11892-015-0633-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26188736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FkslWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=57&author=P.+Bjornstadauthor=D.+Z.+Cherneyauthor=D.+M.+Maahs&title=Update+on+estimation+of+kidney+function+in+diabetic+kidney+disease&doi=10.1007%2Fs11892-015-0633-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Estimation of Kidney Function in Diabetic Kidney Disease</span></div><div class="casAuthors">Bjornstad Petter; Cherney David Z; Maahs David M</div><div class="citationInfo"><span class="NLM_cas:title">Current diabetes reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The American Diabetes Association recommends annual assessment of glomerular filtration rate (GFR) to screen for diabetic nephropathy.  GFR is measured indirectly using markers that, ideally, are eliminated only by glomerular filtration.  Measured GFR, although the gold standard, remains cumbersome and expensive.  GFR is therefore routinely estimated using creatinine and/or cystatin C and clinical variables.  In pediatrics, the Schwartz creatinine-based equation is most frequently used even though combined creatinine and cystatin C-based equations demonstrate stronger agreement with measured GFR.  In adults, the CKD Epidemiology Collaboration (CKD-EPI) equations with creatinine and/or cystatin C are the most accurate and precise estimating equations.  Despite recent advances, current estimates of GFR lack precision and accuracy before chronic kidney disease stage 3 (GFR < 60 mL/min/1.73 m(2)).  There is therefore an urgent need to improve the methods for estimating and measuring GFR.  In this review, we examine the current literature and data addressing measurement and estimation of GFR in diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTH_GNAkXtkK1vAgqb2vdc5fW6udTcc2eYFKyzJqrnPsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FkslWgtg%253D%253D&md5=b818c2a03101d8ed8091b87dc472026f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11892-015-0633-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11892-015-0633-2%26sid%3Dliteratum%253Aachs%26aulast%3DBjornstad%26aufirst%3DP.%26aulast%3DCherney%26aufirst%3DD.%2BZ.%26aulast%3DMaahs%26aufirst%3DD.%2BM.%26atitle%3DUpdate%2520on%2520estimation%2520of%2520kidney%2520function%2520in%2520diabetic%2520kidney%2520disease%26jtitle%3DCurr.%2520Diabetes%2520Rep.%26date%3D2015%26volume%3D15%26spage%3D57%26doi%3D10.1007%2Fs11892-015-0633-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallon, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komers, R.</span></span> <span> </span><span class="NLM_article-title">Pathophysiology of the diabetic kidney</span>. <i>Compr. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1232</span>, <span class="refDoi"> DOI: 10.1002/cphy.c100049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fcphy.c100049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23733640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC3snpsVenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=1175-1232&author=V.+Vallonauthor=R.+Komers&title=Pathophysiology+of+the+diabetic+kidney&doi=10.1002%2Fcphy.c100049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of the diabetic kidney</span></div><div class="casAuthors">Vallon Volker; Komers Radko</div><div class="citationInfo"><span class="NLM_cas:title">Comprehensive Physiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1175-232</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes mellitus contributes greatly to morbidity, mortality, and overall health care costs.  In major part, these outcomes derive from the high incidence of progressive kidney dysfunction in patients with diabetes making diabetic nephropathy a leading cause of end-stage renal disease.  A better understanding of the molecular mechanism involved and of the early dysfunctions observed in the diabetic kidney may permit the development of new strategies to prevent diabetic nephropathy.  Here we review the pathophysiological changes that occur in the kidney in response to hyperglycemia, including the cellular responses to high glucose and the responses in vascular, glomerular, podocyte, and tubular function.  The molecular basis, characteristics, and consequences of the unique growth phenotypes observed in the diabetic kidney, including glomerular structures and tubular segments, are outlined.  We delineate mechanisms of early diabetic glomerular hyperfiltration including primary vascular events as well as the primary role of tubular growth, hyperreabsorption, and tubuloglomerular communication as part of a "tubulocentric" concept of early diabetic kidney function.  The latter also explains the "salt paradox" of the early diabetic kidney, that is, a unique and inverse relationship between glomerular filtration rate and dietary salt intake.  The mechanisms and consequences of the intrarenal activation of the renin-angiotensin system and of diabetes-induced tubular glycogen accumulation are discussed.  Moreover, we aim to link the changes that occur early in the diabetic kidney including the growth phenotype, oxidative stress, hypoxia, and formation of advanced glycation end products to mechanisms involved in progressive kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRUksfu_AqPfIJKJbLTgsvCfW6udTcc2eYFKyzJqrnPsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snpsVenuw%253D%253D&md5=f8a87e98229981f236b5f0e4352a1628</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fcphy.c100049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcphy.c100049%26sid%3Dliteratum%253Aachs%26aulast%3DVallon%26aufirst%3DV.%26aulast%3DKomers%26aufirst%3DR.%26atitle%3DPathophysiology%2520of%2520the%2520diabetic%2520kidney%26jtitle%3DCompr.%2520Physiol.%26date%3D2011%26volume%3D1%26spage%3D1175%26epage%3D1232%26doi%3D10.1002%2Fcphy.c100049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pofi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Mario, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigante, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isidori, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbano, B.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy: focus on current and future therapeutic strategies</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.2174/138920021705160324165553</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2174%2F138920021705160324165553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27025881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=497-502&author=R.+Pofiauthor=F.+Di+Marioauthor=A.+Giganteauthor=E.+Rosatoauthor=A.+M.+Isidoriauthor=A.+Amorosoauthor=R.+Cianciauthor=B.+Barbano&title=Diabetic+nephropathy%3A+focus+on+current+and+future+therapeutic+strategies&doi=10.2174%2F138920021705160324165553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies</span></div><div class="casAuthors">Pofi, Riccardo; Di Mario, Francesca; Gigante, Antonietta; Rosato, Edoardo; Isidori, Andrea M.; Amoroso, Antonio; Cianci, Rosario; Barbano, Biagio</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-502</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: Diabetic nephropathy (DN) is currently the most common cause of end-stage renal disease (ESRD).  Although nowadays much is known about its classification, pathogenesis, clin. manifestations and evolution, to date we are not yet able to stop the natural progression of nephropathy in diabetic patients.  Methods: Treatment options are: lifestyle change with close blood pressure monitoring and tight glycemic control.  The most common therapies adopted for this condition are Angiotensing Converting Enzyme-inhibitors (ACEi).  However these drugs are able to block the progression of renal damage only in a small proportion of patients.  In the remaining, DN progresses and may evolve into ESRD.  Conclusion: The purpose of this review is to summarize the "state of art" of current novel therapeutic strategies to stem this debilitating kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplcNGcI2UHBLVg90H21EOLACvtfcHk0lit-1232iVCLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kgur0%253D&md5=faffcf485059720f4deaa5b19c7f08b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F138920021705160324165553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920021705160324165553%26sid%3Dliteratum%253Aachs%26aulast%3DPofi%26aufirst%3DR.%26aulast%3DDi%2BMario%26aufirst%3DF.%26aulast%3DGigante%26aufirst%3DA.%26aulast%3DRosato%26aufirst%3DE.%26aulast%3DIsidori%26aufirst%3DA.%2BM.%26aulast%3DAmoroso%26aufirst%3DA.%26aulast%3DCianci%26aufirst%3DR.%26aulast%3DBarbano%26aufirst%3DB.%26atitle%3DDiabetic%2520nephropathy%253A%2520focus%2520on%2520current%2520and%2520future%2520therapeutic%2520strategies%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2016%26volume%3D17%26spage%3D497%26epage%3D502%26doi%3D10.2174%2F138920021705160324165553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKintosh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardie, D. G.</span></span> <span> </span><span class="NLM_article-title">AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">2987</span>– <span class="NLM_lpage">3001</span>, <span class="refDoi"> DOI: 10.1111/febs.13698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Ffebs.13698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26934201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=2987-3001&author=F.+A.+Rossauthor=C.+MacKintoshauthor=D.+G.+Hardie&title=AMP-activated+protein+kinase%3A+a+cellular+energy+sensor+that+comes+in+12+flavours&doi=10.1111%2Ffebs.13698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours</span></div><div class="casAuthors">Ross, Fiona A.; MacKintosh, Carol; Hardie, D. Grahame</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2987-3001</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The AMP-activated protein kinase (AMPK) is a sensor of cellular energy status that is expressed in essentially all eukaryotic cells, suggesting that it arose during early eukaryotic evolution.  It occurs universally as heterotrimeric complexes contg. catalytic α subunits and regulatory β and γ subunits.  Although Drosophila melanogaster contains single genes encoding each subunit, in mammals, each subunit exists as multiple isoforms encoded by distinct genes, giving rise to up to 12 heterotrimeric combinations.  The multiple isoforms of each subunit are 2R-ohnologues generated by the two rounds of whole genome duplication that occurred at the evolutionary origin of the vertebrates.  Although the differential roles of these isoform combinations remain only partly understood, there are indications that they may have different subcellular locations, different inputs and outputs, and different functions.  The multiple isoforms are of particular interest with respect to the roles of AMPK in cancer because the genes encoding some isoforms, such as PRKAA1 and PRKAB2 (encoding α1 and β2), are quite frequently amplified in tumor cells, whereas the genes encoding others, such as PRKAA2 (encoding α2), tend to be mutated, which, in some but not all cases, may result in a loss of function.  Thus, although AMPK acts downstream of the tumor suppressor liver kinase B1, and some of its isoform combinations may act as tumor suppressors that restrain the growth and proliferation of tumor cells, other isoform combinations may paradoxically act as oncogenes, perhaps by aiding the survival of tumor cells undergoing environmental stresses such as hypoxia or nutrient deprivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfm7YmLb0fCLVg90H21EOLACvtfcHk0lit-1232iVCLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVSjtro%253D&md5=0b65385fe0f4973621e06b0a204c15aa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13698%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DF.%2BA.%26aulast%3DMacKintosh%26aufirst%3DC.%26aulast%3DHardie%26aufirst%3DD.%2BG.%26atitle%3DAMP-activated%2520protein%2520kinase%253A%2520a%2520cellular%2520energy%2520sensor%2520that%2520comes%2520in%252012%2520flavours%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D2987%26epage%3D3001%26doi%3D10.1111%2Ffebs.13698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mihaylova, M.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span> <span> </span><span class="NLM_article-title">The AMPK signalling pathway coordinates cell growth, autophagy and metabolism</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1016</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1038/ncb2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fncb2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21892142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWlsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1016-1023&author=M.%0AM.+Mihaylovaauthor=R.+J.+Shaw&title=The+AMPK+signalling+pathway+coordinates+cell+growth%2C+autophagy+and+metabolism&doi=10.1038%2Fncb2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The AMPK signaling pathway coordinates cell growth, autophagy and metabolism</span></div><div class="casAuthors">Mihaylova, Maria M.; Shaw, Reuben J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1016-1023</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One of the central regulators of cellular and organismal metab. in eukaryotes is AMP-activated protein kinase (AMPK), which is activated when intracellular ATP prodn. decreases.  AMPK plays crit. roles in regulating growth and reprogramming metab., and has recently been connected to cellular processes such as autophagy and cell polarity.  Here, the authors review a no. of recent breakthroughs in the mechanistic understanding of AMPK function, focusing on a no. of newly identified downstream effectors of AMPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFKHyhC51s5bVg90H21EOLACvtfcHk0lit-1232iVCLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWlsrfO&md5=ad907d9e0f7754f359114327c98aed19</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fncb2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2329%26sid%3Dliteratum%253Aachs%26aulast%3DMihaylova%26aufirst%3DM.%2BM.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520AMPK%2520signalling%2520pathway%2520coordinates%2520cell%2520growth%252C%2520autophagy%2520and%2520metabolism%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2011%26volume%3D13%26spage%3D1016%26epage%3D1023%26doi%3D10.1038%2Fncb2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5139</span>– <span class="NLM_lpage">5148</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.09.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.bmcl.2016.09.065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27727125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1CltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5139-5148&author=K.+O.+Cameronauthor=R.+G.+Kurumbail&title=Recent+progress+in+the+identification+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29+activators&doi=10.1016%2Fj.bmcl.2016.09.065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators</span></div><div class="casAuthors">Cameron, Kimberly O.; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5139-5148</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine monophosphate-activated protein kinase (AMPK), a serine/threonine heterotrimeric protein kinase, is a crit. regulator of cellular and whole body energy homeostasis.  There are twelve known AMPK isoforms that are differentially expressed in tissues and species.  Dysregulation of AMPK signaling is assocd. with a multitude of human pathologies.  Hence isoform-selective activators of AMPK are actively being sought for the treatment of cardiovascular and metabolic diseases.  The present review summarizes the status of direct AMPK activators from the patent and published literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGznmXmj3uArVg90H21EOLACvtfcHk0liH4zDUPeu2kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1CltLrM&md5=4581cdf6c050bd165e9e058ea5551ffb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.09.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.09.065%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DRecent%2520progress%2520in%2520the%2520identification%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%2520activators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5139%26epage%3D5148%26doi%3D10.1016%2Fj.bmcl.2016.09.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasenour, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughey, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donahue, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasserman, D. H.</span></span> <span> </span><span class="NLM_article-title">5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">5950</span>– <span class="NLM_lpage">5959</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.528232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1074%2Fjbc.M113.528232" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=5950-5959&author=C.+M.+Hasenourauthor=D.+E.+Ridleyauthor=C.+C.+Hugheyauthor=F.+D.+Jamesauthor=E.+P.+Donahueauthor=J.+Shearerauthor=B.+Violletauthor=M.+Foretzauthor=D.+H.+Wasserman&title=5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside+%28AICAR%29+effect+on+glucose+production%2C+but+not+energy+metabolism%2C+is+independent+of+hepatic+AMPK+in+vivo&doi=10.1074%2Fjbc.M113.528232"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.528232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.528232%26sid%3Dliteratum%253Aachs%26aulast%3DHasenour%26aufirst%3DC.%2BM.%26aulast%3DRidley%26aufirst%3DD.%2BE.%26aulast%3DHughey%26aufirst%3DC.%2BC.%26aulast%3DJames%26aufirst%3DF.%2BD.%26aulast%3DDonahue%26aufirst%3DE.%2BP.%26aulast%3DShearer%26aufirst%3DJ.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DWasserman%26aufirst%3DD.%2BH.%26atitle%3D5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside%2520%2528AICAR%2529%2520effect%2520on%2520glucose%2520production%252C%2520but%2520not%2520energy%2520metabolism%252C%2520is%2520independent%2520of%2520hepatic%2520AMPK%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D5950%26epage%3D5959%26doi%3D10.1074%2Fjbc.M113.528232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebrard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leclerc, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinpashneh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mithieux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span> <span> </span><span class="NLM_article-title">Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">2355</span>– <span class="NLM_lpage">2369</span>, <span class="refDoi"> DOI: 10.1172/JCI40671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1172%2FJCI40671" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=2355-2369&author=M.+Foretzauthor=S.+Hebrardauthor=J.+Leclercauthor=E.+Zarrinpashnehauthor=M.+Sotyauthor=G.+Mithieuxauthor=K.+Sakamotoauthor=F.+Andreelliauthor=B.+Viollet&title=Metformin+inhibits+hepatic+gluconeogenesis+in+mice+independently+of+the+LKB1%2FAMPK+pathway+via+a+decrease+in+hepatic+energy+state&doi=10.1172%2FJCI40671"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1172%2FJCI40671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI40671%26sid%3Dliteratum%253Aachs%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DHebrard%26aufirst%3DS.%26aulast%3DLeclerc%26aufirst%3DJ.%26aulast%3DZarrinpashneh%26aufirst%3DE.%26aulast%3DSoty%26aufirst%3DM.%26aulast%3DMithieux%26aufirst%3DG.%26aulast%3DSakamoto%26aufirst%3DK.%26aulast%3DAndreelli%26aufirst%3DF.%26aulast%3DViollet%26aufirst%3DB.%26atitle%3DMetformin%2520inhibits%2520hepatic%2520gluconeogenesis%2520in%2520mice%2520independently%2520of%2520the%2520LKB1%252FAMPK%2520pathway%2520via%2520a%2520decrease%2520in%2520hepatic%2520energy%2520state%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2010%26volume%3D120%26spage%3D2355%26epage%3D2369%26doi%3D10.1172%2FJCI40671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cool, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kifle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagne, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyengar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kym, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frevert, E.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2006.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.cmet.2006.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=16753576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1eku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=403-416&author=B.+Coolauthor=B.+Zinkerauthor=W.+Chiouauthor=L.+Kifleauthor=N.+Caoauthor=M.+Perhamauthor=R.+Dickinsonauthor=A.+Adlerauthor=G.+Gagneauthor=R.+Iyengarauthor=G.+Zhaoauthor=K.+Marshauthor=P.+Kymauthor=P.+Jungauthor=H.+S.+Campauthor=E.+Frevert&title=Identification+and+characterization+of+a+small+molecule+AMPK+activator+that+treats+key+components+of+type+2+diabetes+and+the+metabolic+syndrome&doi=10.1016%2Fj.cmet.2006.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome</span></div><div class="casAuthors">Cool, Barbara; Zinker, Bradley; Chiou, William; Kifle, Lemma; Cao, Ning; Perham, Matthew; Dickinson, Robert; Adler, Andrew; Gagne, Gerard; Iyengar, Rajesh; Zhao, Gang; Marsh, Kennan; Kym, Philip; Jung, Paul; Camp, Heidi S.; Frevert, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">403-416</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a key sensor and regulator of intracellular and whole-body energy metab.  The authors have identified a thienopyridone family of AMPK activators.  A-769662 directly stimulated partially purified rat liver AMPK (EC50 = 0.8 μM) and inhibited fatty acid synthesis in primary rat hepatocytes (IC50 = 3.2 μM).  Short-term treatment of normal Sprague Dawley rats with A-769662 decreased liver malonyl Co-A levels and the respiratory exchange ratio, VCO2/VO2, indicating an increased rate of whole-body fatty acid oxidn.  Treatment of ob/ob mice with 30 mg/kg b.i.d. A-769662 decreased hepatic expression of PEPCK, G6Pase, and FAS, lowered plasma glucose by 40%, reduced body wt. gain and significantly decreased both plasma and liver triglyceride levels.  These results demonstrate that small mol. mediated activation of AMPK in vivo is feasible and represents a promising approach for the treatment of type 2 diabetes and the metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcoMCQ6mqiLVg90H21EOLACvtfcHk0liH4zDUPeu2kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1eku70%253D&md5=710c43b18664c5f29b9cdd5dee5e9e90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DCool%26aufirst%3DB.%26aulast%3DZinker%26aufirst%3DB.%26aulast%3DChiou%26aufirst%3DW.%26aulast%3DKifle%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DPerham%26aufirst%3DM.%26aulast%3DDickinson%26aufirst%3DR.%26aulast%3DAdler%26aufirst%3DA.%26aulast%3DGagne%26aufirst%3DG.%26aulast%3DIyengar%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DKym%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DP.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DFrevert%26aufirst%3DE.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520small%2520molecule%2520AMPK%2520activator%2520that%2520treats%2520key%2520components%2520of%2520type%25202%2520diabetes%2520and%2520the%2520metabolic%2520syndrome%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D403%26epage%3D416%26doi%3D10.1016%2Fj.cmet.2006.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Galeno, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grote, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craigo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Poelje, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cable, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolzin, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linemeyer, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span> <span> </span><span class="NLM_article-title">A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1021/ml100143q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100143q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=478-482&author=J.+E.+Gomez-Galenoauthor=Q.+Dangauthor=T.+H.+Nguyenauthor=S.+H.+Boyerauthor=M.+P.+Groteauthor=Z.+Sunauthor=M.+Chenauthor=W.+A.+Craigoauthor=P.+D.+van+Poeljeauthor=D.+A.+MacKennaauthor=E.+E.+Cableauthor=P.+A.+Rolzinauthor=P.+D.+Finnauthor=B.+Chiauthor=D.+L.+Linemeyerauthor=S.+J.+Heckerauthor=M.+D.+Erion&title=A+Potent+and+Selective+AMPK+Activator+That+Inhibits+de+Novo+Lipogenesis&doi=10.1021%2Fml100143q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fml100143q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100143q%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Galeno%26aufirst%3DJ.%2BE.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DNguyen%26aufirst%3DT.%2BH.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DGrote%26aufirst%3DM.%2BP.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DCraigo%26aufirst%3DW.%2BA.%26aulast%3Dvan%2BPoelje%26aufirst%3DP.%2BD.%26aulast%3DMacKenna%26aufirst%3DD.%2BA.%26aulast%3DCable%26aufirst%3DE.%2BE.%26aulast%3DRolzin%26aufirst%3DP.%2BA.%26aulast%3DFinn%26aufirst%3DP.%2BD.%26aulast%3DChi%26aufirst%3DB.%26aulast%3DLinemeyer%26aufirst%3DD.%2BL.%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DA%2520Potent%2520and%2520Selective%2520AMPK%2520Activator%2520That%2520Inhibits%2520de%2520Novo%2520Lipogenesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D478%26epage%3D482%26doi%3D10.1021%2Fml100143q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cashion, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenna, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">Hit-to-lead optimization and discovery of 5-((5-([1,1’-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid (MK-3903): a novel class of benzimidazole-based activators of amp-activated protein kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9040</span>– <span class="NLM_lpage">9052</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9040-9052&author=P.+Lanauthor=F.+A.+Romeroauthor=D.+Wodkaauthor=A.+J.+Kassickauthor=Q.+Dangauthor=T.+Gibsonauthor=D.+Cashionauthor=G.+Zhouauthor=Y.+Chenauthor=X.+Zhangauthor=A.+Zhangauthor=Y.+Liauthor=M.+E.+Trujilloauthor=Q.+Shaoauthor=M.+Wuauthor=S.+Xuauthor=H.+Heauthor=D.+MacKennaauthor=J.+Stauntonauthor=K.+T.+Chapmanauthor=A.+Weberauthor=I.+K.+Sebhatauthor=G.+M.+Makara&title=Hit-to-lead+optimization+and+discovery+of+5-%28%285-%28%5B1%2C1%E2%80%99-Biphenyl%5D-4-yl%29-6-chloro-1H-benzo%5Bd%5Dimidazol-2-yl%29oxy%29-2-methylbenzoic+acid+%28MK-3903%29%3A+a+novel+class+of+benzimidazole-based+activators+of+amp-activated+protein+kinase&doi=10.1021%2Facs.jmedchem.7b01344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase</span></div><div class="casAuthors">Lan, Ping; Romero, F. Anthony; Wodka, Dariusz; Kassick, Andrew J.; Dang, Qun; Gibson, Tony; Cashion, Daniel; Zhou, Gaochao; Chen, Yuli; Zhang, Xiaoping; Zhang, Aihua; Li, Ying; Trujillo, Maria E.; Shao, Qing; Wu, Margaret; Xu, Shiyao; He, Huaibing; MacKenna, Deidre; Staunton, Jocelyn; Chapman, Kevin T.; Weber, Ann; Sebhat, Iyassu K.; Makara, Gergely M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9040-9052</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays an essential role as a cellular energy sensor and master regulator of metab. in eukaryotes.  Dysregulated lipid and carbohydrate metab. resulting from insulin resistance leads to hyperglycemia, the hallmark of type 2 diabetes mellitus (T2DM).  While pharmacol. activation of AMPK is anticipated to improve these parameters, the discovery of selective, direct activators has proven challenging.  The authors now describe a hit-to-lead effort resulting in the discovery of a potent and selective class of benzimidazole-based direct AMPK activators, exemplified by 5-((5-([1,1'-biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid, (I) (MK-3903).  Compd. I exhibited robust target engagement in mouse liver following oral dosing, leading to improved lipid metab. and insulin sensitization in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq1hsQVY4LybVg90H21EOLACvtfcHk0lhlFzmhLD6NCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Kns77K&md5=83e7343b1bfa589036c3bcb5ab8e62c1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01344%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DP.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DWodka%26aufirst%3DD.%26aulast%3DKassick%26aufirst%3DA.%2BJ.%26aulast%3DDang%26aufirst%3DQ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DCashion%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DMacKenna%26aufirst%3DD.%26aulast%3DStaunton%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%2BT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DHit-to-lead%2520optimization%2520and%2520discovery%2520of%25205-%2528%25285-%2528%255B1%252C1%25E2%2580%2599-Biphenyl%255D-4-yl%2529-6-chloro-1H-benzo%255Bd%255Dimidazol-2-yl%2529oxy%2529-2-methylbenzoic%2520acid%2520%2528MK-3903%2529%253A%2520a%2520novel%2520class%2520of%2520benzimidazole-based%2520activators%2520of%2520amp-activated%2520protein%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9040%26epage%3D9052%26doi%3D10.1021%2Facs.jmedchem.7b01344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrhart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prahalada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozzo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez Trotter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conarello, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souza, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Painter, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohm, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaFranco Scheuch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Heek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelley, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornberry, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erion, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1126/science.aah5582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1126%2Fscience.aah5582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=28705990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GgsrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2017&pages=507-511&author=R.+W.+Myersauthor=H.+P.+Guanauthor=J.+Ehrhartauthor=A.+Petrovauthor=S.+Prahaladaauthor=E.+Tozzoauthor=X.+Yangauthor=M.+M.+Kurtzauthor=M.+Trujilloauthor=D.+Gonzalez+Trotterauthor=D.+Fengauthor=S.+Xuauthor=G.+Eiermannauthor=M.+A.+Holahanauthor=D.+Rubinsauthor=S.+Conarelloauthor=X.+Niuauthor=S.+C.+Souzaauthor=C.+Millerauthor=J.+Liuauthor=K.+Luauthor=W.+Fengauthor=Y.+Liauthor=R.+E.+Painterauthor=J.+A.+Milliganauthor=H.+Heauthor=F.+Liuauthor=A.+Ogawaauthor=D.+Wisniewskiauthor=R.+J.+Rohmauthor=L.+Wangauthor=M.+Bunzelauthor=Y.+Qianauthor=W.+Zhuauthor=H.+Wangauthor=B.+Bennetauthor=L.+LaFranco+Scheuchauthor=G.+E.+Fernandezauthor=C.+Liauthor=M.+Klimasauthor=G.+Zhouauthor=M.+van+Heekauthor=T.+Biftuauthor=A.+Weberauthor=D.+E.+Kelleyauthor=N.+Thornberryauthor=M.+D.+Erionauthor=D.+M.+Kempauthor=I.+K.+Sebhat&title=Systemic+pan-AMPK+activator+MK-8722+improves+glucose+homeostasis+but+induces+cardiac+hypertrophy&doi=10.1126%2Fscience.aah5582"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy</span></div><div class="casAuthors">Myers, Robert W.; Guan, Hong-Ping; Ehrhart, Juliann; Petrov, Aleksandr; Prahalada, Srinivasa; Tozzo, Effie; Yang, Xiaodong; Kurtz, Marc M.; Trujillo, Maria; Gonzalez Trotter, Dinko; Feng, Danqing; Xu, Shiyao; Eiermann, George; Holahan, Marie A.; Rubins, Daniel; Conarello, Stacey; Niu, Xiaoda; Souza, Sandra C.; Miller, Corin; Liu, Jinqi; Lu, Ku; Feng, Wen; Li, Ying; Painter, Ronald E.; Milligan, James A.; He, Huaibing; Liu, Franklin; Ogawa, Aimie; Wisniewski, Douglas; Rohm, Rory J.; Wang, Liyang; Bunzel, Michelle; Qian, Ying; Zhu, Wei; Wang, Hongwu; Bennet, Bindu; La Franco Scheuch, Lisa; Fernandez, Guillermo E.; Li, Cai; Klimas, Michael; Zhou, Gaochao; van Heek, Margaret; Biftu, Tesfaye; Weber, Ann; Kelley, David E.; Thornberry, Nancy; Erion, Mark D.; Kemp, Daniel M.; Sebhat, Iyassu K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">6350</span>),
    <span class="NLM_cas:pages">507-511</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">5'-Adenosine monophosphate-activated protein kinase (AMPK) is a master regulator of energy homeostasis in eukaryotes.  Despite three decades of investigation, the biol. roles of AMPK and its potential as a drug target remain incompletely understood, largely because of a lack of optimized pharmacol. tools.  We developed MK-8722, a potent, direct, allosteric activator of all 12 mammalian AMPK complexes.  In rodents and rhesus monkeys, MK-8722-mediated AMPK activation in skeletal muscle induced robust, durable, insulin-independent glucose uptake and glycogen synthesis, with resultant improvements in glycemia and no evidence of hypoglycemia.  These effects translated across species, including diabetic rhesus monkeys, but manifested with concomitant cardiac hypertrophy and increased cardiac glycogen without apparent functional sequelae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0ek6_5L1ybVg90H21EOLACvtfcHk0lhlFzmhLD6NCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GgsrfO&md5=9dcb25412cf382cb3e1c8908a467f4b1</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aah5582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aah5582%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DEhrhart%26aufirst%3DJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DPrahalada%26aufirst%3DS.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DTrujillo%26aufirst%3DM.%26aulast%3DGonzalez%2BTrotter%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHolahan%26aufirst%3DM.%2BA.%26aulast%3DRubins%26aufirst%3DD.%26aulast%3DConarello%26aufirst%3DS.%26aulast%3DNiu%26aufirst%3DX.%26aulast%3DSouza%26aufirst%3DS.%2BC.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPainter%26aufirst%3DR.%2BE.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DWisniewski%26aufirst%3DD.%26aulast%3DRohm%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBunzel%26aufirst%3DM.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBennet%26aufirst%3DB.%26aulast%3DLaFranco%2BScheuch%26aufirst%3DL.%26aulast%3DFernandez%26aufirst%3DG.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DKlimas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3Dvan%2BHeek%26aufirst%3DM.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DKelley%26aufirst%3DD.%2BE.%26aulast%3DThornberry%26aufirst%3DN.%26aulast%3DErion%26aufirst%3DM.%2BD.%26aulast%3DKemp%26aufirst%3DD.%2BM.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DSystemic%2520pan-AMPK%2520activator%2520MK-8722%2520improves%2520glucose%2520homeostasis%2520but%2520induces%2520cardiac%2520hypertrophy%26jtitle%3DScience%26date%3D2017%26volume%3D357%26spage%3D507%26epage%3D511%26doi%3D10.1126%2Fscience.aah5582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biftu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kekec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dropinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassick, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebhat, I. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8722: a systemic, direct pan-activator of AMP-activated protein kinase</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2mt77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=39-44&author=D.+Fengauthor=T.+Biftuauthor=F.+A.+Romeroauthor=A.+Kekecauthor=J.+Dropinskiauthor=A.+Kassickauthor=S.+Xuauthor=M.+M.+Kurtzauthor=A.+Gollapudiauthor=Q.+Shaoauthor=X.+Yangauthor=K.+Luauthor=G.+Zhouauthor=D.+Kempauthor=R.+W.+Myersauthor=H.+P.+Guanauthor=M.+E.+Trujilloauthor=C.+Liauthor=A.+Weberauthor=I.+K.+Sebhat&title=Discovery+of+MK-8722%3A+a+systemic%2C+direct+pan-activator+of+AMP-activated+protein+kinase&doi=10.1021%2Facsmedchemlett.7b00417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase</span></div><div class="casAuthors">Feng, Danqing; Biftu, Tesfaye; Romero, F. Anthony; Kekec, Ahmet; Dropinski, James; Kassick, Andrew; Xu, Shiyao; Kurtz, Marc M.; Gollapudi, Anantha; Shao, Qing; Yang, Xiaodong; Lu, Ku; Zhou, Gaochao; Kemp, Daniel; Myers, Robert W.; Guan, Hong-Ping; Trujillo, Maria E.; Li, Cai; Weber, Ann; Sebhat, Iyassu K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-44</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">5'-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and wt. loss including lipid and glucose trafficking.  As such, the enzyme has long been of interest as a target for the treatment of Type 2 Diabetes Mellitus.  The authors describe the optimization of β1-selective, liver-targeted AMPK activators and their evolution into systemic pan-activators capable of acutely lowering glucose in mouse models.  Identifying surrogates for the key acid moiety in early generation compds. proved essential in improving β2-activation and in balancing improvements in plasma unbound fraction while avoiding liver sequestration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ68Ya7WPDaLVg90H21EOLACvtfcHk0ljpmcrNqsD36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2mt77J&md5=c3cc173033071b400200fbed73d91087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00417%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DKekec%26aufirst%3DA.%26aulast%3DDropinski%26aufirst%3DJ.%26aulast%3DKassick%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DKurtz%26aufirst%3DM.%2BM.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DShao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DKemp%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DGuan%26aufirst%3DH.%2BP.%26aulast%3DTrujillo%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWeber%26aufirst%3DA.%26aulast%3DSebhat%26aufirst%3DI.%2BK.%26atitle%3DDiscovery%2520of%2520MK-8722%253A%2520a%2520systemic%252C%2520direct%2520pan-activator%2520of%2520AMP-activated%2520protein%2520kinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D39%26epage%3D44%26doi%3D10.1021%2Facsmedchemlett.7b00417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dugan, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond-Stanic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreyev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quach, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhtman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chepetan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paik, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosius, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naviaux, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">4888</span>– <span class="NLM_lpage">4899</span>, <span class="refDoi"> DOI: 10.1172/JCI66218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1172%2FJCI66218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24135141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2013&pages=4888-4899&author=L.+L.+Duganauthor=Y.+H.+Youauthor=S.+S.+Aliauthor=M.+Diamond-Stanicauthor=S.+Miyamotoauthor=A.+E.+DeClevesauthor=A.+Andreyevauthor=T.+Quachauthor=S.+Lyauthor=G.+Shekhtmanauthor=W.+Nguyenauthor=A.+Chepetanauthor=T.+P.+Leauthor=L.+Wangauthor=M.+Xuauthor=K.+P.+Paikauthor=A.+Fogoauthor=B.+Violletauthor=A.+Murphyauthor=F.+Brosiusauthor=R.+K.+Naviauxauthor=K.+Sharma&title=AMPK+dysregulation+promotes+diabetes-related+reduction+of+superoxide+and+mitochondrial+function&doi=10.1172%2FJCI66218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function</span></div><div class="casAuthors">Dugan, Laura L.; You, Young-Hyun; Ali, Sameh S.; Diamond-Stanic, Maggie; Miyamoto, Satoshi; De Cleves, Anne-Emilie; Andreyev, Aleksander; Quach, Tammy; Ly, San; Shekhtman, Grigory; Nguyen, William; Chepetan, Andre; Le, Thuy P.; Wang, Lin; Xu, Ming; Paik, Kacie P.; Fogo, Agnes; Viollet, Benoit; Murphy, Anne; Brosius, Frank; Naviaux, Robert K.; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4888-4899</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion prodn.  Here, we report that superoxide prodn. was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and ESR anal.  Redn. of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were obsd. in kidneys from diabetic mice.  These observations were consistent with an overall redn. of mitochondrial glucose oxidn.  Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans.  Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR).  AICAR treatment induced superoxide prodn. and was linked with glomerular matrix and albuminuria redn. in the diabetic kidney.  Furthermore, diabetic heterozygous superoxide dismutase 2 (Sod2+/-) mice had no evidence of increased renal disease, and Ampka2-/- mice had increased albuminuria that was not reduced with AICAR treatment.  Redn. of mitochondrial superoxide prodn. with rotenone was sufficient to reduce AMPK phosphorylation in mouse kidneys.  Taken together, these results demonstrate that diabetic kidneys have reduced superoxide and mitochondrial biogenesis and activation of AMPK enhances superoxide prodn. and mitochondrial function while reducing disease activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqQbY5f3Z-crVg90H21EOLACvtfcHk0lhmSCIswLdHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKksb3O&md5=e907941fec351c3da469acc473e24ae6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI66218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI66218%26sid%3Dliteratum%253Aachs%26aulast%3DDugan%26aufirst%3DL.%2BL.%26aulast%3DYou%26aufirst%3DY.%2BH.%26aulast%3DAli%26aufirst%3DS.%2BS.%26aulast%3DDiamond-Stanic%26aufirst%3DM.%26aulast%3DMiyamoto%26aufirst%3DS.%26aulast%3DDeCleves%26aufirst%3DA.%2BE.%26aulast%3DAndreyev%26aufirst%3DA.%26aulast%3DQuach%26aufirst%3DT.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DShekhtman%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DW.%26aulast%3DChepetan%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DT.%2BP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DPaik%26aufirst%3DK.%2BP.%26aulast%3DFogo%26aufirst%3DA.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DBrosius%26aufirst%3DF.%26aulast%3DNaviaux%26aufirst%3DR.%2BK.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520dysregulation%2520promotes%2520diabetes-related%2520reduction%2520of%2520superoxide%2520and%2520mitochondrial%2520function%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2013%26volume%3D123%26spage%3D4888%26epage%3D4899%26doi%3D10.1172%2FJCI66218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariappan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sataranatarajan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahimainathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viollet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudhury, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasinath, B. S.</span></span> <span> </span><span class="NLM_article-title">A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">F617</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00278.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1152%2Fajprenal.00278.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=17018841" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=F617-627&author=M.+J.+Leeauthor=D.+Feliersauthor=M.+M.+Mariappanauthor=K.+Sataranatarajanauthor=L.+Mahimainathanauthor=N.+Musiauthor=M.+Foretzauthor=B.+Violletauthor=J.+M.+Weinbergauthor=G.+G.+Choudhuryauthor=B.+S.+Kasinath&title=A+role+for+AMP-activated+protein+kinase+in+diabetes-induced+renal+hypertrophy&doi=10.1152%2Fajprenal.00278.2006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00278.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00278.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DFeliers%26aufirst%3DD.%26aulast%3DMariappan%26aufirst%3DM.%2BM.%26aulast%3DSataranatarajan%26aufirst%3DK.%26aulast%3DMahimainathan%26aufirst%3DL.%26aulast%3DMusi%26aufirst%3DN.%26aulast%3DForetz%26aufirst%3DM.%26aulast%3DViollet%26aufirst%3DB.%26aulast%3DWeinberg%26aufirst%3DJ.%2BM.%26aulast%3DChoudhury%26aufirst%3DG.%2BG.%26aulast%3DKasinath%26aufirst%3DB.%2BS.%26atitle%3DA%2520role%2520for%2520AMP-activated%2520protein%2520kinase%2520in%2520diabetes-induced%2520renal%2520hypertrophy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DF617%26epage%3D627%26doi%3D10.1152%2Fajprenal.00278.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decleves, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span> <span> </span><span class="NLM_article-title">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1846</span>– <span class="NLM_lpage">1855</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011010026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1681%2FASN.2011010026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21921143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1846-1855&author=A.+E.+Declevesauthor=A.+V.+Mathewauthor=R.+Cunardauthor=K.+Sharma&title=AMPK+mediates+the+initiation+of+kidney+disease+induced+by+a+high-fat+diet&doi=10.1681%2FASN.2011010026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">AMPK mediates the initiation of kidney disease induced by a high-fat diet</span></div><div class="casAuthors">Decleves, Anne-Emilie; Mathew, Anna V.; Cunard, Robyn; Sharma, Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1846-1855</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The mechanisms underlying the assocn. between obesity and progressive renal disease are not well understood.  Exposure to a high-fat diet decreases levels of the cellular energy sensor AMPK in many organs, including the kidney, but whether AMPK contributes to the pathophysiol. of kidney disease induced by a high-fat diet is unknown.  In this study, we randomly assigned C57BL/6J mice to a std. or high-fat diet.  After 1 wk, mice fed a high-fat diet exhibited an increase in body wt., renal hypertrophy, an increase in urine H2O2 and urine MCP-1, and a decrease in circulating adiponectin levels and renal AMPK activity.  Urine ACR progressively increased after 4 wk of a high-fat diet.  After 12 wk, kidneys of mice fed a high-fat diet demonstrated a marked increase in markers of fibrosis and inflammation, and AMPK activity remained significantly suppressed.  To det. whether inhibition of AMPK activity explained these renal effects, we administered an AMPK activator along with a high-fat diet for 1 wk.  Although AMPK activation did not abrogate the wt. gain, it reduced the renal hypertrophy, urine H2O2, and urine and renal MCP-1.  In vitro, AMPK activation completely inhibited the induction of MCP-1 by palmitic acid in mesangial cells.  In conclusion, these data suggest that the energy sensor AMPK mediates the early renal effects of a high-fat diet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLyy7LBMHJALVg90H21EOLACvtfcHk0lhmSCIswLdHAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlCls7nM&md5=7e1ca714e5b6c691934a75df032eda20</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1681%2FASN.2011010026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011010026%26sid%3Dliteratum%253Aachs%26aulast%3DDecleves%26aufirst%3DA.%2BE.%26aulast%3DMathew%26aufirst%3DA.%2BV.%26aulast%3DCunard%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DK.%26atitle%3DAMPK%2520mediates%2520the%2520initiation%2520of%2520kidney%2520disease%2520induced%2520by%2520a%2520high-fat%2520diet%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2011%26volume%3D22%26spage%3D1846%26epage%3D1855%26doi%3D10.1681%2FASN.2011010026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K. P.</span></span> <span> </span><span class="NLM_article-title">Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1302</span>, <span class="refDoi"> DOI: 10.3892/ijmm.2013.1508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.3892%2Fijmm.2013.1508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24068196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFymtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1293-1302&author=D.+Kimauthor=J.+E.+Leeauthor=Y.+J.+Jungauthor=A.+S.+Leeauthor=S.+Leeauthor=S.+K.+Parkauthor=S.+H.+Kimauthor=B.+H.+Parkauthor=W.+Kimauthor=K.+P.+Kang&title=Metformin+decreases+high-fat+diet-induced+renal+injury+by+regulating+the+expression+of+adipokines+and+the+renal+AMP-activated+protein+kinase%2Facetyl-CoA+carboxylase+pathway+in+mice&doi=10.3892%2Fijmm.2013.1508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice</span></div><div class="casAuthors">Kim, Dal; Lee, Jung Eun; Jung, Yu Jin; Lee, Ae Sin; Lee, Sik; Park, Sung Kwang; Kim, Suhn Hee; Park, Byung-Hyun; Kim, Won; Kang, Kyung Pyo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-1302</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Metabolic syndrome is characterized by insulin resistance, dyslipidemia and hypertension.  These metabolic changes contribute to the development of obesity-induced kidney injury.  AMP-activated protein kinase (AMPK) is a ubiquitous enzyme that is involved in the cellular metabolic response to metabolic stress.  Metformin, an AMPK activator, has been reported to exert a protective effect against nonalcoholic steatohepatitis.  However, little is known about its role in the pathogenesis of obesity-induced renal injury.  The aim of this study was to investigate the effects of metformin on high-fat diet (HFD)-induced kidney injury.  Obesity was induced by HFD (60% of total calories from fat, 20% protein and 20% carbohydrates) in 6-wk-old C57BL/6 mice.  Mice were fed HFD plus 0.5% metformin.  The effects of metformin on HFD-induced renal injury were evaluated by detg. metabolic parameters, serum adipokine levels and renal AMPK/acetyl-CoA carboxylase (ACC) activities, as well as a histol. examn.  HFD induced metabolic derangement, systemic insulin resistance and glomerular mesangial matrix expansion.  The administration of metformin reduced HFD-induced metabolic derangement and renal injury.  The administration of metformin reduced the HFD-induced increase in adipokine expression and macrophage infiltration.  Moreover, renal AMPK activity, which was decreased by HFD, was recovered following the administration of metformin; in addn., fatty acid oxidn. was increased by the inhibition of ACC.  These results indicate that metformin exerts beneficial effects on obesity-induced renal injury by regulating systemic inflammation, insulin resistance and the renal AMPK/ACC pathway.  The clin. application of metformin to obese or early diabetic patients may be helpful in preventing obesity- or diabetes-related kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGat_Fam-w-7Vg90H21EOLACvtfcHk0lh8CQrmZdXmjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFymtrvI&md5=8c8662b3eb7903dbddfe68c4baa4b587</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fijmm.2013.1508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.2013.1508%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%2BE.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DA.%2BS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DKang%26aufirst%3DK.%2BP.%26atitle%3DMetformin%2520decreases%2520high-fat%2520diet-induced%2520renal%2520injury%2520by%2520regulating%2520the%2520expression%2520of%2520adipokines%2520and%2520the%2520renal%2520AMP-activated%2520protein%2520kinase%252Facetyl-CoA%2520carboxylase%2520pathway%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2013%26volume%3D32%26spage%3D1293%26epage%3D1302%26doi%3D10.3892%2Fijmm.2013.1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0lh8CQrmZdXmjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmena, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bright, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haire, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of AMPK regulation by small molecule activators</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">3017</span>, <span class="refDoi"> DOI: 10.1038/ncomms4017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fncomms4017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24352254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=3017&author=B.+Xiaoauthor=M.+J.+Sandersauthor=D.+Carmenaauthor=N.+J.+Brightauthor=L.+F.+Haireauthor=E.+Underwoodauthor=B.+R.+Patelauthor=R.+B.+Heathauthor=P.+A.+Walkerauthor=S.+Hallenauthor=F.+Giordanettoauthor=S.+R.+Martinauthor=D.+Carlingauthor=S.+J.+Gamblin&title=Structural+basis+of+AMPK+regulation+by+small+molecule+activators&doi=10.1038%2Fncomms4017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of AMPK regulation by small molecule activators</span></div><div class="casAuthors">Xiao Bing; Sanders Matthew J; Heath Richard B; Carmena David; Bright Nicola J; Patel Bhakti R; Carling David; Haire Lesley F; Underwood Elizabeth; Walker Philip A; Martin Stephen R; Gamblin Steven J; Hallen Stefan; Giordanetto Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3017</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance by sensing and responding to increases in AMP/ADP concentration relative to ATP.  Binding of AMP causes allosteric activation of the enzyme and binding of either AMP or ADP promotes and maintains the phosphorylation of threonine 172 within the activation loop of the kinase.  AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases including type 2 diabetes and, more recently, cancer.  A number of direct AMPK activators have been reported as having beneficial effects in treating metabolic diseases, but there has been no structural basis for activator binding to AMPK.  Here we present the crystal structure of human AMPK in complex with a small molecule activator that binds at a site between the kinase domain and the carbohydrate-binding module, stabilising the interaction between these two components.  The nature of the activator-binding pocket suggests the involvement of an additional, as yet unidentified, metabolite in the physiological regulation of AMPK.  Importantly, the structure offers new opportunities for the design of small molecule activators of AMPK for treatment of metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKRk4-m-rMp1w2ofyr07jXfW6udTcc2eb5LZJhPqmTYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3oslGmtQ%253D%253D&md5=b261b7498514e258ea6ec99a34d04794</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms4017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms4017%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSanders%26aufirst%3DM.%2BJ.%26aulast%3DCarmena%26aufirst%3DD.%26aulast%3DBright%26aufirst%3DN.%2BJ.%26aulast%3DHaire%26aufirst%3DL.%2BF.%26aulast%3DUnderwood%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DB.%2BR.%26aulast%3DHeath%26aufirst%3DR.%2BB.%26aulast%3DWalker%26aufirst%3DP.%2BA.%26aulast%3DHallen%26aufirst%3DS.%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DS.%2BR.%26aulast%3DCarling%26aufirst%3DD.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520AMPK%2520regulation%2520by%2520small%2520molecule%2520activators%26jtitle%3DNat.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D3017%26doi%3D10.1038%2Fncomms4017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magyar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahasrabudhe, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subashi, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1161</span>– <span class="NLM_lpage">1172</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.str.2014.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=25066137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1161-1172&author=M.+F.+Calabreseauthor=F.+Rajamohanauthor=M.+S.+Harrisauthor=N.+L.+Caspersauthor=R.+Magyarauthor=J.+M.+Withkaauthor=H.+Wangauthor=K.+A.+Borzilleriauthor=P.+V.+Sahasrabudheauthor=L.+R.+Hothauthor=K.+F.+Geogheganauthor=S.+Hanauthor=J.+Brownauthor=T.+A.+Subashiauthor=A.+R.+Reyesauthor=R.+K.+Frisbieauthor=J.+Wardauthor=R.+A.+Millerauthor=J.+A.+Landroauthor=A.+T.+Londreganauthor=P.+A.+Carpinoauthor=S.+Cabralauthor=A.+C.+Smithauthor=E.+L.+Connauthor=K.+O.+Cameronauthor=X.+Qiuauthor=R.+G.+Kurumbail&title=Structural+basis+for+AMPK+activation%3A+natural+and+synthetic+ligands+regulate+kinase+activity+from+opposite+poles+by+different+molecular+mechanisms&doi=10.1016%2Fj.str.2014.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms</span></div><div class="casAuthors">Calabrese, Matthew F.; Rajamohan, Francis; Harris, Melissa S.; Caspers, Nicole L.; Magyar, Rachelle; Withka, Jane M.; Wang, Hong; Borzilleri, Kris A.; Sahasrabudhe, Parag V.; Hoth, Lise R.; Geoghegan, Kieran F.; Han, Seungil; Brown, Janice; Subashi, Timothy A.; Reyes, Allan R.; Frisbie, Richard K.; Ward, Jessica; Miller, Russell A.; Landro, James A.; Londregan, Allyn T.; Carpino, Philip A.; Cabral, Shawn; Smith, Aaron C.; Conn, Edward L.; Cameron, Kimberly O.; Qiu, Xiayang; Kurumbail, Ravi G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1161-1172</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a principal metabolic regulator affecting growth and response to cellular stress.  Comprised of catalytic and regulatory subunits, each present in multiple forms, AMPK is best described as a family of related enzymes.  In recent years, AMPK has emerged as a desirable target for modulation of numerous diseases, yet clin. therapies remain elusive.  Challenges result, in part, from an incomplete understanding of the structure and function of full-length heterotrimeric complexes.  In this work, we provide the full-length structure of the widely expressed α1β1γ1 isoform of mammalian AMPK, along with detailed kinetic and biophys. characterization.  We characterize binding of the broadly studied synthetic activator A769662 and its analogs.  Our studies follow on the heels of the recent disclosure of the α2β1γ1 structure and provide insight into the distinct mol. mechanisms of AMPK regulation by AMP and A769662.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFqyeOwFToerVg90H21EOLACvtfcHk0li4aC8_zXceaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ags7bM&md5=8a4edd6c5ff990d9e4c7e0cb16b7b873</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DM.%2BF.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DM.%2BS.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DMagyar%26aufirst%3DR.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%2BV.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DSubashi%26aufirst%3DT.%2BA.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DLandro%26aufirst%3DJ.%2BA.%26aulast%3DLondregan%26aufirst%3DA.%2BT.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DCabral%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26atitle%3DStructural%2520basis%2520for%2520AMPK%2520activation%253A%2520natural%2520and%2520synthetic%2520ligands%2520regulate%2520kinase%2520activity%2520from%2520opposite%2520poles%2520by%2520different%2520molecular%2520mechanisms%26jtitle%3DStructure%26date%3D2014%26volume%3D22%26spage%3D1161%26epage%3D1172%26doi%3D10.1016%2Fj.str.2014.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burckhardt, G.</span></span> <span> </span><span class="NLM_article-title">Drug transport by organic anion transporters (OATs)</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2012.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.pharmthera.2012.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=22841915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=106-130&author=G.+Burckhardt&title=Drug+transport+by+organic+anion+transporters+%28OATs%29&doi=10.1016%2Fj.pharmthera.2012.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drug transport by Organic Anion Transporters (OATs)</span></div><div class="casAuthors">Burckhardt, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-130</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Common to all so far functionally characterized Org. Anion Transporters (OATs) is their broad substrate specificity and their ability to exchange extracellular against intracellular org. anions.  Many OATs occur in renal proximal tubules, the site of active drug secretion.  Exceptions are murine Oat6 (nasal epithelium), human OAT7 (liver), and rat Oat8 (renal collecting ducts).  In human kidneys, OAT1, OAT2, and OAT3 are localized in the basolateral membrane, and OAT4, OAT10, and URAT1 in the apical cell membrane of proximal tubule cells, resp.  In rats and mice, Oat1 and Oat3 are located basolaterally, and Oat2, Oat5, Oat9, Oat10, and Urat1 apically.  Several classes of drugs interact with human OAT1-3, including ACE inhibitors, angiotensin II receptor antagonists, diuretics, HMG CoA reductase inhibitors, β-lactam antibiotics, antineoplastic and antiviral drugs, and uricosuric drugs.  For most drugs, interaction was demonstrated in vitro by inhibition of OAT-mediated transport of model substrates; for some drugs, transport by OATs was directly proven.  Based on IC50 values reported in the literature, OAT1 and OAT3 show comparable affinities for diuretics, cephalosporins, and nonsteroidal anti-inflammatory drugs whereas OAT2 has a lower affinity to most of these compds.  Drug-drug interactions at OAT1 and OAT3 may retard renal drug secretion and cause untoward effects.  OAT4, OAT10, and URAT1 in the apical membrane contribute to proximal tubular urate absorption, and OAT10 to nicotinate absorption.  OAT4 is in addn. able to release drugs, e.g. diuretics, into the tubule lumen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGgKkR2dJ8ZbVg90H21EOLACvtfcHk0ljfVOcR1OqFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGrs7zE&md5=b037994259a278be88d5dae854857abf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DBurckhardt%26aufirst%3DG.%26atitle%3DDrug%2520transport%2520by%2520organic%2520anion%2520transporters%2520%2528OATs%2529%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D106%26epage%3D130%26doi%3D10.1016%2Fj.pharmthera.2012.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromm, M. F.</span></span> <span> </span><span class="NLM_article-title">Transporter-mediated drug-drug interactions</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1017</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.2217/pgs.11.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2217%2Fpgs.11.44" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=1017-1037&author=F.+Mullerauthor=M.+F.+Fromm&title=Transporter-mediated+drug-drug+interactions&doi=10.2217%2Fpgs.11.44"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2217%2Fpgs.11.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fpgs.11.44%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DF.%26aulast%3DFromm%26aufirst%3DM.%2BF.%26atitle%3DTransporter-mediated%2520drug-drug%2520interactions%26jtitle%3DPharmacogenomics%26date%3D2011%26volume%3D12%26spage%3D1017%26epage%3D1037%26doi%3D10.2217%2Fpgs.11.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">VanWert, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gionfriddo, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, D. H.</span></span> <span> </span><span class="NLM_article-title">Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology</span>. <i>Biopharm. Drug Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1002/bdd.693</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fbdd.693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19953504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsF2jtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=1-71&author=A.+L.+VanWertauthor=M.+R.+Gionfriddoauthor=D.+H.+Sweet&title=Organic+anion+transporters%3A+discovery%2C+pharmacology%2C+regulation+and+roles+in+pathophysiology&doi=10.1002%2Fbdd.693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology</span></div><div class="casAuthors">VanWert, Adam L.; Gionfriddo, Michael R.; Sweet, Douglas H.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-71</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the mechanisms behind inter- and intra-patient variability in drug response is inadequate.  Advances in the cytochrome P 450 drug metabolizing enzyme field have been remarkable, but those in the drug transporter field have trailed behind.  Currently, however, interest in carrier-mediated disposition of pharmacotherapeutics is on a substantial uprise.  This is exemplified by the 2006 FDA guidance statement directed to the pharmaceutical industry.  The guidance recommended that industry ascertain whether novel drug entities interact with transporters.  This suggestion likely stems from the observation that several novel cloned transporters contribute significantly to the disposition of various approved drugs.  Many drugs bear anionic functional groups, and thus interact with org. anion transporters (OATs).  Collectively, these transporters are nearly ubiquitously expressed in barrier epithelia.  Moreover, several reports indicate that OATs are subject to diverse forms of regulation, much like drug metabolizing enzymes and receptors.  Thus, crit. to furthering our understanding of patient- and condition-specific responses to pharmacotherapy is the complete characterization of OAT interactions with drugs and regulatory factors.  This review provides the reader with a comprehensive account of the function and substrate profile of cloned OATs.  In addn., a major focus of this review is on the regulation of OATs including the impact of transcriptional and epigenetic factors, phosphorylation, hormones and gender.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xJ8gprENA7Vg90H21EOLACvtfcHk0ljfVOcR1OqFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsF2jtrzM&md5=edffeb6b5fedca641828c2c077abda13</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fbdd.693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.693%26sid%3Dliteratum%253Aachs%26aulast%3DVanWert%26aufirst%3DA.%2BL.%26aulast%3DGionfriddo%26aufirst%3DM.%2BR.%26aulast%3DSweet%26aufirst%3DD.%2BH.%26atitle%3DOrganic%2520anion%2520transporters%253A%2520discovery%252C%2520pharmacology%252C%2520regulation%2520and%2520roles%2520in%2520pathophysiology%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2010%26volume%3D31%26spage%3D1%26epage%3D71%26doi%3D10.1002%2Fbdd.693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldenberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balac, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nigam, S. K.</span></span> <span> </span><span class="NLM_article-title">Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approach</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.116.232660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27488918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWju77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2016&pages=215-229&author=H.+C.+Liuauthor=A.+Goldenbergauthor=Y.+Chenauthor=C.+Lunauthor=W.+Wuauthor=K.+T.+Bushauthor=N.+Balacauthor=P.+Rodriguezauthor=R.+Abagyanauthor=S.+K.+Nigam&title=Molecular+properties+of+drugs+interacting+with+SLC22+transporters+OAT1%2C+OAT3%2C+OCT1%2C+and+OCT2%3A+a+machine-learning+approach&doi=10.1124%2Fjpet.116.232660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular properties of drugs interacting with SLC22 transporters OAT1, OAT3, OCT1, and OCT2: a machine-learning approachs</span></div><div class="casAuthors">Liu, Henry C.; Goldenberg, Anne; Chen, Yuchen; Lun, Christina; Wu, Wei; Bush, Kevin T.; Balac, Natasha; Rodriguez, Paul; Abagyan, Ruben; Nigam, Sanjay K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">215-229</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Statistical anal. was performed on physicochem. descriptors of ∼250 drugs known to interact with one or more SLC22 "drug" transporters (i.e., SLC22A6 or OAT1, SLC22A8 or OAT3, SLC22A1 or OCT1, and SLC22A2 or OCT2), followed by application of machine-learning methods and wet lab. testing of novel predictions.  In addn. to mol. charge, org. anion transporters (OATs) were found to prefer interacting with planar structures, whereas org. cation transporters (OCTs) interact with more three-dimensional structures (i.e., greater SP3 character).  Moreover, compared with OAT1 ligands, OAT3 ligands possess more acyclic tetravalent bonds and have a more zwitterionic/cationic character.  In contrast, OCT1 and OCT2 ligands were not clearly distinquishable form one another by the methods employed.  Multiple pharmacophore models were generated on the basis of the drugs and, consistent with themachinelearning analyses, one unique pharmacophore created from ligands of OAT3 possessed cationic properties similar to OCT ligands; this was confirmed by quant. at. property field anal.  Virtual screening with this pharmacophore, followed by transport assays, identified several cationic drugs that selectively interact with OAT3 but not OAT1.  Although the present anal. may be somewhat limited by the need to rely largely on inhibition data formodeling, wet lab./in vitro transport studies, as well as anal. of drug/metabolite handling in Oat and Oct knockout animals, support the general validity of the approach-which can also be applied to other SLC and ATP binding cassette drug transporters.  This may make it possible to predict the mol. properties of a drug or metabolite necessary for interaction with the transporter(s), thereby enabling better prediction of drug-drug interactions and drug-metabolite interactions.  Furthermore, understanding the overlapping specificities of OATs and OCTs in the context of dynamic transporter tissue expression patterns should help predict net flux in a particular tissue of anionic, cationic, and zwitterionic mols. in normal and pathophysiol. states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBDvxy5NzvY7Vg90H21EOLACvtfcHk0ljfVOcR1OqFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWju77L&md5=89d3dbedb4b038fa5c4da6d8aa93d01d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232660%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%2BC.%26aulast%3DGoldenberg%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLun%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBush%26aufirst%3DK.%2BT.%26aulast%3DBalac%26aufirst%3DN.%26aulast%3DRodriguez%26aufirst%3DP.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DNigam%26aufirst%3DS.%2BK.%26atitle%3DMolecular%2520properties%2520of%2520drugs%2520interacting%2520with%2520SLC22%2520transporters%2520OAT1%252C%2520OAT3%252C%2520OCT1%252C%2520and%2520OCT2%253A%2520a%2520machine-learning%2520approach%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D359%26spage%3D215%26epage%3D229%26doi%3D10.1124%2Fjpet.116.232660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Radcliffe, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seah, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerums, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekinci, E. I.</span></span> <span> </span><span class="NLM_article-title">Clinical predictive factors in diabetic kidney disease progression</span>. <i>J. Diabetes Invest.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1111/jdi.12533</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fjdi.12533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=27181363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=6-18&author=N.+J.+Radcliffeauthor=J.+M.+Seahauthor=M.+Clarkeauthor=R.+J.+MacIsaacauthor=G.+Jerumsauthor=E.+I.+Ekinci&title=Clinical+predictive+factors+in+diabetic+kidney+disease+progression&doi=10.1111%2Fjdi.12533"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical predictive factors in diabetic kidney disease progression</span></div><div class="casAuthors">Radcliffe, Nicholas J.; Seah, Jas-mine; Clarke, Michele; MacIsaac, Richard J.; Jerums, George; Ekinci, Elif I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Diabetes Investigation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-18</span>CODEN:
                <span class="NLM_cas:coden">JDIOAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-1124</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Diabetic kidney disease (DKD) represents a major component of the health burden assocd. with type 1 and type 2 diabetes.  Recent advances have produced an explosion of 'novel' assay-based risk markers for DKD, though clin. use remains restricted.  Although many patients with progressive DKD follow a classical albuminuria-based pathway, non-albuminuric DKD progression is now well recognized.  In general, the following clin. and biochem. characteristics have been assocd. with progressive DKD in both type 1 and type 2 diabetes: increased Hb A1c, systolic blood pressure, albuminuria grade, early glomerular filtration rate decline, duration of diabetes, age (including pubertal onset) and serum uric acid; the presence of concomitant microvascular complications; and pos. family history.  The same is true in type 2 diabetes for male sex category, in patients following an albuminuric pathway to DKD, and also true for the presence of increased pulse wave velocity.  The following baseline clin. characteristics have been proposed as risk factors for DKD progression, but with further research required to assess the nature of any relationship: dyslipidemia (including low-d. lipoprotein, total and high-d. lipoprotein cholesterol); elevated body mass index; smoking status; hyperfiltration; decreases in vitamin D, Hb and uric acid excretion (all known consequences of advanced DKD); and patient test result visit-to-visit variability (Hb A1c, blood pressure and high-d. lipoprotein cholesterol).  The development of multifactorial 'renal risk equations' for type 2 diabetes has the potential to simplify the task of DKD prognostication; however, there are currently none for type 1 diabetes-specific populations.  Significant progress has been made in the prediction of DKD progression using readily available clin. data, though further work is required to elicit the role of several variables, and to consolidate data to facilitate clin. implementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolhKY_NSRrX7Vg90H21EOLACvtfcHk0lhqIZP1kEF13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt1Kksg%253D%253D&md5=2fe1e8dbe268dadbff81bb3d17373a7b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Fjdi.12533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdi.12533%26sid%3Dliteratum%253Aachs%26aulast%3DRadcliffe%26aufirst%3DN.%2BJ.%26aulast%3DSeah%26aufirst%3DJ.%2BM.%26aulast%3DClarke%26aufirst%3DM.%26aulast%3DMacIsaac%26aufirst%3DR.%2BJ.%26aulast%3DJerums%26aufirst%3DG.%26aulast%3DEkinci%26aufirst%3DE.%2BI.%26atitle%3DClinical%2520predictive%2520factors%2520in%2520diabetic%2520kidney%2520disease%2520progression%26jtitle%3DJ.%2520Diabetes%2520Invest.%26date%3D2017%26volume%3D8%26spage%3D6%26epage%3D18%26doi%3D10.1111%2Fjdi.12533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thallas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osicka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerums, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghabrial, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantharidis, P.</span></span> <span> </span><span class="NLM_article-title">Reduced tubular cation transport in diabetes: prevented by ACE inhibition</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2152</span>– <span class="NLM_lpage">2161</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.2003.00006.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1046%2Fj.1523-1755.2003.00006.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=12753302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVyiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2152-2161&author=M.+C.+Thomasauthor=C.+Tikellisauthor=W.+C.+Burnsauthor=V.+Thallasauthor=J.+M.+Forbesauthor=Z.+Caoauthor=T.+M.+Osickaauthor=L.+M.+Russoauthor=G.+Jerumsauthor=H.+Ghabrialauthor=M.+E.+Cooperauthor=P.+Kantharidis&title=Reduced+tubular+cation+transport+in+diabetes%3A+prevented+by+ACE+inhibition&doi=10.1046%2Fj.1523-1755.2003.00006.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced tubular cation transport in diabetes: prevented by ACE inhibition</span></div><div class="casAuthors">Thomas, Merlin C.; Tikellis, Chris; Burns, Wendy C.; Thallas, Vicki; Forbes, Josephine M.; Cao, Zemin; Osicka, Tanya M.; Russo, Leileata M.; Jerums, George; Ghabrial, Hany; Cooper, Mark E.; Kantharidis, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2152-2161</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">The renal clearance of org. cations is important for the homeostasis of a no. of exogenous and endogenous compds.  The org. cation transporters (OCTs) situated on the basolateral surface of proximal tubular cells mediate active cation excretion.  Alterations of cation transport may occur in diabetes, although the role of the OCTs has not been previously assessed.  Exptl. diabetes was induced in rats with streptozotocin (55 mg/kg) and animals were randomly assigned to receive ramipril (3 mg/mL) in drinking water for 24 wk.  In a second protocol, rats were infused with angiotensin II (Ang II) at a dose of 58.3 ng/kg/min for 2 wk via an implanted osmotic pump.  Expression of the OCTs and renal clearance of the endogenous cation N-methyl-nicotinamide (NMN) was assessed.  Diabetes was assocd. with a redn. in gene and protein expression of both OCT-1 and OCT-2 and a redn. in NMN clearance.  These effects were prevented by ramipril, assocd. with the prevention of albuminuria and tubular injury as demonstrated by the expression of osteopontin and glutathione peroxidase 3 (GPX-3).  An infusion of Ang II also reduced NMN clearance but without altering the renal expression of OCTs.  We hypothesize that reduced expression of OCTs in diabetes may be a marker of tubular injury.  However, Ang II may also directly augment renal cation clearance independent of changes in transporter expression.  Together these effects may provide addnl. mechanism to explain treatment-related improvements in creatinine clearance and renoprotection in diabetes following blockade of the renin-angiotensin system (RAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohYJGbHac5hbVg90H21EOLACvtfcHk0lhqIZP1kEF13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVyiu7k%253D&md5=bb0888b2e017ad07ff5d12433ef335d2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.2003.00006.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.2003.00006.x%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BC.%26aulast%3DTikellis%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DW.%2BC.%26aulast%3DThallas%26aufirst%3DV.%26aulast%3DForbes%26aufirst%3DJ.%2BM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DOsicka%26aufirst%3DT.%2BM.%26aulast%3DRusso%26aufirst%3DL.%2BM.%26aulast%3DJerums%26aufirst%3DG.%26aulast%3DGhabrial%26aufirst%3DH.%26aulast%3DCooper%26aufirst%3DM.%2BE.%26aulast%3DKantharidis%26aufirst%3DP.%26atitle%3DReduced%2520tubular%2520cation%2520transport%2520in%2520diabetes%253A%2520prevented%2520by%2520ACE%2520inhibition%26jtitle%3DKidney%2520Int.%26date%3D2003%26volume%3D63%26spage%3D2152%26epage%3D2161%26doi%3D10.1046%2Fj.1523-1755.2003.00006.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, T.</span></span> <span> </span><span class="NLM_article-title">Roles of organic anion transporters in the progression of chronic renal failure</span>. <i>Ther. Apheresis Dial.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">S27</span>– <span class="NLM_lpage">S31</span>, <span class="refDoi"> DOI: 10.1111/j.1744-9987.2007.00515.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fj.1744-9987.2007.00515.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=17976081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=S27-S31&author=A.+Enomotoauthor=T.+Niwa&title=Roles+of+organic+anion+transporters+in+the+progression+of+chronic+renal+failure&doi=10.1111%2Fj.1744-9987.2007.00515.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of organic anion transporters in the progression of chronic renal failure</span></div><div class="casAuthors">Enomoto, Atsushi; Niwa, Toshimitsu</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Apheresis and Dialysis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S27-S31</span>CODEN:
                <span class="NLM_cas:coden">TADHA9</span>;
        ISSN:<span class="NLM_cas:issn">1744-9979</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Renal proximal and distal tubules carry out specialized directional transport of various solutes.  The family of org. anion transporters (OATs), which belongs to the major facilitator superfamily (SLC22A), are expressed in the renal epithelial cells to regulate the excretion and the reabsorption of endogenous and exogenous org. anions that include various kinds of drugs and their metabolites.  In recent years, it is revealed that indoxyl sulfate, one of uremic toxins, is a novel physiol. substrate for OAT family, and its accumulation within the renal tubules via OATs induces renal dysfunction.  The OATs are also expressed in the blood-brain barrier, muscle cells, and bone osteoblasts, which hint at various pathogenic roles of OAT-mediated transport of uremic toxins.  In this review, we introduce and discuss the function of OATs in the context of their roles in the progression of chronic renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2WE3TyycBLVg90H21EOLACvtfcHk0lhqIZP1kEF13Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFOitg%253D%253D&md5=de74d877264aa6d4460120994d1711db</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1111%2Fj.1744-9987.2007.00515.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1744-9987.2007.00515.x%26sid%3Dliteratum%253Aachs%26aulast%3DEnomoto%26aufirst%3DA.%26aulast%3DNiwa%26aufirst%3DT.%26atitle%3DRoles%2520of%2520organic%2520anion%2520transporters%2520in%2520the%2520progression%2520of%2520chronic%2520renal%2520failure%26jtitle%3DTher.%2520Apheresis%2520Dial.%26date%3D2007%26volume%3D11%26spage%3DS27%26epage%3DS31%26doi%3D10.1111%2Fj.1744-9987.2007.00515.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnikov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinour, D.</span></span> <span> </span><span class="NLM_article-title">Urinary organic anion transporter protein profiles in AKI</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1387</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.1093/ndt/gfr541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1093%2Fndt%2Fgfr541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21945944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2012&pages=1387-1395&author=M.+Kuninauthor=E.+J.+Holtzmanauthor=S.+Melnikovauthor=D.+Dinour&title=Urinary+organic+anion+transporter+protein+profiles+in+AKI&doi=10.1093%2Fndt%2Fgfr541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary organic anion transporter protein profiles in AKI</span></div><div class="casAuthors">Kunin, Margarita; Holtzman, Eli J.; Melnikov, Semyon; Dinour, Dganit</div><div class="citationInfo"><span class="NLM_cas:title">Nephrology, Dialysis, Transplantation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1387-1395</span>CODEN:
                <span class="NLM_cas:coden">NDTREA</span>;
        ISSN:<span class="NLM_cas:issn">0931-0509</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Org. anion transporters (OATs) are located on either the basolateral or the apical membrane of the proximal tubule cell and mediate the absorption and secretion of various drugs and endogenous metabolites.  It has been shown that cellular damage in acute kidney injury (AKI) involves three forms of injury: sublethal damage resulting in loss of cell polarity, cell death through apoptosis and necrosis.  We hypothesize that cellular mistargeting of OAT proteins in AKI will change the profile of OAT proteins in urine.  Methods: Thirty AKI patients were included in the study.  AKI was defined by clin. course, daily urine output, response to fluid repletion, urinary sediment, fractional excretion of sodium (FeNa) and urine osmolality.  Urinary OAT1, OAT3 and OAT4 protein abundance was measured from semiquant. immunoblots of urine membrane fraction samples (exosome) collected from patients with AKI and from control subjects.  Results: Although all patients studied reached a similar severity of renal failure measured by serum creatinine, some of them recovered from AKI with supportive care only, while others required renal replacement therapy (RRT).  OAT1 and OAT3, which are normally localized in the basolateral membrane of the proximal tubule cell, were detected at low levels in urine from control subjects and were increased significantly in all patients with AKI.  OAT4 protein, which is normally localized in the luminal membrane of proximal tubule cells, was present in abundance in urine of control subjects.  Interestingly, in patients with AKI who eventually recovered, urinary OAT4 was found to be significantly lower than in controls, while in patients who needed RRT, it was higher than in controls.  Conclusions: We have shown that OATs are mistargeted in AKI.  The urinary OAT protein profile can help us to learn about the pathophysiol. of the disease and might be a marker of AKI severity.  AKI patients with early reversible proximal tubular damage will have high urine OAT1 and OAT3 and low OAT4, while patients with severe AKI will have high urine OAT1, OAT3 and OAT4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGper23DU_wrMbVg90H21EOLACvtfcHk0lhbMwDAXxDY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFGktLs%253D&md5=bd62fc18ff53df91a40988e7c344b6c2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfr541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfr541%26sid%3Dliteratum%253Aachs%26aulast%3DKunin%26aufirst%3DM.%26aulast%3DHoltzman%26aufirst%3DE.%2BJ.%26aulast%3DMelnikov%26aufirst%3DS.%26aulast%3DDinour%26aufirst%3DD.%26atitle%3DUrinary%2520organic%2520anion%2520transporter%2520protein%2520profiles%2520in%2520AKI%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2012%26volume%3D27%26spage%3D1387%26epage%3D1395%26doi%3D10.1093%2Fndt%2Fgfr541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. H.</span></span> <span> </span><span class="NLM_article-title">Species similarities and differences in pharmacokinetics</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1008</span>– <span class="NLM_lpage">1021</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=8654187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK2MXovFGksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=1008-1021&author=J.+H.+Lin&title=Species+similarities+and+differences+in+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Species similarities and differences in pharmacokinetics</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1008-21</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 141 refs.  One of the fundamental challenges drug metab. scientists face in drug discovery and development is the extrapolation of metabolic data and risk assessment from animals to humans.  Although it is generally believed that data from animal studies can be reasonably extrapolated to humans with the application of appropriate pharmacokinetic principles, there are certainly some limitations.  The purpose of this review is to show some species similarities and differences in absorption, distribution, metab., and excretion, with an attempt to address the questions of whether animal data can be extrapolated and what the limitations are.  The underlying mechanisms responsible for these similarities and differences are discussed and examples given for illustration.  In addn., the concepts of allometric and physiol. models for extrapolation of kinetic data are briefly highlighted.  In conclusion, although pharmacokinetics has been advanced greatly in recent years, it is not yet possible to predict all of the pharmacokinetic parameters of a drug in humans from animal studies.  Nevertheless, under certain well-defined conditions, it may be possible to make reasonably good predictions.  For example, the intrinsic absorption of a given drug across the wall of the gastrointestinal tract is probably similar among species, because the nature of the biomembrane of epithelial cells is similar in mammals and because the absorption process is basically an interaction between the drug and the biomembrane.  However, other factors, such as pH-dependent soly. and first-pass metab. that affect the absorption, may differ from species to species resulting in species differences in absorption.  Predicting the renal excretion of drugs in humans has been relatively successful using the glomerular filtration rate ratio between humans and animals.  Similarly, if the elimination of a drug is mainly by the liver and the rate of elimination is limited by hepatic blood flow, one could predict the clearance of the drug in humans by the hepatic blood flow.  However, biochem. parameters, such as protein binding and drug metab., are less predictable.  These parameters vary considerably among species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqiSrG8wRhqrVg90H21EOLACvtfcHk0lhbMwDAXxDY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFGksbw%253D&md5=75eb38c7d6c9ed949c93c2363545b2d8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DSpecies%2520similarities%2520and%2520differences%2520in%2520pharmacokinetics%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1995%26volume%3D23%26spage%3D1008%26epage%3D1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">GTEx
Consortium</span> <span> </span><span class="NLM_article-title">The Genotype-Tissue
Expression (GTEx) project</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/ng.2653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fng.2653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23715323" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=580-585&author=GTEx%0AConsortium&title=The+Genotype-Tissue%0AExpression+%28GTEx%29+project&doi=10.1038%2Fng.2653"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fng.2653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2653%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520Genotype-Tissue%250AExpression%2520%2528GTEx%2529%2520project%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D580%26epage%3D585%26doi%3D10.1038%2Fng.2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puppala, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapworth, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic analysis of intertissue and interspecies isoform diversity of AMP-activated protein kinase (AMPK)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">35904</span>– <span class="NLM_lpage">35912</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.508747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1074%2Fjbc.M113.508747" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=24187138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=35904-35912&author=J.+Wuauthor=D.+Puppalaauthor=X.+Fengauthor=M.+Monettiauthor=A.+L.+Lapworthauthor=K.+F.+Geoghegan&title=Chemoproteomic+analysis+of+intertissue+and+interspecies+isoform+diversity+of+AMP-activated+protein+kinase+%28AMPK%29&doi=10.1074%2Fjbc.M113.508747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic Analysis of Intertissue and Interspecies Isoform Diversity of AMP-activated Protein Kinase (AMPK)</span></div><div class="casAuthors">Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Monetti, Mara; Lapworth, Amanda Lee; Geoghegan, Kieran F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">35904-35912</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that senses and governs changes in the cellular energy balance represented by concns. of AMP, ADP, and ATP.  Each of its three chains (α, β, and γ) exists as either two or three subtypes, theor. allowing up to 12 different forms of the complete enzyme.  Tissue specificity in the distribution of AMPK subtypes is believed to underpin a range of biol. functions for AMPK, a central regulator of metabolic function and response.  It is of particular interest for drug discovery purposes to compare AMPK isoforms that are most prevalent in human liver and muscle with isoforms present in key preclin. species.  To complement immunocapture/immunodetection methods, which for AMPK are challenged by sequence similarities and difficulties of obtaining accurate relative quantitation, AMPK was captured from lysates of a range of cells and tissues using the ActivX ATP probe.  This chem. probe covalently attaches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinases, including AMPK, while also labeling a wide range of ATP-utilizing proteins.  Affinity-based recovery of labeled proteins followed by gel-based fractionation of the captured sample was followed by proteomic characterization of AMPK polypeptides.  In agreement with transcript-based anal. and previous indications from immunodetection, the results indicated that the predominant AMPK heterotrimer in human liver is α1β2γ1 but that dog and rat livers mainly contain the α1β1γ1 and α2β1γ1 forms, resp.  Differences were not detected between the AMPK profiles of normal and diabetic human liver tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFqkqJBumTmLVg90H21EOLACvtfcHk0lhbMwDAXxDY8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7jM&md5=3a4b7aa1268fe2bd6d460d319bf48b0b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.508747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.508747%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPuppala%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DLapworth%26aufirst%3DA.%2BL.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26atitle%3DChemoproteomic%2520analysis%2520of%2520intertissue%2520and%2520interspecies%2520isoform%2520diversity%2520of%2520AMP-activated%2520protein%2520kinase%2520%2528AMPK%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D35904%26epage%3D35912%26doi%3D10.1074%2Fjbc.M113.508747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tess, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jatkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciejewski, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhok, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cialdea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreeger, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opsahl, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva-Jardine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolph, T.</span></span> <span> </span><span class="NLM_article-title">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.237925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.116.237925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=28289077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2017&pages=303-311&author=C.+T.+Salattoauthor=R.+A.+Millerauthor=K.+O.+Cameronauthor=E.+Cokorinosauthor=A.+Reyesauthor=J.+Wardauthor=M.+Calabreseauthor=R.+Kurumbailauthor=F.+Rajamohanauthor=A.+S.+Kalgutkarauthor=D.+A.+Tessauthor=A.+Shavnyaauthor=N.+E.+Genungauthor=D.+J.+Edmondsauthor=A.+Jatkarauthor=B.+S.+Maciejewskiauthor=M.+Amaroauthor=H.+Gandhokauthor=M.+Monettiauthor=K.+Cialdeaauthor=E.+Bollingerauthor=J.+M.+Kreegerauthor=T.+M.+Coskranauthor=A.+C.+Opsahlauthor=G.+G.+Boucherauthor=M.+J.+Birnbaumauthor=P.+DaSilva-Jardineauthor=T.+Rolph&title=Selective+activation+of+AMPK+%CE%B21-containing+isoforms+improves+kidney+function+in+a+rat+model+of+diabetic+nephropathy&doi=10.1124%2Fjpet.116.237925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of AMPK β1-containing isoforms improves kidney function in a rat model of diabetic nephropathy</span></div><div class="casAuthors">Salatto, Christopher T.; Miller, Russell A.; Cameron, Kimberly O.; Cokorinos, Emily; Reyes, Allan; Ward, Jessica; Calabrese, Matthew F.; Kurumbail, Ravi G.; Rajamohan, Francis; Kalgutkar, Amit S.; Tess, David A.; Shavnya, Andre; Genung, Nathan E.; Edmonds, David J.; Jatkar, Aditi; Maciejewski, Benjamin S.; Amaro, Marina; Gandhok, Harmeet; Monetti, Mara; Cialdea, Katherine; Bollinger, Eliza; Kreeger, John M.; Coskran, Timothy M.; Opsahl, Alan C.; Boucher, Germaine G.; Birnbaum, Morris J.; Da Silva-Jardine, Paul; Rolph, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-311, S1-S33</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Diabetic nephropathy remains an area of high unmet medical need, with current therapies that slow down, but do not prevent, the progression of disease.  A reduced phosphorylation state of adenosine monophosphate-activated protein kinase (AMPK) has been correlated with diminished kidney function in both humans and animal models of renal disease.  Here, we describe the identification of novel, potent, small mol. activators of AMPK that selectively activate AMPK heterotrimers contg. the β1 subunit.  After confirming that human and rodent kidney predominately express AMPK β1, we explore the effects of pharmacol. activation of AMPK in the ZSF1 rat model of diabetic nephropathy.  Chronic administration of these direct activators elevates the phosphorylation of AMPK in the kidney, without impacting blood glucose levels, and reduces the progression of proteinuria to a greater degree than the current std. of care, angiotensin-converting enzyme inhibitor ramipril.  Further analyses of urine biomarkers and kidney tissue gene expression reveal AMPK activation leads to the modulation of multiple pathways implicated in kidney injury, including cellular hypertrophy, fibrosis, and oxidative stress.  These results support the need for further investigation into the potential beneficial effects of AMPK activation in kidney disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8STmG-nZsrVg90H21EOLACvtfcHk0lg4clK_Jfi2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqtb3E&md5=808a4036f5c55486c3d8f61beeb2faa4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.237925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.237925%26sid%3Dliteratum%253Aachs%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DMiller%26aufirst%3DR.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DReyes%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DJatkar%26aufirst%3DA.%26aulast%3DMaciejewski%26aufirst%3DB.%2BS.%26aulast%3DAmaro%26aufirst%3DM.%26aulast%3DGandhok%26aufirst%3DH.%26aulast%3DMonetti%26aufirst%3DM.%26aulast%3DCialdea%26aufirst%3DK.%26aulast%3DBollinger%26aufirst%3DE.%26aulast%3DKreeger%26aufirst%3DJ.%2BM.%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DOpsahl%26aufirst%3DA.%2BC.%26aulast%3DBoucher%26aufirst%3DG.%2BG.%26aulast%3DBirnbaum%26aufirst%3DM.%2BJ.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DRolph%26aufirst%3DT.%26atitle%3DSelective%2520activation%2520of%2520AMPK%2520%25CE%25B21-containing%2520isoforms%2520improves%2520kidney%2520function%2520in%2520a%2520rat%2520model%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D361%26spage%3D303%26epage%3D311%26doi%3D10.1124%2Fjpet.116.237925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+E.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lg4clK_Jfi2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stopher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, S.</span></span> <span> </span><span class="NLM_article-title">An improved method for the determination of distribution coefficients</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1990.tb05373.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1111%2Fj.2042-7158.1990.tb05373.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1972404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1990&pages=144&author=D.+Stopherauthor=S.+McClean&title=An+improved+method+for+the+determination+of+distribution+coefficients&doi=10.1111%2Fj.2042-7158.1990.tb05373.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An improved method for the determination of distribution coefficients</span></div><div class="casAuthors">Stopher, David; McClean, Siobhan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The traditional shake flash method for measuring the distribution coeff. (D) of drugs (Leo et al., 1971) was modified to minimize the amt. of compd. required by employing HPLC to detn. the concn. of the compd. in the octanol and buffer phases.  The HPLC employed a reverse-phase Spherisorb octyl column with a mobile phase of MeOH-ammonium phosphate 0.01 M, pH 7.  The method was validated using drugs with a range of log D values of -2 to 4.  The method is suitable for rapid evaluation of the compds. since it decreases errors due to any impurities present.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodB1AZ9RwrrLVg90H21EOLACvtfcHk0lg4clK_Jfi2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXitFSntbc%253D&md5=4d4ab2e9a04d54dbb868cb1b212e8e55</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1990.tb05373.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1990.tb05373.x%26sid%3Dliteratum%253Aachs%26aulast%3DStopher%26aufirst%3DD.%26aulast%3DMcClean%26aufirst%3DS.%26atitle%3DAn%2520improved%2520method%2520for%2520the%2520determination%2520of%2520distribution%2520coefficients%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1990%26volume%3D42%26spage%3D144%26doi%3D10.1111%2Fj.2042-7158.1990.tb05373.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalaeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenseth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastin, A.</span></span> <span> </span><span class="NLM_article-title">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">2581</span>– <span class="NLM_lpage">2606</span>, <span class="refDoi"> DOI: 10.1002/jps.21287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1002%2Fjps.21287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=18228610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2008&pages=2581-2606&author=M.+Shalaevaauthor=J.+Kensethauthor=F.+Lombardoauthor=A.+Bastin&title=Measurement+of+dissociation+constants+%28pKa+values%29+of+organic+compounds+by+multiplexed+capillary+electrophoresis+using+aqueous+and+cosolvent+buffers&doi=10.1002%2Fjps.21287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers</span></div><div class="casAuthors">Shalaeva, Marina; Kenseth, Jeremy; Lombardo, Franco; Bastin, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2581-2606</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Evaluation of a multiplexed capillary electrophoresis (CE) method for pKa measurements of org. compds., including low soly. compds., is presented.  The method is validated on a set of 105 diverse compds., mostly drugs, and results are compared to literature values obtained from multiple refs.  Two versions of the instrument in two different labs were used to collect data over a period of 3 years and inter-lab. and inter-instrument variations are discussed.  Twenty-four point aq. and mixed cosolvent buffer systems were employed to improve the accuracy of pKa measurements.  It has been demonstrated that the method allows direct pKa measurements in aq. buffers for many compds. of low soly., often unattainable by other methods.  The pKa measurements of compds. with extremely low soly. using multiplexed CE with methanol/water cosolvent buffers are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyedITaWF77Vg90H21EOLACvtfcHk0liZzkSyfnsuvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotF2mu78%253D&md5=0945460c6ace92ced07cfc4209995c7d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fjps.21287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21287%26sid%3Dliteratum%253Aachs%26aulast%3DShalaeva%26aufirst%3DM.%26aulast%3DKenseth%26aufirst%3DJ.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DBastin%26aufirst%3DA.%26atitle%3DMeasurement%2520of%2520dissociation%2520constants%2520%2528pKa%2520values%2529%2520of%2520organic%2520compounds%2520by%2520multiplexed%2520capillary%2520electrophoresis%2520using%2520aqueous%2520and%2520cosolvent%2520buffers%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2008%26volume%3D97%26spage%3D2581%26epage%3D2606%26doi%3D10.1002%2Fjps.21287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chupka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bond, B. R.</span></span> <span> </span><span class="NLM_article-title">Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>330</i></span>,  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1124/jpet.108.149476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.108.149476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19349522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=191-197&author=H.+Yuanauthor=B.+Fengauthor=Y.+Yuauthor=J.+Chupkaauthor=J.+Y.+Zhengauthor=T.+G.+Heathauthor=B.+R.+Bond&title=Renal+organic+anion+transporter-mediated+drug-drug+interaction+between+gemcabene+and+quinapril&doi=10.1124%2Fjpet.108.149476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril</span></div><div class="casAuthors">Yuan, Haodan; Feng, Bo; Yu, Ying; Chupka, Jonathan; Zheng, Jenny Y.; Heath, Timothy G.; Bond, Brian R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">191-197</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In humans and rats, a synergistic blood pressure redn. was obsd. when the fibrate gemcabene (CI-1027) was coadministered with the angiotensin-converting enzyme inhibitor quinapril.  In a quinapril (3 mg/kg) pharmacokinetic rat study, there was a 40% decrease in urinary excretion and a 53% increase in plasma area under the curve from 0 to 24 h of the active metabolite quinaprilat when coadministered with gemcabene (30 mg/kg).  This observation revealed a possible transporter-mediated drug-drug interaction (DDI) between gemcabene and quinapril.  This led to a series of studies investigating the underlying clearance mechanisms assocd. with these compds. intended to elucidate renal transporter interactions between quinapril and gemcabene.  In vitro transporter studies using human embryonic kidney 293 cells transfected with human or rat org. anion transporter 3 (hOAT3, rOat3) revealed that quinaprilat is a substrate in both species, with a Km value of 13.4 μM for hOAT3.  Subsequent studies discovered that gemcabene inhibited quinaprilat uptake by hOAT3 and rOat3 at IC50 values of 35 and 48 μM, resp.  Moreover, gemcabene acylglucuronide, the major metabolite of gemcabene glucuronidation, also inhibited hOAT3- and rOat3-mediated uptake of quinaprilat at IC50 values of 197 and 133 μM, resp.  High plasma concns. of gemcabene (>100 μM) achieved in humans and rats upon oral dosing corroborate with gemcabene inhibition of renal OAT3-mediated secretion of quinaprilat in vitro.  This investigation established that a DDI between gemcabene and quinapril involving inhibition of renal transporters and subsequent elevation in plasma concns. of quinaprilat is responsible for the apparent synergistic blood pressure redn. obsd. with these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofjsC2fkPbn7Vg90H21EOLACvtfcHk0liZzkSyfnsuvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeltbw%253D&md5=1bcf7a9378e604bca5321c30fb18ec85</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.149476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.149476%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DChupka%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DJ.%2BY.%26aulast%3DHeath%26aufirst%3DT.%2BG.%26aulast%3DBond%26aufirst%3DB.%2BR.%26atitle%3DRenal%2520organic%2520anion%2520transporter-mediated%2520drug-drug%2520interaction%2520between%2520gemcabene%2520and%2520quinapril%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26spage%3D191%26epage%3D197%26doi%3D10.1124%2Fjpet.108.149476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/clpt.2013.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1038%2Fclpt.2013.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=23588318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A280%3ADC%252BC3srltl2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2013&pages=113-125&author=D.+Tweedieauthor=J.+W.+Polliauthor=E.+G.+Berglundauthor=S.+M.+Huangauthor=L.+Zhangauthor=A.+Poirierauthor=X.+Chuauthor=B.+Feng&title=Transporter+studies+in+drug+development%3A+experience+to+date+and+follow-up+on+decision+trees+from+the+International+Transporter+Consortium&doi=10.1038%2Fclpt.2013.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium</span></div><div class="casAuthors">Tweedie D; Polli J W; Berglund E Gil; Huang S M; Zhang L; Poirier A; Chu X; Feng B</div><div class="citationInfo"><span class="NLM_cas:title">Clinical pharmacology and therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-25</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The International Transporter Consortium (ITC) organized a second workshop in March 2012 to expand on the themes developed during the inaugural ITC workshop held in 2008.  The final session of the workshop provided perspectives from regulatory and industry-based scientists, with input from academic scientists, and focused primarily on the decision trees published from the first workshop.  These decision trees have become a central part of subsequent regulatory drug-drug interaction (DDI) guidances issued over the past few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTujrz08uS8s1WTCLT8lX9SfW6udTcc2eYRNCU5A-jun7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srltl2ruw%253D%253D&md5=bc460caa642b9132681aa4184f8c9f58</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2013.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2013.77%26sid%3Dliteratum%253Aachs%26aulast%3DTweedie%26aufirst%3DD.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBerglund%26aufirst%3DE.%2BG.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DTransporter%2520studies%2520in%2520drug%2520development%253A%2520experience%2520to%2520date%2520and%2520follow-up%2520on%2520decision%2520trees%2520from%2520the%2520International%2520Transporter%2520Consortium%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2013%26volume%3D94%26spage%3D113%26epage%3D125%26doi%3D10.1038%2Fclpt.2013.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">A novel relay method for determining low-clearance values</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1860</span>– <span class="NLM_lpage">1865</span>, <span class="refDoi"> DOI: 10.1124/dmd.112.046425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fdmd.112.046425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=22645091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1860-1865&author=L.+Diauthor=P.+Trapaauthor=R.+S.+Obachauthor=K.+Atkinsonauthor=Y.+A.+Biauthor=A.+C.+Wolfordauthor=B.+Tanauthor=T.+S.+McDonaldauthor=Y.+Laiauthor=L.+M.+Tremaine&title=A+novel+relay+method+for+determining+low-clearance+values&doi=10.1124%2Fdmd.112.046425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A novel relay method for determining low-clearance values</span></div><div class="casAuthors">Di, Li; Trapa, Patrick; Obach, R. Scott; Atkinson, Karen; Bi, Yi-An; Wolford, Angela C.; Tan, Beijing; McDonald, Thomas S.; Lai, Yurong; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1860-1865</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compds.  The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes.  An accumulative incubation time of 20 h or longer in hepatocytes can be achieved using the method.  The relay method was validated using seven com. drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approx. 2 to 15 mL · min-1 · kg-1.  The results showed that the relay method produced excellent predictions of human in vivo clearance.  The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compds., which is similar to the std. prediction accuracy for moderate to high clearance compds. using hepatocytes.  The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz1LvwK-CqOLVg90H21EOLACvtfcHk0lh8aujc50hYXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlShur7O&md5=faab456749ff398ad63d11eff6412fbc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.046425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.046425%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DTrapa%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DAtkinson%26aufirst%3DK.%26aulast%3DBi%26aufirst%3DY.%2BA.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DA%2520novel%2520relay%2520method%2520for%2520determining%2520low-clearance%2520values%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1860%26epage%3D1865%26doi%3D10.1124%2Fdmd.112.046425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sproston, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Application of an in vitro OAT assay in drug design and optimization of renal clearance</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.3109/00498254.2013.879625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.3109%2F00498254.2013.879625" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=657-665&author=M.+G.+Soarsauthor=P.+Bartonauthor=L.+L.+Elkinauthor=K.+W.+Mosureauthor=J.+L.+Sprostonauthor=R.+J.+Riley&title=Application+of+an+in+vitro+OAT+assay+in+drug+design+and+optimization+of+renal+clearance&doi=10.3109%2F00498254.2013.879625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3109%2F00498254.2013.879625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2013.879625%26sid%3Dliteratum%253Aachs%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DElkin%26aufirst%3DL.%2BL.%26aulast%3DMosure%26aufirst%3DK.%2BW.%26aulast%3DSproston%26aufirst%3DJ.%2BL.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DApplication%2520of%2520an%2520in%2520vitro%2520OAT%2520assay%2520in%2520drug%2520design%2520and%2520optimization%2520of%2520renal%2520clearance%26jtitle%3DXenobiotica%26date%3D2014%26volume%3D44%26spage%3D657%26epage%3D665%26doi%3D10.3109%2F00498254.2013.879625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Z. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokarski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wautlet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhide, R. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.12.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1016%2Fj.bmcl.2004.12.079" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1429-1433&author=R.+M.+Borzilleriauthor=Z.+W.+Caiauthor=C.+Ellisauthor=J.+Fargnoliauthor=A.+Furaauthor=T.+Gerhardtauthor=B.+Goyalauthor=J.+T.+Huntauthor=S.+Mortilloauthor=L.+Qianauthor=J.+Tokarskiauthor=V.+Vyasauthor=B.+Wautletauthor=X.+Zhengauthor=R.+S.+Bhide&title=Synthesis+and+SAR+of+4-%283-hydroxyphenylamino%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+based+VEGFR-2+kinase+inhibitors&doi=10.1016%2Fj.bmcl.2004.12.079"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.12.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.12.079%26sid%3Dliteratum%253Aachs%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DCai%26aufirst%3DZ.%2BW.%26aulast%3DEllis%26aufirst%3DC.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DGerhardt%26aufirst%3DT.%26aulast%3DGoyal%26aufirst%3DB.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DTokarski%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DWautlet%26aufirst%3DB.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DSynthesis%2520and%2520SAR%2520of%25204-%25283-hydroxyphenylamino%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520based%2520VEGFR-2%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2004.12.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodfellow, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. W.</span></span> <span> </span><span class="NLM_article-title">Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1032</span>– <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=9311617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADyaK2sXmt1Wqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=1032-1038&author=J.+J.+Bouskaauthor=R.+L.+Bellauthor=C.+L.+Goodfellowauthor=A.+O.+Stewartauthor=C.+D.+Brooksauthor=G.+W.+Carter&title=Improving+the+in+vivo+duration+of+5-lipoxygenase+inhibitors%3A+application+of+an+in+vitro+glucuronosyltransferase+assay"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the in vivo duration of 5-lipoxygenase inhibitors: application of an in vitro glucuronosyltransferase assay</span></div><div class="casAuthors">Bouska, Jennifer J.; Bell, Randy L.; Goodfellow, Carole L.; Stewart, Andrew O.; Brooks, Clint D. W.; Carter, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1032-1038</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">An in vitro glucuronidation assay was used to optimize a series of N-hydroxyurea-contg. 5-lipoxygenase inhibitors for metabolic stability.  The glucuronidation of these compds. in cynomolgus monkey microsomes followed Michaelis-Menten kinetics allowing calcn. of Vmax and KM.  The Vmax values ranged from 0.02 to 7.9 nmol/min/mg microsomal protein, a 400-fold difference, whereas KM ranged from 204 to 2500 μM, only a 12-fold difference.  In vitro intrinsic clearance values (CLint) were calcd. for 18 compds. tested in the kinetic assay and compared with the in vivo plasma clearance (CLp) calcd. from i.v. studies done in cynomolgus monkeys.  These initial results suggested a relation between the in vitro CLint and in vivo duration as defined by CLp.  A more rapid in vitro assay was developed in a 96-well format using a single concn. of substrate (100 μM) from which a glucuronidation rate was calcd.  The results from this assay for 40 compds. correlated with in vivo plasma clearance (r = 0.57).  This more efficient assay was used to test more than 100 compds. and develop structure-metab. relationships based on metabolic stability and improved duration.  The culmination of this effort contributed to the discovery of ABT-761, a 5-lipoxygenase inhibitor with in vivo duration in monkey improved 40-fold over the first generation inhibitor.  Further studies performed in human liver microsomes demonstrated a similar trend that was corroborated by the 8-fold increase in duration after oral dosing in humans obsd. with ABT-761.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKusP0a0dCmbVg90H21EOLACvtfcHk0lh8aujc50hYXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmt1Wqsbg%253D&md5=1779014c9842d5927a96e5ea3e4503fb</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DGoodfellow%26aufirst%3DC.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3DImproving%2520the%2520in%2520vivo%2520duration%2520of%25205-lipoxygenase%2520inhibitors%253A%2520application%2520of%2520an%2520in%2520vitro%2520glucuronosyltransferase%2520assay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1997%26volume%3D25%26spage%3D1032%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsaker, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoigne, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conery, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spillane, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochran, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and selective in vivo probe (GNE-272) for the bromodomains of CBP/EP300</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10549</span>– <span class="NLM_lpage">10563</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGhsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10549-10563&author=T.+D.+Crawfordauthor=F.+A.+Romeroauthor=K.+W.+Laiauthor=V.+Tsuiauthor=A.+M.+Taylorauthor=G.+de+Leon+Boenigauthor=C.+L.+Nolandauthor=J.+Murrayauthor=J.+Lyauthor=E.+F.+Chooauthor=T.+L.+Hunsakerauthor=E.+W.+Chanauthor=M.+Merchantauthor=S.+Kharbandaauthor=K.+E.+Gascoigneauthor=S.+Kaufmanauthor=M.+H.+Beresiniauthor=J.+Liaoauthor=W.+Liuauthor=K.+X.+Chenauthor=Z.+Chenauthor=A.+R.+Coneryauthor=A.+Coteauthor=H.+Jayaramauthor=Y.+Jiangauthor=J.+R.+Kieferauthor=T.+Kleinheinzauthor=Y.+Liauthor=J.+Maherauthor=E.+Pardoauthor=F.+Poyauthor=K.+L.+Spillaneauthor=F.+Wangauthor=J.+Wangauthor=X.+Weiauthor=Z.+Xuauthor=Z.+Xuauthor=I.+Yenauthor=L.+Zawadzkeauthor=X.+Zhuauthor=S.+Bellonauthor=R.+Cummingsauthor=A.+G.+Cochranauthor=B.+K.+Albrechtauthor=S.+Magnuson&title=Discovery+of+a+potent+and+selective+in+vivo+probe+%28GNE-272%29+for+the+bromodomains+of+CBP%2FEP300&doi=10.1021%2Facs.jmedchem.6b01022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300</span></div><div class="casAuthors">Crawford, Terry D.; Romero, F. Anthony; Lai, Kwong Wah; Tsui, Vickie; Taylor, Alexander M.; de Leon Boenig, Gladys; Noland, Cameron L.; Murray, Jeremy; Ly, Justin; Choo, Edna F.; Hunsaker, Thomas L.; Chan, Emily W.; Merchant, Mark; Kharbanda, Samir; Gascoigne, Karen E.; Kaufman, Susan; Beresini, Maureen H.; Liao, Jiangpeng; Liu, Wenfeng; Chen, Kevin X.; Chen, Zhongguo; Conery, Andrew R.; Cote, Alexandre; Jayaram, Hariharan; Jiang, Ying; Kiefer, James R.; Kleinheinz, Tracy; Li, Yingjie; Maher, Jonathan; Pardo, Eneida; Poy, Florence; Spillane, Kerry L.; Wang, Fei; Wang, Jian; Wei, Xiaocang; Xu, Zhaowu; Xu, Zhongya; Yen, Ivana; Zawadzke, Laura; Zhu, Xiaoyu; Bellon, Steven; Cummings, Richard; Cochran, Andrea G.; Albrecht, Brian K.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10549-10563</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation.  A co-crystal structure of a ligand-efficient screening hit and the CBP bromodomain guided initial design targeting the LPF shelf, ZA loop, and acetylated lysine binding regions.  Structure-activity relationship studies allowed the authors to identify a more potent analog.  Optimization of permeability and microsomal stability and subsequent improvement of mouse hepatocyte stability afforded 59 (GNE-272, TR-FRET IC50 = 0.02 μM, BRET IC50 = 0.41 μM, BRD4(1) IC50 = 13 μM) that retained the best balance of cell potency, selectivity, and in vivo PK.  GNE-272 showed a marked antiproliferative effect in hematol. cancer cell lines and modulates MYC expression in vivo that corresponds with antitumor activity in an AML tumor model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6T5ODn2Q-2LVg90H21EOLACvtfcHk0lhNEfZsvbH8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGhsb%252FO&md5=22ed46cb031022aa6aff23c20d07e7dd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01022%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DNoland%26aufirst%3DC.%2BL.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DLy%26aufirst%3DJ.%26aulast%3DChoo%26aufirst%3DE.%2BF.%26aulast%3DHunsaker%26aufirst%3DT.%2BL.%26aulast%3DChan%26aufirst%3DE.%2BW.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSpillane%26aufirst%3DK.%2BL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYen%26aufirst%3DI.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520in%2520vivo%2520probe%2520%2528GNE-272%2529%2520for%2520the%2520bromodomains%2520of%2520CBP%252FEP300%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10549%26epage%3D10563%26doi%3D10.1021%2Facs.jmedchem.6b01022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawant-Basak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttle, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dounay, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawadzke, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salafia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rago, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1039/C2MD20166F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1039%2FC2MD20166F" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=125-129&author=J.+L.+Hendersonauthor=A.+Sawant-Basakauthor=J.+B.+Tuttleauthor=A.+B.+Dounayauthor=L.+A.+McAllisterauthor=J.+Panditauthor=S.+Rongauthor=X.+Houauthor=B.+M.+Bechleauthor=J.-Y.+Kimauthor=V.+Parikhauthor=S.+Ghoshauthor=E.+Evrardauthor=L.+E.+Zawadzkeauthor=M.+A.+Salafiaauthor=B.+Ragoauthor=R.+S.+Obachauthor=A.+Clarkauthor=K.+R.+Fonsecaauthor=C.+Changauthor=P.+R.+Verhoest&title=Discovery+of+hydroxamate+bioisosteres+as+KAT+II+inhibitors+with+improved+oral+bioavailability+and+pharmacokinetics&doi=10.1039%2FC2MD20166F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1039%2FC2MD20166F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20166F%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DSawant-Basak%26aufirst%3DA.%26aulast%3DTuttle%26aufirst%3DJ.%2BB.%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DMcAllister%26aufirst%3DL.%2BA.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DRong%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DKim%26aufirst%3DJ.-Y.%26aulast%3DParikh%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DSalafia%26aufirst%3DM.%2BA.%26aulast%3DRago%26aufirst%3DB.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DClark%26aufirst%3DA.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDiscovery%2520of%2520hydroxamate%2520bioisosteres%2520as%2520KAT%2520II%2520inhibitors%2520with%2520improved%2520oral%2520bioavailability%2520and%2520pharmacokinetics%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D125%26epage%3D129%26doi%3D10.1039%2FC2MD20166F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mascitti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boustany-Kari, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenotic, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leininger, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masterson, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preville, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">She, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobol, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steppan, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuma, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugnait, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2952</span>– <span class="NLM_lpage">2960</span>, <span class="refDoi"> DOI: 10.1021/jm200049r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200049r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVCntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2952-2960&author=V.+Mascittiauthor=T.+S.+Maurerauthor=R.+P.+Robinsonauthor=J.+Bianauthor=C.+M.+Boustany-Kariauthor=T.+Brandtauthor=B.+M.+Collmanauthor=A.+S.+Kalgutkarauthor=M.+K.+Klenoticauthor=M.+T.+Leiningerauthor=A.+Loweauthor=R.+J.+Maguireauthor=V.+M.+Mastersonauthor=Z.+Miaoauthor=E.+Mukaiyamaauthor=J.+D.+Patelauthor=J.+C.+Pettersenauthor=C.+Previlleauthor=B.+Samasauthor=L.+Sheauthor=Z.+Sobolauthor=C.+M.+Steppanauthor=B.+D.+Stevensauthor=B.+A.+Thumaauthor=M.+Tugnaitauthor=D.+Zengauthor=T.+Zhu&title=Discovery+of+a+clinical+candidate+from+the+structurally+unique+dioxa-bicyclo%5B3.2.1%5Doctane+class+of+sodium-dependent+glucose+cotransporter+2+inhibitors&doi=10.1021%2Fjm200049r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors</span></div><div class="casAuthors">Mascitti, Vincent; Maurer, Tristan S.; Robinson, Ralph P.; Bian, Jianwei; Boustany-Kari, Carine M.; Brandt, Thomas; Collman, Benjamin M.; Kalgutkar, Amit S.; Klenotic, Michelle K.; Leininger, Michael T.; Lowe, Andre; Maguire, Robert J.; Masterson, Victoria M.; Miao, Zhuang; Mukaiyama, Emi; Patel, Jigna D.; Pettersen, John C.; Preville, Cathy; Samas, Brian; She, Li; Sobol, Zhanna; Steppan, Claire M.; Stevens, Benjamin D.; Thuma, Benjamin A.; Tugnait, Meera; Zeng, Dongxiang; Zhu, Tong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2952-2960</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">PF-04971729 (I) belongs to a new class of potent and selective sodium-dependent glucose cotransporter 2 inhibitors incorporating a unique dioxa-bicyclo[3.2.1]octane (bridged ketal) ring system.  In this paper we present the design, synthesis, preclin. evaluation, and human dose predictions related to I.  This compd. demonstrated robust urinary glucose excretion in rats and an excellent preclin. safety profile.  It is currently in phase 2 clin. trials and is being evaluated for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoytwz0hHDVmrVg90H21EOLACvtfcHk0lhNEfZsvbH8vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVCntrY%253D&md5=80e156d19d3a6a87a61dca59cc1a0e99</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm200049r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200049r%26sid%3Dliteratum%253Aachs%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DBrandt%26aufirst%3DT.%26aulast%3DCollman%26aufirst%3DB.%2BM.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKlenotic%26aufirst%3DM.%2BK.%26aulast%3DLeininger%26aufirst%3DM.%2BT.%26aulast%3DLowe%26aufirst%3DA.%26aulast%3DMaguire%26aufirst%3DR.%2BJ.%26aulast%3DMasterson%26aufirst%3DV.%2BM.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DMukaiyama%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DJ.%2BD.%26aulast%3DPettersen%26aufirst%3DJ.%2BC.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DSamas%26aufirst%3DB.%26aulast%3DShe%26aufirst%3DL.%26aulast%3DSobol%26aufirst%3DZ.%26aulast%3DSteppan%26aufirst%3DC.%2BM.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DThuma%26aufirst%3DB.%2BA.%26aulast%3DTugnait%26aufirst%3DM.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520a%2520clinical%2520candidate%2520from%2520the%2520structurally%2520unique%2520dioxa-bicyclo%255B3.2.1%255Doctane%2520class%2520of%2520sodium-dependent%2520glucose%2520cotransporter%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2952%26epage%3D2960%26doi%3D10.1021%2Fjm200049r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship (SAR): effort towards blocking N-glucuronidation of indazoles (PF-03376056) by human UGT1A enzymes</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.2174/187231209787176371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.2174%2F187231209787176371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=19356114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=28-34&author=K.+Roseauthor=Y.+S.+Yangauthor=R.+Sciottiauthor=H.+Cai&title=Structure-activity+relationship+%28SAR%29%3A+effort+towards+blocking+N-glucuronidation+of+indazoles+%28PF-03376056%29+by+human+UGT1A+enzymes&doi=10.2174%2F187231209787176371"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship (SAR): effort towards blocking N-glucuronidation of indazoles (PF-03376056) by human UGT1A enzymes</span></div><div class="casAuthors">Rose, Kelly; Yang, Young-Sun; Sciotti, Richard; Cai, Hongliang</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">GyrATPase is a cellular enzyme that has been used as an antibacterial target for treatment of nosocomial and community acquired bacterial infections.  The leading chem. series targeted at inhibiting this enzyme, indazoles, were rapidly cleared in rats (CL > 70 mL/min/kg).  The predominant metabolite identified in both urine and bile samples from a bile duct-cannulated study corresponded to direct glucuronidation of the parent compd. and was excreted rapidly.  Subsequently, a carefully designed analog was used to pinpoint the site of glucuronidation (N-glucuronidation) by incubation with rat hepatocytes and followed by mass spectrometry anal.  Reaction mapping with an array of recombinant UGT isoenzymes revealed that N-glucuronidation was predominantly catalyzed by the UGT1A family of enzymes.  Based on the results, the following approaches were considered to reduce or eliminate glucuronidation: 1) adding sterically hindered substitutions on the Ph ring of the indazole core; 2) changing the electron distribution by substituting with electron-dontaing or-withdrawing groups; 3) replacing the site of glucuronidation.  The resulted compds. were evaluated in vitro in rat hepatocytes to assess their metabolic stabilities followed by in vivo efficacy studies in the murine peritonitis sepsis model (at 50 mg/kg) for selected compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWWg2vSxGL57Vg90H21EOLACvtfcHk0lg1yI0_JF9dOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSgsbk%253D&md5=314aed3e65d2a899ad591e076ef93bcb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2174%2F187231209787176371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231209787176371%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DY.%2BS.%26aulast%3DSciotti%26aufirst%3DR.%26aulast%3DCai%26aufirst%3DH.%26atitle%3DStructure-activity%2520relationship%2520%2528SAR%2529%253A%2520effort%2520towards%2520blocking%2520N-glucuronidation%2520of%2520indazoles%2520%2528PF-03376056%2529%2520by%2520human%2520UGT1A%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2009%26volume%3D3%26spage%3D28%26epage%3D34%26doi%3D10.2174%2F187231209787176371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takenaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamei, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasumori, T.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship in O-glucuronidation of indolocarbazole analogs</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1124/dmd.30.5.494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fdmd.30.5.494" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=494-497&author=N.+Takenagaauthor=M.+Ishiiauthor=T.+Kameiauthor=T.+Yasumori&title=Structure-activity+relationship+in+O-glucuronidation+of+indolocarbazole+analogs&doi=10.1124%2Fdmd.30.5.494"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.5.494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.5.494%26sid%3Dliteratum%253Aachs%26aulast%3DTakenaga%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DKamei%26aufirst%3DT.%26aulast%3DYasumori%26aufirst%3DT.%26atitle%3DStructure-activity%2520relationship%2520in%2520O-glucuronidation%2520of%2520indolocarbazole%2520analogs%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D494%26epage%3D497%26doi%3D10.1124%2Fdmd.30.5.494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rais, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burzynski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusher, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, T.</span></span> <span> </span><span class="NLM_article-title">Structure–metabolism relationships in the glucuronidation of d-amino acid oxidase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1253</span>, <span class="refDoi"> DOI: 10.1021/ml500335z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500335z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1251-1253&author=S.+C.+Zimmermannauthor=R.+Raisauthor=J.+Altauthor=C.+Burzynskiauthor=B.+S.+Slusherauthor=T.+Tsukamoto&title=Structure%E2%80%93metabolism+relationships+in+the+glucuronidation+of+d-amino+acid+oxidase+inhibitors&doi=10.1021%2Fml500335z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fml500335z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500335z%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DS.%2BC.%26aulast%3DRais%26aufirst%3DR.%26aulast%3DAlt%26aufirst%3DJ.%26aulast%3DBurzynski%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DTsukamoto%26aufirst%3DT.%26atitle%3DStructure%25E2%2580%2593metabolism%2520relationships%2520in%2520the%2520glucuronidation%2520of%2520d-amino%2520acid%2520oxidase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1251%26epage%3D1253%26doi%3D10.1021%2Fml500335z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatia, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summers, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriques, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holms, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolasa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratajczyk, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazdiyasni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdesky, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeNinno, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maki, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships of <i>N</i>-hydroxyurea 5-lipoxygenase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1955</span>– <span class="NLM_lpage">1968</span>, <span class="refDoi"> DOI: 10.1021/jm9700474</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9700474" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1955-1968&author=A.+O.+Stewartauthor=P.+A.+Bhatiaauthor=J.+G.+Martinauthor=J.+B.+Summersauthor=K.+E.+Rodriquesauthor=M.+B.+Martinauthor=J.+H.+Holmsauthor=J.+L.+Mooreauthor=R.+A.+Craigauthor=T.+Kolasaauthor=J.+D.+Ratajczykauthor=H.+Mazdiyasniauthor=F.+A.+Kerdeskyauthor=S.+L.+DeNinnoauthor=R.+G.+Makiauthor=J.+B.+Bouskaauthor=P.+R.+Youngauthor=C.+Lanniauthor=R.+L.+Bellauthor=G.+W.+Carterauthor=C.+D.+Brooks&title=Structure-activity+relationships+of+N-hydroxyurea+5-lipoxygenase+inhibitors&doi=10.1021%2Fjm9700474"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm9700474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9700474%26sid%3Dliteratum%253Aachs%26aulast%3DStewart%26aufirst%3DA.%2BO.%26aulast%3DBhatia%26aufirst%3DP.%2BA.%26aulast%3DMartin%26aufirst%3DJ.%2BG.%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DRodriques%26aufirst%3DK.%2BE.%26aulast%3DMartin%26aufirst%3DM.%2BB.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DMoore%26aufirst%3DJ.%2BL.%26aulast%3DCraig%26aufirst%3DR.%2BA.%26aulast%3DKolasa%26aufirst%3DT.%26aulast%3DRatajczyk%26aufirst%3DJ.%2BD.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DKerdesky%26aufirst%3DF.%2BA.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DMaki%26aufirst%3DR.%2BG.%26aulast%3DBouska%26aufirst%3DJ.%2BB.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DBell%26aufirst%3DR.%2BL.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26aulast%3DBrooks%26aufirst%3DC.%2BD.%26atitle%3DStructure-activity%2520relationships%2520of%2520N-hydroxyurea%25205-lipoxygenase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1955%26epage%3D1968%26doi%3D10.1021%2Fjm9700474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reuter, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1021/ci7002494</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci7002494" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1-24&author=K.%0AA.+Brameldauthor=B.+Kuhnauthor=D.+C.+Reuterauthor=M.+Stahl&title=Small+molecule+conformational+preferences+derived+from+crystal+structure+data.+A+medicinal+chemistry+focused+analysis&doi=10.1021%2Fci7002494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule conformational preferences derived from crystal structure data. a medicinal chemistry focused analysis</span></div><div class="casAuthors">Brameld, Ken A.; Kuhn, Bernd; Reuter, Deborah C.; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-24</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Based on torsion angle distributions of frequently occurring substructures, conformation preferences of druglike mols. are presented, accompanied by a review of the relevant literature.  First, the relevance of the Cambridge Structural Database (CSD) for drug design is demonstrated by comparing substructures present in compds. entering clin. trials with those found in the CSD and protein-bound ligands in the Protein Data Bank (PDB).  Next, we briefly highlight preferred conformations of elementary acyclic systems, followed by a discussion of sulfonamide conformations.  Due to their central role in medicinal chem., we discuss properties of aryl ring substituents in depth, including biaryl systems and systems of two aryl rings connected by two acyclic bonds.  For a subset of torsion motifs, we also compare torsion angle histograms derived from CSD structures with those derived from ligands in the PDB.  Furthermore, selected properties of some six- and seven-membered ring systems are discussed.  The article closes with a section on attractive sulfur-oxygen contacts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBrdvMrRvKirVg90H21EOLACvtfcHk0lg1yI0_JF9dOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksV2isA%253D%253D&md5=289969338dcb94a145ce736d19d05cf4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci7002494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci7002494%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DReuter%26aufirst%3DD.%2BC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DSmall%2520molecule%2520conformational%2520preferences%2520derived%2520from%2520crystal%2520structure%2520data.%2520A%2520medicinal%2520chemistry%2520focused%2520analysis%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D1%26epage%3D24%26doi%3D10.1021%2Fci7002494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="note"><p class="first last">Solubility was measured at Analiza, Ohio, USA; compounds were added to 50 mM sodium phosphate buffer (pH 7.4), stirred for 24 h, filtered, and the dissolved concentration determined by nitrogen detection.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilan, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salah, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bastacky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zinker, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poucher, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tofovic, S. P.</span></span> <span> </span><span class="NLM_article-title">Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats</span>. <i>J. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1530/JOE-11-0122</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1530%2FJOE-11-0122" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=21680617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOhtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2011&pages=293-308&author=V.+P.+Bilanauthor=E.+M.+Salahauthor=S.+Bastackyauthor=H.+B.+Jonesauthor=R.+M.+Mayersauthor=B.+Zinkerauthor=S.+M.+Poucherauthor=S.+P.+Tofovic&title=Diabetic+nephropathy+and+long-term+treatment+effects+of+rosiglitazone+and+enalapril+in+obese+ZSF1+rats&doi=10.1530%2FJOE-11-0122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats</span></div><div class="casAuthors">Bilan, Victor P.; Salah, Eman M.; Bastacky, Sheldon; Jones, Huw B.; Mayers, Rachel M.; Zinker, Bradley; Poucher, Simon M.; Tofovic, Stevan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-308</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">BioScientifica Ltd.</span>)
        </div><div class="casAbstract">Diabetic nephropathy (DN) is a major cause of end-stage renal disease.  Yet the pathogenic mechanisms underlying the development of DN are not fully defined, partially due to lack of suitable models that mimic the complex pathogenesis of renal disease in diabetic patients.  In this study, we describe early and late renal manifestations of DN and renal responses to long-term treatments with rosiglitazone or high-dose enalapril in ZSF1 rats, a model of metabolic syndrome, diabetes, and chronic renal disease.  At 8 wk of age, obese ZSF1 rats developed metabolic syndrome and diabetes (hyperglycemia, glucosuria, hyperlipidemia, and hypertension) and early signs of renal disease (proteinuria, glomerular collagen IV deposition, tubulointerstitial inflammation, and renal hypertrophy).  By 32 wk of age, animals developed renal histopathol. consistent with DN, including mesangial expansion, glomerulosclerosis, tubulointerstitial inflammation and fibrosis, tubular dilation and atrophy, and arteriolar thickening.  Rosiglitazone markedly increased body wt. but reduced food intake, improved glucose control, and attenuated hyperlipidemia and liver and kidney injury.  In contrast, rosiglitazone markedly increased cardiac hypertrophy via a blood pressure-independent mechanism.  High-dose enalapril did not improve glucose homeostasis, but normalized blood pressure, and nearly prevented diabetic renal injury.  The ZSF1 model thus detects the clin. observations seen with rosiglitazone and enalapril in terms of primary and secondary endpoints of cardiac and renal effects.  This and previous reports indicate that the obese ZSF1 rat meets currently accepted criteria for progressive exptl. diabetic renal disease in rodents, suggesting that this may be the best available rat model for simulation of human DN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbsfPXctq-mbVg90H21EOLACvtfcHk0lgJ-lqi3v0tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOhtL7N&md5=0dd45862d740985f1417234d4df8344d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1530%2FJOE-11-0122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FJOE-11-0122%26sid%3Dliteratum%253Aachs%26aulast%3DBilan%26aufirst%3DV.%2BP.%26aulast%3DSalah%26aufirst%3DE.%2BM.%26aulast%3DBastacky%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DH.%2BB.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DZinker%26aufirst%3DB.%26aulast%3DPoucher%26aufirst%3DS.%2BM.%26aulast%3DTofovic%26aufirst%3DS.%2BP.%26atitle%3DDiabetic%2520nephropathy%2520and%2520long-term%2520treatment%2520effects%2520of%2520rosiglitazone%2520and%2520enalapril%2520in%2520obese%2520ZSF1%2520rats%26jtitle%3DJ.%2520Endocrinol.%26date%3D2011%26volume%3D210%26spage%3D293%26epage%3D308%26doi%3D10.1530%2FJOE-11-0122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boustany-Kari, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lincoln, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueneva-Boucheva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosanac, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richman, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pullen, S. S.</span></span> <span> </span><span class="NLM_article-title">A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1124/jpet.115.230706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=10.1124%2Fjpet.115.230706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=26729306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;key=1%3ACAS%3A528%3ADC%252BC28XpvVelu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2016&pages=712-719&author=C.+M.+Boustany-Kariauthor=P.+C.+Harrisonauthor=H.+Chenauthor=K.+A.+Lincolnauthor=H.+S.+Qianauthor=H.+Cliffordauthor=H.+Wangauthor=X.+Zhangauthor=K.+Gueneva-Bouchevaauthor=T.+Bosanacauthor=D.+Wongauthor=R.+M.+Fryerauthor=J.+G.+Richmanauthor=C.+Sarkoauthor=S.+S.+Pullen&title=A+soluble+guanylate+cyclase+activator+inhibits+the+progression+of+diabetic+nephropathy+in+the+ZSF1+rat&doi=10.1124%2Fjpet.115.230706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A soluble guanylate cyclase activator inhibits the progression of diabetic nephropathy in the ZSF1 rat</span></div><div class="casAuthors">Boustany-Kari, Carine M.; Harrison, Paul C.; Chen, Hongxing; Lincoln, Kathleen A.; Qian, Hu Sheng; Clifford, Holly; Wang, Hong; Zhang, Xiaomei; Gueneva-Boucheva, Kristina; Bosanac, Todd; Wong, Diane; Fryer, Ryan M.; Richman, Jeremy G.; Sarko, Chris; Pullen, Steven S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Therapies that restore renal cGMP levels are hypothesized to slow the progression of diabetic nephropathy.  We investigated the effect of BI 703704, a sol. guanylate cyclase (sGC) activator, on disease progression in obese ZSF1 rats.  BI 703704 was administered at doses of 0.3, 1, 3, and 10 mg/kg/d to male ZSF1 rats for 15 wk, during which mean arterial pressure (MAP), heart rate (HR), and urinary protein excretion (UPE) were detd.  Histol. assessment of glomerular and interstitial lesions was also performed.  Renal cGMP levels were quantified as an indicator of target modulation.  BI 703704 resulted in sGC activation, as evidenced by dose-dependent increases in renal cGMP levels.  After 15 wk of treatment, sGC activation resulted in dose-dependent decreases in UPE (from 463 ± 58 mg/d in vehicle controls to 328 ± 55, 348 ± 23, 283 ± 45, and 108 ± 23 mg/d in BI 703704-treated rats at 0.3, 1, 3, and 10 mg/kg, resp.).  These effects were accompanied by a significant redn. in the incidence of glomerulosclerosis and interstitial lesions.  Decreases in MAP and increases in HR were only obsd. at the high dose of BI 703704.  These results are the first demonstration of renal protection with sGC activation in a nephropathy model induced by type 2 diabetes.  Importantly, beneficial effects were obsd. at doses that did not significantly alter MAP and HR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriDtsMxLG1NLVg90H21EOLACvtfcHk0lgJ-lqi3v0tYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpvVelu7Y%253D&md5=638e527952bd81b55d7d70ecaa3e1786</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230706%26sid%3Dliteratum%253Aachs%26aulast%3DBoustany-Kari%26aufirst%3DC.%2BM.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLincoln%26aufirst%3DK.%2BA.%26aulast%3DQian%26aufirst%3DH.%2BS.%26aulast%3DClifford%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGueneva-Boucheva%26aufirst%3DK.%26aulast%3DBosanac%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DRichman%26aufirst%3DJ.%2BG.%26aulast%3DSarko%26aufirst%3DC.%26aulast%3DPullen%26aufirst%3DS.%2BS.%26atitle%3DA%2520soluble%2520guanylate%2520cyclase%2520activator%2520inhibits%2520the%2520progression%2520of%2520diabetic%2520nephropathy%2520in%2520the%2520ZSF1%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D356%26spage%3D712%26epage%3D719%26doi%3D10.1124%2Fjpet.115.230706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5','PDB','5KQ5'); return false;">PDB: 5KQ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T','PDB','5T5T'); return false;">PDB: 5T5T</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01641">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07210"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01641">10.1021/acs.jmedchem.7b01641</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional experimental and characterization data for compound synthesis; experimental details for the SPR assay, the in vitro OAT uptake assays, the in vivo PK studies, and the in vivo ZSF-1 rat study; additional AMPK isoform pharmacology data including dose response curves and confidence intervals for the FRET and SPR assays; plasma protein binding data for compounds tested in vivo (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_001.pdf">jm7b01641_si_001.pdf (1.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01641/suppl_file/jm7b01641_si_002.csv">jm7b01641_si_002.csv (0.77 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structure coordinates for compounds <b>1</b> and <b>14</b> have been deposited to the RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>, accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KQ5">5KQ5</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5T5T">5T5T</a>, respectively). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01641&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01641%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01641" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799ba628cf33cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
